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Abstract 
Inflammatory airway disease (IAD) is a common performance limiting pulmonary 
disorder in young racehorses in training. Although the precise aetiopathogenesis is 
poorly understood, proposed mechanisms include opportunistic bacterial infections 
and/or suboptimal air-hygiene. Since alveolar macrophages (AMs) are the first line 
defence in the lungs of mammalian species, they may constitute an appropriate 
therapeutic target cell in the treatment and the prevention of opportunistic airway 
infections. This thesis aimed to investigate the basic biology of the equine AM. A 
series of experiments were conducted to investigate the function and phenotype of 
this cell and comparisons made with equine macrophages derived from other 
anatomical sites and macrophage datasets derived from other species. The lung 
environment is unique, and may direct a unique phenotype and function compared 
with macrophages derived from other sites. Macrophages were isolated from the 
lungs, peritoneal cavity and other regions of healthy horses. Excellent cell recovery 
was demonstrated and associated with good viability, RNA yield and a demonstrable 
response to several stimuli, both when fresh and following cryopreservation. AMs 
produced tumor necrosis factor alpha (TNFα) when stimulated with 
lipopolysaccharide (LPS), polyinosinic-polycytidylic acid (Poly IC) and heat-killed 
Salmonella typhimurium and were actively phagocytic.  By comparison, peritoneal 
macrophages (PMs) did not respond to these inducers and lacked phagocytic activity. 
In contrast to AMs, which showed high expression of the specific macrophage 
markers cluster of differentiation (CD) 14, CD163 and toll-like receptor 4 (TLR4), 
PMs lacked CD14.  Moreover, gene expression analysis revealed an alternative 
macrophage activation for AMs, whereas PM showed a hybrid macrophage 
activation potentially attributed to the phenomenon of endotoxin tolerance. 
The response of equine AMs to LPS was analysed using microarrays. There was 
significant change in the expression of 240 genes.  Those that were upregulated 
included well known inflammatory genes such as TNFα, IL1A and CXCL6. The 
pattern of response more closely resembled human and pig macrophages than mouse, 
including the LPS-induced expression of STAT4, IDO, IL7R genes and the failure to 
produce nitrite in response to LPS. These data suggest that the horse may represent a 
 
  x 
suitable animal model for human macrophage-associated lung inflammation, and 
conversely that data from humans may translate to horses.  
A final aim of this study was to investigate the effect of exercise on equine AM 
function. Therefore, AMs were isolated from bronchoalveolar lavage samples 
obtained from Standardbred racehorses at rest and during the training period and 
microarray analysis performed. Despite important limitations of the study, a few 
mechanisms at the molecular level were detected which may be involved in the 
development of either training-associated symptoms of, or susceptibility to IAD. 
Overall, this thesis aims to improve our understanding of equine macrophage biology 
and to provide useful information regarding the role of AMs in exercise-associated 
inflammation. Moreover, the findings presented here may help to inform future 
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Chapter 1: Introduction 
1.1 Macrophage biology and the mononuclear 
phagocyte system 
Macrophages (from Greek “μακρόν” meaning big and “φαγείν” meaning to eat) are 
large leukocytes (white blood cells) that comprise 10-15% of all cells in most organs 
of all animal species (Hume et al., 2002, Gordon and Taylor, 2005, Hume, 2008a). 
They were originally identified in the 19
th
 century by Metchnikoff, who 
distinguished them from related microphages, now known more commonly as 
granulocytes or polymorphonuclear (PMN) leukocytes.  They are mononuclear, in 
contrast with the apparent multinuclearity of PMN cells (Kaufmann, 2008). Their 
numbers increase in tissues through extravasation and/or local proliferation in 
response to inflammation, injury and malignancy and they play a crucial role in 
tissue remodelling and the innate and adaptive immune system (Hume, 2006).  
Macrophage functions include antigen presentation, phagocytosis, cytokine 
production, microbicidal activity, tissue repair and the general regulation of tissue 
homeostasis (Figure 1.1). The population of macrophages and their progenitors in 
the whole body defines the mononuclear phagocyte system (MPS) (Volkman and 
Gowans, 1965, Hume et al., 2002, Hume, 2008b). The MPS of adults consists of 
cells originating from bone marrow progenitor cells that become monocytes 
circulating in the blood.  Monocytes may enter tissues during inflammation and may 
differentiate into tissue resident phagocytes (Hume et al., 2002). Cells of the MPS 
may present in any tissue type (Gordon and Taylor, 2005) 
(http://www.macrophages.com/category/imagelibrary/macrophage-images/tissue-
macrophages). Table 1.1 lists the main cells that comprise the MPS in adults. 
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Mononuclear phagocytes Anatomical site 
Osteoclasts Bone matrix 
Monocytes Bone marrow, blood, can migrate to any tissues 
Histiocytes Connective tissue 
Macrophages of the central 
nervous system 
Central nervous system  
Microglial cells Parenchyma of the central nervous system 
Meningeal macrophages Meninges 
Choroid plexus macrophages Interface between the blood and the cerebrospinal fluid in the 
brain  
Lung macrophages Lungs 
Alveolar macrophages Airway wall of the pulmonary alveolus 
Pulmonary intravascular 
macrophages (not detected in 
healthy humans/mice, but present 
in horse, pig, sheep and other 
mammals) 
Capillary endothelium on the thicker side of the alveolar septum 
Interstitial macrophages Lung parenchyma 
Perivascular macrophages Small blood vessels 
Peritoneal macrophages Peritoneal cavity 
Intestinal macrophages Lamina propria 
Thymic macrophages Thymus 
Kupffer cells Liver, vascular sinuses, attached to the outer surface of 
endothelial cells 
Splenic macrophages  Spleen 
Red pulp macrophages Spleen red pulp 
Marginal zone macrophages Spleen marginal zone 
White pulp macrophages  Spleen white pulp 
Metallophilic macrophages Surround the splenic white pulp, adjacent to the marginal sinus 
Tingible body macrophages Spleen white pulp, germinal centres of lymph nodes  
Pleural macrophages Pleural cavity 
Dendritic cells (DCs) Skin, inner lining of the nose, lungs, stomach, lamina propria, 
lymph nodes 
Langerhans cells  Epidermal layer of the skin 
 
Table 1.1:  Main types of cells comprising the mononuclear phagocyte system in adult mammals. 
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Figure 1.2 shows a schematic diagram of macrophage development and 
differentiation in rodents (Gordon and Taylor, 2005). During development, murine 
macrophages appear first in the yolk sac, where they seem to arise through a distinct 
pathway that does not require the haemapoietic transcription factor, c-myb 
(Vanfurth, 1992, Schulz et al., 2012).  Subsequently, definitive haematopoiesis in 
mammals arises in the aorta-gonad-mesonephros and then the liver, where the 
classical blood monocytes are produced, differentiate to macrophages and migrate 
throughout the embryo (Lichanska and Hume, 2000). Later in development, 
haematopoiesis commences within bone marrow and bone marrow derived 
monocytes (BMDMs) appear in the blood (Vanfurth, 1992, Lichanska and Hume, 
2000).The granulocyte macrophage colony forming unit (GM-CFU) that derives 
from the haematopoietic stem cell (HSC) develops into the macrophage colony 
forming unit (M-CFU) and subsequently into the monoblast and the pro-monocyte, 
that are the progenitors of the monocyte/macrophage (Gordon and Taylor, 2005). 
 
Figure 1.2 Origin of the murine mononuclear phagocyte system.  
Figure adapted from Gordon et al (2005). HSC: haematopoietic stem cell, GM-CFU: 
granulocyte/macrophage colony-forming unit, M-CFU, macrophage colony-forming unit. 
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The concept that tissue macrophages are renewed from monocytes or adult 
haemopoietic progenitors in the steady state has recently been challenged (Merad et 
al., 2002, Ajami et al., 2007, Hashimoto et al., 2013). Lineage-trace studies suggest 
that brain, lung, splenic red pulp, peritoneal and bone marrow tissue macrophages in 
the mouse do not originate from monocytes (Schulz et al., 2012, Hashimoto et al., 
2013, Yona et al., 2013). As an example, no macrophages are detected in the lungs of 
mice before birth.  Rather they are derived from fetal monocytes and adopt their final 
mature phenotype post-natally (Guilliams et al., 2013). This maturation requires 
strong input from colony stimulating factor 2 (CSF2) and takes around seven days, 
with mature AMs appearing within the lungs 1-3 days following birth. Afterwards 
they are self-maintained in the lung milieu throughout life and do not require a 
significant degree of blood monocyte differentiation (Guilliams et al., 2013).  
 
1.1.1 Important factors of haemopoietic regulation 
The proliferation and differentiation of blood cells is controlled by hormone-like 
regulators collectively called colony stimulating factors (CSFs) (Hamilton and 
Achuthan, 2013). These include macrophage-CSF (M-CSF, commonly known as 
CSF1), granulocyte macrophage-CSF (GM-CSF, commonly known as CSF2) and 
granulocyte-CSF (G-CSF, commonly known as CSF3), responsible for the 
differentiation and proliferation of stem cells into myeloid cell types (Bradley et al., 
1967, Hamilton and Achuthan, 2013). The last is responsible for neutrophil 
production and proliferation and although difficult to detect in blood, is secreted to a 
greater extent during infectious or inflammatory conditions (Roberts, 2005, 
Hamilton, 2008). CSF2 promotes the differentiation, proliferation and activation of 
granulocytes, macrophages and dendritic cells (DCs) and can act as a 
proinflammatory cytokine (Hamilton, 2008); whereas CSF1 promotes differentiation 
proliferation and maintenance of the monocyte/macrophage lineage (Hamilton and 
Achuthan, 2013).  In addition to its proinflammatory function, CSF1 also has anti-
inflammatory activities (Hamilton, 2008). Its receptor, CSF1R (M-CSFR, CD115 or 
FMS), is expressed by all cells of the MPS (Table 1.1) and their progenitors and is 
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essential for the differentiation of HSCs into monocyte/macrophages (Cecchini et al., 
1997).  
CSF1 can interact with other factors, including CSF2, the FMS-like tyrosine kinase 3 
ligand (FLT3L), interleukin 3 (IL3) and receptor activator of nuclear factor kappa-B 
ligand (RANKL) (Barton and Mayer, 1989, McKenna et al., 2000, Yao et al., 2002, 
D'Amico and Wu, 2003, Chitu and Stanley, 2006, Fleetwood et al., 2007, Bonifer 
and Hume, 2008, Hume, 2008b), resulting in the generation of specific subsets such 
as DCs or osteoclasts and the initiation of emergency haematopoiesis in response to 
pathogen challenge. CSF2 may have a specific function in the lung, since deficiency 
of this factor in humans and mice leads to alveolar proteinosis (Nishinakamura et al., 
1995, Kitamura et al., 1999). The central importance of CSF1 is evident from 
mutations of either Csf1 or Csf1r genes in rodents, which generates macrophage and 
osteoclast insufficiency and has severe pleiotropic effects on multiple organ systems 
(Chitu and Stanley, 2006, Hume, 2008b, Gow et al., 2010). Recently, IL34, an 
alternative CSF1R ligand, has been discovered (Lin et al., 2008), explaining the fact 
that a CSF1R mutant has a more severe phenotype than a CSF1 mutation (Dai et al, 
2002).  IL34 seems to have a non-redundant function in development of certain 
macrophage populations. IL34-deficient mice had reduced Langerhans and microglia 
cells and a compromised immune response to skin antigens and viral infection of the 
central nervous system (Marks and Lane, 1976, Wang et al., 2012).  
Other factors such as IL6, the transcription factor PU.1 (responsible for CSF1R 
expression) and the cytokine stem cell factor, also contribute to 
monocyte/macrophage differentiation, although to a lesser extent (Chomarat et al., 
2000, Hume et al., 2002, Gordon and Taylor, 2005, Pollard, 2009). Most knowledge 
of haemopoietic regulation derives from mouse and human studies.  This project 
deals specifically with the MPS of the horse.  There is limited information on the 
function of macrophage growth factors in this species. Sequence variation in 
mammalian CSF1 and IL34 sequences has been shown to influence species cross-
reactivity (Gow et al., 2013).  Equine CSF1 has not yet been fully cloned and 
expressed. Equine IL34, on the other hand, has been sequenced, and the predicted 
protein is 75% conserved with human/primates (differing mainly in the final 10-13 
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C-terminal amino acids), 86% with cattle and 71% with mice.  Recombinant human 
(rh) CSF1 is active on all species-derived cells previously tested (Garceau et al., 
2010, Kapetanovic et al., 2012, Gow et al., 2013). Other groups have also 
successfully used rhCSF1 in addition to rhRANKL to grow equine osteoclasts from 
equine spongy bone and bone marrow cells (Perrotti et al., 2009, Gray et al., 2002). 
Equine CSF2 has been cloned and unlike the equivalent murine growth factor, was 
found to cross-react with human cells, consistent with the high level of sequence 
conservation (83.7% of nucleotides) (Vecchione et al., 2002, Steinbach et al., 2005). 
Interestingly, equine CSF2 protein differs from the equivalent factor in other 
mammals through an altered signal peptide, which generates a distinct N-terminus, 
and a frame-shift and alternative stop codon at the 3’ end of the messenger 
ribonucleic acid (mRNA), which adds eight C-terminal amino acids (Mauel et al., 
2006). While equine CSF2 was active on a human factor-dependent cell line (a cell 
line entirely dependent on the continuous presence of one or more of growth factors), 
a much higher concentration of the human factor was required to stimulate equine 
cells, indicating the effects of subtle sequence variations on receptor affinity 
(Hammond et al., 1999b, Vecchione et al., 2002).  Equine CSF2 in combination with 
IL4 has also been used to drive equine monocyte differentiation towards DCs (Mauel 
et al., 2006).  
 
1.2 Markers of the mononuclear phagocyte system 
Mononuclear phagocytes (MPCs) share stellate morphology and characteristic 
location in tissue (Hume, 2006). They secrete certain enzymes (nonspecific esterase, 
lysosomal hydrolases, ectoenzymes) which can be identified by histochemical assays 
and possess numerous endocytic receptors, especially for the Fc portion of 
immunoglobulin and complement coated particles (Hume, 2006).  Monoclonal 
antibody technologies, which have significantly improved cell surface protein 
identification, have been useful in defining mononuclear phagocytes, yet have also 
illustrated the remarkable phenotypic diversity of these cells (Hume et al., 2002, 
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Taylor et al., 2005, Hume, 2008a). This diversity is a significant focus of this project, 
which examines the phenotypic specialisation of macrophages in different tissues of 
the horse. The majority of published work on macrophage markers has studied mice 
and humans (Table 1.2). This section will focus on what is known about markers in 
these species, before reviewing in detail what is known about the equine system. 
Full name Official gene 
symbol 
Synonyms 
Chemokine (C-C motif) receptor 1 CCR1 CD191, CKR-1, MIP1aR 
Chemokine (C-C motif) receptor 2 CCR2 CC-CKR-2, CD192, CKR2, 
FLJ78302, MCP-1-R 
Chemokine (C-X3-C motif) receptor 1 CX3CR1 CCRL1, CMKDR1, V28 
Cluster of differentiation 14 CD14 _ 
Cluster of differentiation 163 CD163 M130, MM130 
Fc fragment of IgG, low affinity III (a and b), 
receptor 
FCGR3A  and 
FCGR3B 
CD16 (CD16a and CD16b) 
Colony stimulating factor 1 receptor CSF1R C-FMS, CD115, CSFR 
Epidermal growth factor -like module containing, 
mucin-like, hormone receptor-like 1 
EMR1 F4/80  
Integrin, alpha M (complement component 3 
receptor 3 subunit) 
ITGAM CD11b, MAC-1 
Integrin, alpha X (complement component 3 
receptor 4 subunit) 
ITGAX CD11c 
lymphocyte antigen 6 complex Ly6C _ 
Sialophorin SPN CD43, GPL115, 
"leukosialin", LSN 
Signal-regulatory protein alpha SIRPA CD172α, BIT, MFR, MYD-




Table 1.2: Main monocyte/macrophage markers studied in mice and human. 
Information for this table was based on the Hugo gene nomenclature committee 
(http://www.genenames.org/) 
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Numerous cell surface markers, including EMR1, CSF1R, CD14, CD16, CD11b, 
CD11c, Ly6C and several chemokine receptors (CCR1,CCR2, CX3CR1) have been 
used to categorise MPCs in blood and tissues into functional subgroups in mammals 
(Gordon and Taylor, 2005, Hume, 2006). Nevertheless, not all markers are 
consistently expressed on the same mononuclear phagocyte subtypes in different 
species, nor do they even exist in some cases (Gordon and Taylor, 2005).  
For instance, EMR1, part of the EGF-TM7 family which also includes CD97 
(Gordon et al., 1986) and considered a pan-macrophage marker, is encoded by the 
EMR1 gene.  Mice have only two EMR members (EMR1 and 4) while humans have 
four (EMR1-4) (Kwakkenbos et al., 2004).  Human monocytes express EMR1-3, 
while EMR3 is expressed in granulocytes (Kwakkenbos et al., 2004, Matmati et al., 
2007). It is likely that the human EMR4 gene mutated to a pseudogene and became 
inactive after Pan-Homo divergence (Hamann et al., 2003). In mice, EMR1 and 
EMR4 are also well studied (Stacey et al., 2002, Schaller et al., 2002). Schaller et al 
(2002) demonstrated that EMR1 deficient mice failed to show any functional 
abnormality, perhaps because another member of the EGF-TM7 family, such as 
EMR4, might compensate for the deficiency (Schaller et al., 2002, Stacey et al., 
2002). Nevertheless, in a later study EMR1 knockout mice showed a significant 
deficiency in the differentiation of regulatory T (Treg) cells, which highlighted the 
role of EMR1 in immunological tolerance (Lin et al., 2005).   
The CD16, is highly expressed on subsets of human, porcine and equine monocytes  
(Ingersoll et al., 2010, Noronha et al., 2012, Fairbairn et al., 2013a). CD16 has been 
used as a marker in humans to distinguish subpopulations of blood monocytes 
(Passlick et al., 1989, Ziegler-Heitbrock, 2000, Ziegler-Heitbrock et al., 2010) but it 
has also been detected on natural killer (NK) cells and PMNs (Ravetch and Perussia, 
1989).  The CD16 gene is duplicated (CD16a and CD16b) in the genome of most 
humans, but not in mouse, and one of the genes encodes a 
glycosylphosphatidylinositol (GPI) anchored form of the protein. CD16 is a low 
affinity Fc receptor that is shown to have a vital role in the inflammatory and 
immune responses of many species (Hazenbos et al., 1996, Galon et al., 1996). CD16 
deficient mice showed impaired function of immune cells and a defective 
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inflammatory response (Hazenbos et al., 1996) and copy number polymorphism of 
CD16 is related to susceptibility to disease in both humans and rats (Aitman et al., 
2006). 
The most widely-used marker for the separation of monocytes from PBMCs is 
CD14.  CD14 is the receptor for lipopolysaccharide (LPS) , lipopolysaccharide-
binding protein (LBP) and toll like receptor 4 (TLR4) (Steinemann et al., 1994). It is 
a GPI anchored protein expressed highly on the cell surface of most monocytes and 
macrophages (Peterson et al., 1995, AntalSzalmas et al., 1997, Liu et al., 1998, 
Nanbo et al., 1999), although it is also detected to a lesser extent on human and 
murine neutrophils and B-cells (Chaby et al., 1984, Haziot et al., 1993, AntalSzalmas 
et al., 1997).  Equine CD14 has been cloned and sequenced, and the mRNA is 
expressed by horse monocytes (Kabithe et al., 2010). The coding sequence shares 
high homology with human CD14 and the antihuman CD14 antibody was found to 
cross-react with equine monocytes in several studies (Steinbach et al., 2005, Durán et 
al., 2013). 
Another important marker for the detection of MPS is CSF1R. Anti-CSF1R has been 
used to detect monocytes and macrophages in mice and humans (Hume and 
MacDonald, 2012), and a CSF1R-EGFP transgene provides a convenient marker in 
mice (Sasmono et al., 2003). Thus far, anti-CSF1R antibody is not available for the 
horse.  Anti-pig CSF1R, produced in our group (Manuscript submitted), and anti-
human CD115 (unpublished) apparently did not cross-react.  
CD163 is a haemoglobin scavenger receptor that plays a role in the endocytosis of 
human haptoglobin–haemoglobin complexes and is specifically expressed on 
monocytes and tissue macrophages (Kristiansen et al., 2001).  Moreover, it acts as an 
erythroblast adhesion receptor (Fabriek et al., 2007), a receptor for the TNF-like 
weak inducer of apoptosis (Bover et al., 2007) and as a gram positive and gram 
negative bacterial sensor (Fabriek et al., 2009).  Apart from membrane bound 
CD163, it also exists in a soluble form (Moller et al., 2002). In man, CD163 is most 
highly-expressed in the CD14
++ 
classical monocytes, but CSF1 augments the 
expression of CD163 in all monocyte subsets (Tippett et al., 2011). Mouse monocyte 






 seem not to differentially express CD163 (Ingersoll et al., 
2010), while in the rat CD163 is expressed in tissue macrophages but not in 
monocytes (Polfliet et al., 2006).  Similar to humans, by using antihuman CD163 
monoclonal antibody, it was shown that both equine monocytes and tissue 
macrophages express CD163 (Yamate et al., 2000, Steinbach et al., 2005). CD163 
has a vital role in the modulation of the immune response and is considered to be a 
marker of anti-inflammatory macrophage activation (Komohara et al., 2006). 
Numerous factors have been reported so far to regulate its cell surface expression 
(Kowal et al., 2011). The anti-inflammatory factors IL10 and glucorticoids (Sulahian 
et al., 2000), the pro and anti-inflammatory cytokine IL6 (Weaver et al., 2007) and 
CSF1 enhance CD163 expression (Tippett et al., 2011), whereas other 
proinflammatory [tumor necrosis factor alpha (TNFα), IL1, interferon gamma 
(IFNγ)] and anti-inflammatory mediators [IL4, IL13, transforming growth factor beta 
(TGFβ)], as well as other factors (LPS, hypoxia) downregulate its expression  
(Weaver et al., 2007, Kowal et al., 2011). It is detected in several pathologic tissues 
and macrophages in humans and other species (Yamate et al., 2000, Tippett et al., 
2011). In horses, CD163 was associated with wound healing and tissue repair 
(Lefebvre-Lavoie et al., 2005) and it was also detected in laminar tissue of horses 
with laminitis (Faleiros et al., 2011) and in intestinal macrophages from horses with 
large colon ischaemia (Grosche et al., 2011). 
 
1.3 Monocyte subsets 
Monocytes are commonly distinguished from other mononuclear cells (lymphocytes 
and natural killer cells) based upon the presence of the surface marker CD14, but 
they vary significantly in size, granularity and nuclear morphology. As noted above, 
monocytes can also be subdivided into distinct subclasses based upon additional 
markers. The available markers differ between species. CD16 antibodies, were found 









cells (Passlick et al., 1989). In addition to their phenotypic 
differences, these subsets had functional differences, characterised by different gene 
Characterisation of the equine macrophage/monocyte 
 12 
expression profiles (Ingersoll et al., 2010, Passlick et al., 1989).  The subsets differ in 
their level of CD14 expression, and subsequent analysis defined a third subset 




, consists of a 
small population which is enhanced under cytokine stimulation and inflammatory 
conditions (Ellery et al., 2007, Ancuta et al., 2003, Weiner et al., 1994). The 
International Union of Immunological Societies and the World Health Organization 
adopted a nomenclature in which the three blood monocyte subsets were defined as 













 (Ziegler-Heitbrock et al., 2010).  This distinction is 
clearly somewhat arbitrary, and there is no absolute delineation on a fluorescence 
activated cell sorting between “low” and “high” for any of the markers (Ziegler-
Heitbrock et al., 2010). A developmental relationship is believed to exist between the 
different monocyte subsets; the intermediate subset arises from classical monocytes 
in response to CSF1 or during infection (Weiner et al., 1994, Ziegler-Heitbrock et al., 
2010).  The populations have different functions and gene expression profiles and 
respond differently to infections (Table 1.3) (Geissmann et al., 2010, Wong et al., 
2012, Wong et al., 2011).  A recent detailed promoter-based analysis indicates that 
the large majority of “markers” do actually exhibit a gradient of expression, either 
increasing or decreasing in parallel with the variation in CD14 and CD16, strongly 
supporting the view that subsets are no more than a differentiation series (Schmidl et 
al., 2014).    
Human Monocyte subset Monocyte percentage Main functions 









 5% T cell activation 
  Reactive oxygen species 
production 
  Angiogenesis 




++ 10% T cell activation 
 
Table 1.3: The human monocyte subsets nomenclature and their main functions. 
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Murine monocytes have also been subdivided into three different subpopulations that 
adopt the same nomenclature as human monocytes (classical, intermediate and non- 
classical), and have similar functions (Ziegler-Heitbrock et al., 2010). Moreover, the 
same developmental relationship seems to exist between the murine monocyte 
subsets, since the nonclassical subset is apparently derived from the classical subset 
(Sunderkötter et al., 2004).  Unlike humans and horses, mice do not have duplicated 
CD16 gene, CD16 is not used as a marker and CD14 is not as highly-regulated 
(Ziegler-Heitbrock et al., 2010). The most widely-used marker is Ly6C, although 
other markers, such as CD43 and the chemokine receptors CCR2 and CX3CR1, have 
also been used (Ziegler-Heitbrock et al., 2010). Monocytes with high Ly6C 




), those with 










). Murine monocytes with high Ly6C expression share many 
similarities in their gene expression profile with human CD14
+
 monocytes (Ingersoll 
et al., 2010), while those with low Ly6C expression were initially thought to 
contribute to tissue macrophage recruitment (Auffray et al., 2007, Auffray et al., 
2009), but more recently have been considered as an end-stage blood macrophage 
that “patrols” the vessel wall (Auffray et al., 2007, Auffray et al., 2009, Yona et al., 
2013). 
In the pig, blood monocytes have been also subdivided into two main subpopulations 
based on their expression of CD14, CD16, CD163 and CD172α (Fairbairn et al., 









subpopulations in approximately equal numbers (Fairbairn et al., 
2013a). Microarray analysis of these two subpopulations followed by comparisons 
with human and murine monocyte subpopulations suggested that there was no clear 




cells were more 
“intermediate” in their phenotype (Fairbairn et al., 2013a) (Table 1.4).  
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Human Mouse Pig 




































 Not detected 
 
Table 1.4: The monocyte subset nomenclature of human, mouse and pig and their association. 
 
There has been limited analysis of equine monocytes, but variation in CD14 and 
CD16 expression amongst monocyte “subsets” has been reported (Noronha et al., 
2012). As early as 1976, horse monocytes were found to be a more appropriate 
source of indicator cells for human migration-inhibiting factor assays than guinea pig 
monocytes, which were previously the population of choice (Friedrich et al., 1976). 
A recent study divided equine monocyte-derived DCs into two different 
subpopulations; the immature DCs and the mature DCs (Moyo et al., 2013). In this 
study, equine monocytes differentiated into immature DCs via CSF2 and IL4 
stimulation and into mature DCs via stimulation with a cytokine cocktail [TNFα, 
IL6, IL1β, prostaglandin E2 (PGE2) and IFNγ] (Moyo et al., 2013, Durán et al., 
2013). Subsequent microarray analysis confirmed a clear distinction between these 
two cell subsets (Moyo et al., 2013). In contrast to human DCs, the mature cells did 
not express high levels of the traditional DC markers CD83 and CD206 (Moyo et al., 
2013). 
 
1.4 Macrophage activation 
Macrophages, as an integral part of the MPS, detect and attempt to destroy potential 
pathogens, while alerting other components of the immune system (Kapetanovic and 
Cavaillon, 2007). Almost by definition, a successful pathogen evades macrophage-
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mediated killing.  Many pathogens do so by replicating within the phagocytes, 
despite being internalised (Friedrich et al., 2012). Macrophage recognition of 
pathogens is dependent on their expression of a range of cell surface and intracellular 
receptors, including the toll-like receptor (TLRs) and nucleotide oligomerisation 
domain classes (Taylor et al., 2005, Brooks et al., 2011, Akira and Sato, 2003).  
These receptors distinguish “non-self” by binding to molecules that are conserved 
amongst broad classes of pathogens but are absent in the host, the so called 
pathogen-associated molecular patterns (PAMPs). Furthermore, innate immune cells 
recognise molecules found in the extracellular environment in response to injury, the 
damage-associated molecular patterns (Tang et al., 2012).  
The well characterised PAMPs include the following: LPS, a structural component of 
gram negative bacterial cell walls, detected by TLR4 and co-receptors CD14 and 
myeloid differentiation protein-2 (MD2); microbial lipoproteins, recognized by 
heterodimers of TLR2-TLR1 or TLR2-TLR6; single or double stranded RNA, 
recognised byTLR3 and RIGI; flagellin, recognised by TLR5; unmethylated DNA, 
recognised by TLR9 (Akira and Sato, 2003, O'Neill, 2006). In response to PAMP-
mediated pathogen recognition, macrophages and other cells initiate a complex 
signalling cascade that leads to secretion of numerous effector molecules that in turn 
promote recruitment and activation of other cells to the process of inflammation 
(Hume, 2008b, Akira and Sato, 2003). This type of macrophage activation, mediated 
via TLRs and the T cell cytokine IFNγ, is widely known as classical activation 
(Mantovani et al., 2004). It is characterised by enhanced microbicidal-tumoricidal 
activity and proinflammatory cytokine (TNFα, IL1, IL12) and mediator (CXCL9, 
CXCL10, C-C chemokine receptor type 7) release (Mosser and Edwards, 2010, 
Mantovani et al., 2004).  
An alternative activation phenotype is linked predominantly to the actions of the 
cytokines IL4 and IL13 (Mantovani et al., 2004, Gordon and Martinez, 2010). 
Alternative activation of macrophages is associated with distinct physiologic and 
pathologic conditions, such as wound healing, fibrosis, malignancy, hypersensitivity, 
parasitic infection and even homeostasis (Gordon and Martinez, 2010, Chawla, 2010, 
Mantovani et al., 2013). Based upon the relationship to the Th1 and Th2 states of T 
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helper cell function, these macrophage states have been referred to as M1 and M2, 
respectively, summarised in (Figure 1.3) (Gordon and Martinez, 2010, Mantovani et 
al., 2013).  However, others have argued that the macrophage activation states are 
considerably more variable, and reflect the massive diversity of possible stimuli 
(Mosser and Edwards, 2010).  Moreover, global meta-analysis of mouse and human 
microarray datasets do not support the idea of any transcriptional signature that is 
linked to the M1 or M2 states (Wells et al., 2003, Mabbott et al., 2010). Macrophages 
are characterised by a high level of plasticity and their regulation depends on 
different environmental challenges (Mosser and Edwards, 2010). Due to the large 
variety of in vivo environmental stimuli that macrophages interact with, several 
hybrid macrophage activations states may occur, characterised with an overlapping 
sate between M1 and M2 polarisation. Examples represent tumor associated 
macrophages (Mosser and Edwards, 2010, Biswas and Mantovani, 2010), endotoxin 
tolerant macrophages (Rajaiah et al., 2013, Pena et al., 2011), intestinal macrophages 
(Bain and Mowat, 2011, Mowat, 2011) and Kupffer cells (Hafenrichter et al., 1994). 
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Figure 1.3: Classical and alternative activation of macrophages.  
Classical macrophage activation (M1) is induced by TNFα,  LPS or other PAMPs and results in a Th1 
immune response, associated with microbicidal activity, inflammation and tissue damage. Alternative 
macrophage activation (M2) is induced by IL4, IL13, IL21 or  IL33 and results in Th2 cytokine 
production, TGFβ, vascular endothelial growth factors (VEGFs) or matrix metalloproteinases 
(MMPs) secretion. The latter is related to humoral immunity, hypersensitivity, parasitic infections, 
tissue remodelling and repair, angiogenesis, immunoregulation and tumorigenesis. 
 
In contrast to the extensive literature on humans, mice and even pigs (Fairbairn et al., 
2011), there is very limited literature regarding the MPS of the horse, especially at a 
transcriptional level. This thesis constitutes a first step in the investigation of the 
MPS of the horse through the study of the alveolar and peritoneal macrophage (PM) 
response to several stimuli, in particular LPS. It also focuses on the effect of the 
microenvironment on the phenotype and function of different types of equine 
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macrophages, a subject area on which there is a dearth of information compared with 
the human and mouse literature. 
 
1.4.1 The phenomenon of endotoxin tolerance 
As discussed earlier (Section 1.4), innate immune cells respond to pathogen-
associated molecules via pattern recognition receptors, such as TLR4 in the case of 
LPS, and induce inflammation (Steinemann et al., 1994, Lien and Ingalls, 2002). 
Continuous exposure to LPS can result in the extreme production of proinflammatory 
cytokines, such as TNFα, IL1 and IL6, in turn leading to tissue damage, septic shock 
and ultimately death (Hotchkiss and Karl, 2003, Karin et al., 2006).  A natural 
feedback mechanism, referred to as endotoxin tolerance, provides some protection 
against such an occurrence in vivo, thus limiting endotoxin-induced pathology. 
Macrophages/monocytes are critical in endotoxin tolerance as summarised in  Figure 
1.4.  
Endotoxin tolerance is manifest in isolated macrophages. Tolerised mouse or human 
macrophages show a downregulation of several inflammatory cytokines such as 
TNFα, IL6, IL1β and an upregulation of anti-inflammatory cytokines such as IL10 
and TGFβ, as well as of scavenger and c-type lectin receptors, negative regulators 
and antimicrobial genes (del Fresno et al., 2009, Mages et al., 2008, Biswas and 
Lopez-Collazo, 2009), in some ways resembling the so-called alternative 
macrophage activation or M2 phenotype (Deepak et al., 2007). Although antigen 
presentation activity of LPS tolerant macrophages is impaired, phagocytic activity 
remains high (del Fresno et al., 2009). These characteristics were also observed in 
monocytes derived from patients with sepsis (del Fresno et al., 2009, Pachot et al., 
2006). Mouse macrophages and human monocytes become tolerised when exposed 
to LPS (del Fresno et al., 2009, Dobrovolskaia and Vogel, 2002). Del Fresno et al 
(2009) reported that a eight hour exposure of human monocytes to LPS is sufficient 
for them to become refractory to the effects of endotoxin for as long as five days (del 
Fresno et al., 2009).  These results suggest the potential existence of a type of 
“memory’’ in the innate immune system that could be modulated by epigenetic 
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factors (Biswas and Lopez-Collazo, 2009). Several in vivo and in vitro studies have 
been performed in order to mimic the optimal in vivo septic conditions in humans 
and study the endotoxin tolerance of macrophages/monocytes (Biswas and Lopez-
Collazo, 2009, Dobrovolskaia and Vogel, 2002, del Fresno et al., 2009, Mages et al., 
2008). It is suggested that the model of two consecutive endotoxin challenges, 
including a time lapse between them, represents the most appropriate model for 
studying endotoxin tolerance on macrophages/monocytes (Biswas and Lopez-
Collazo, 2009). Thus, the two consecutive challenges are representative of a primary 
and secondary infection that may occur in human patients. 
 
Figure 1.4: Function and phenotype of the endotoxin tolerant macrophage/monocyte.  
After LPS restimulation with the same LPS dose, macrophages become refractory to LPS and 
overexpress anti-inflammatory cytokines, scavenging c-type lectin receptors and antimicrobial genes. 
They show low expression of inflammatory cytokines and have reduced antigen presentation even 
though their phagocytic activity remains high. MARCO: Macrophage receptor with collagenous 
structure, CLEC4a: C-type Lectin domain family 4, member A, FPR1: Formyl peptide receptor 1, 
AOAH: Acyloxyacyl hydrolase, RNASET2: Ribonucelase T2. 
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1.5 Lung macrophages and their microenvironment 
 
1.5.1 Lung microenvironment 
The lung is responsible for gas exchange and the alveoli provide an exceptionally 
large epithelial surface area to facilitate this process. For this reason, the lung is 
exposed to a great variety of aeroallergens and pathogens.  Innate immunity provides 
the first line of defence against pathogens and also interacts with the adaptive 
immune system. It consists of structural defenses, antibacterial substances produced 
in the airways and phagocytosis (Coonrod, 1986). 
Coughing, sneezing, nasal hair, the anatomic nature of the nasopharynx, glottis and 
trachea followed by the branching of bronchi and bronchioles restrict inhaled 
particulates greater than 5μm in diameter from entering the lower airways (Mercer 
and Crapo, 1998). The airway surface also contains complex glycoproteins called 
mucins, which capture the inhaled particulates and transport them to the oropharynx 
where they are swallowed or expectorated. Particles less than 5μm in diameter (e.g. 
microorganisms) can enter the lower airways.  Airway antimicrobial factors are 
produced from ciliated cells and goblet cells of the respiratory epithelium in response 
to these pathogens (Martin et al., 1992, Coonrod, 1986, Hiratsuka et al., 1998, 
Schnapp and Harris, 1998). Examples include lysozyme, complement, 
immunoglobulin (Ig) A and G, fibronectin, defensins, lactoferin and LBP (Coonrod, 
1986, Martin et al., 1992, Hiratsuka et al., 1998, Schnapp and Harris, 1998). These 
substances either have direct anti-microbial activity or stimulate AMs and PMN 
leukocytes to initiate immune defence.  
The lung alveoli consist of type I and type II alveolar epithelial cells (AECs). Type II 
AECs are more cuboidal, whereas type I AECs are thinner and both are self renewed 
and differentiated (Lambrecht, 2006). Lung alveoli are rich in capillaries, separated 
from the type I AECs only by a thin (0.2µm) membrane, thus facilitating efficient 
gas exchange (Lambrecht, 2006).  During inhalation of microorganisms or toxic 
particles there is a high risk of these substances entering the blood. Therefore, in 
order to prevent such an occurrence, a network of immune cells are present to 
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preserve host defence at this level (Lambrecht, 2006). This network is comprised 
mainly of macrophages, but also includes DCs, AECs, lymphocytes and 
polymorphonuclear cells.  AMs reside in the lung alveoli and are the first cells that 
contact inhaled antigens in the airways. AMs alone can cope with the instillation of 
up to 10
9
 bacteria into the trachea before there is any requirement for the adaptive 
immune system to be recruited (Lambrecht, 2006).  
It is important that immune activation is not triggered unnecessarily as inflammation 
and immune cell recruitment can lead to oedema and obstruction of the alveolar wall, 
thus compromising gas exchange. Indeed, given the airway surface area and the 
quantity of foreign particles inhaled on a breath-by-breath basis, it is perhaps 
surprising why the airways are not in a constant state of inflammation. Under normal 
conditions, AMs secrete small amounts of cytokines, have low phagocytic activity, 
low CD11b expression and limited interaction with the adaptive immune system and 
are characterised by an M2 phenotype (Holt, 1978, Jones et al., 2013). Antigen 
presentation and T cell activation are suppressed by the physical separation of 
antigen-presenting cells expressing class II major histocompatibility complex (MHC) 
from AMs, which are adherent to the alveolar wall (Holt et al., 1993), and via AM 
secretion of anti-inflammatory molecules such as TGFβ (Holt et al., 1993). AEC may 
express the integrin aνβ6, which binds the TGFβ and activates it, thereby preventing 
AM activation (Takabayshi et al., 2006, Lambrecht, 2006). Nevertheless, during 
infection AMs are activated by TLRs and detach from the AECs which stop 
expressing avβ6 integrin (Lambrecht, 2006, Takabayshi et al., 2006). Thus AMs may 
be able to switch to become classically-activated macrophages by releasing 
proinflammatory cytokines, inducing phagocytosis and interacting with the adaptive 
immunity (Lambrecht, 2006, Takabayshi et al., 2006).  This pathway is outlined in 
Figure 1.5. 
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Figure 1.5: Mechanism of AM activation. 
During homeostatic conditions AMs are attached to the AECs located on the surface of the alveoli, 
which express avβ6 integrin in a TGFβ dependent way and AM activity is suppressed. Under infection 
the expression of avβ6 integrin is lost and the inhibition of AMs by TGFβ is blocked; thus AMs are 
activated in order to kill the pathogens by phagocytosis and secretion of proinflammatory cytokines. A 
few days after infection, activated T cells trigger the production of the matrix metallopeptidase 9 
(MMP9) by AMs. MMP9 production activates the TGFβ which inhibits AM activation and restores 
homeostasis.  
 
1.5.2 Phenotype and function of alveolar macrophages in 
comparison with macrophages/monocytes from 
different anatomical locations in humans and mice 
At least three types of macrophages have been identified so far in the lungs, the 
AMs, the interstitial macrophages (IMs), and the pulmonary intravascular 
macrophages (PIMs) that are absent in healthy humans and mice (Schneberger et al., 
2012, Laskin et al., 2001).  Published studies have differed as to whether there are 
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significant functional differences between these populations of lung macrophages 
(Bilyk and Holt, 1991, Nibbering et al., 1987, Cai et al., 2014, Bilyk et al., 1988). 
AMs are believed to originate from IMs, are bigger in size with more granules in 
their cytoplasm and they resemble resident tissue macrophages, whereas IMs 
resemble blood monocytes (Laskin et al., 2001). Despite the functional and 
morphological differences between these two cell types, both are essential for lung 
homeostasis and immune response (Laskin et al., 2001, Cai et al., 2014).  
Compared to both blood monocytes and other tissue derived macrophages, a number 
of surface markers are specifically enriched in AMs of several species, (Bosio and 
Dow, 2005, Gonzalez-Juarrero and Orme, 2001, von Garnier et al., 2005). For 
example, in the mouse, AMs showed high expression of CD11c and DEC-205, while 
PMs did not express these two surface markers; rather, they expressed high levels of 
CD11b and EMR1 (Guth et al., 2009). Moreover, DEC-205 has also been found in 
AMs, but not in other types of macrophages (Bilyk and Holt, 1991, Bosio and Dow, 
2005, Bosio et al., 2005). This phenotype seems to resemble that of DCs, which are 
characterised mainly by CD11c, DEC-205, MHC II, CD40, CD80 and CD86.  Sialic 
acid-binding immunoglobulin-like lectin F (SiglecF), a single-pass transmembrane 
surface protein that triggers apoptosis in human eosinophils is also expressed by 
mouse AMs but not by PMs (Feng and Mao, 2012).  





monocytes migrate to the lungs, where expression of CD11c 




, with subsequent 




AMs or immature DCs in the alveolar spaces are activated due to infection and 





macrophages or differentiating DCs (Gonzalez-Juarrero et al., 2003).
 
 
The phenotype of lung macrophages may be partly dependent on the production of 
local cytokines, such as CSF1 and CSF2 (Chen et al., 1988, Higgins et al., 2008, 
Trapnell and Whitsett, 2002).  Apart from CSF2, surfactant protein (SP) D 
contributes to macrophage differentiation in the airway microenvironment.  SPA 
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downregulates the ability of bone marrow derived DCs to develop antigen presenting 
capacities and inhibits macrophage function in mouse or human lungs (Brinker et al., 
2003, Gardai et al., 2003, Janssen et al., 2008, Guth et al., 2009). Therefore, the local 
microenvironment is of major importance for their growth and activity (Gonzalez-
Juarrero et al., 2003). 
There are contradictory views about the interactions between AMs and T cells. One 
view is that AMs have relatively poor antigen presentation activity, presumably 
avoiding excessive lung inflammation (Thepen et al., 1989). In humans, some studies 
claim that AMs are poor at inducing activation of naïve T cells, but active in eliciting 
a recall response.  Others suggest that AMs are effective antigen presentation cells 
for initiation of T cell-mediated immunity (Lipscomb et al., 1986, Lyons et al., 1986, 
Toews et al., 1984, Upham et al., 1997, Weissler et al., 1994, Twigg et al., 1989, 
Nicod et al., 1987).  In response to pathogen challenge, a subset of AMs are able to 
migrate to the lung lymph nodes, in particular at B cell sites, and transfer antigens 
(Kirby et al., 2009). 
AMs also showed a high capacity for macropinocytosis, a feature shared with 
immature DCs and less so by mature tissue macrophages (Sallusto et al., 1995). 
Similar to DCs, the macropinocytosis of AMs was reduced after stimulation with 
LPS, while that of PMs remained unaffected (Sallusto et al., 1995). The same study 
also demonstrated AMs to have a greater antigen presenting capacity compared to 
PMs.  So-called cross-presentation, the processing and presenting of antigens via 
MHC I to CD8
+ 
T cells, has been considered an exclusive function of DCs (Guth et 
al., 2009). Moreover, after 24h culture AMs showed greater stimulation of a mixed 
lymphocyte reaction than PMs (Guth et al., 2009). This level of T cell stimulation 
was comparable to that induced by bone marrow-derived DCs and blood monocyte-
derived DCs (Sallusto et al., 1995). Hence, the consensus is that in some respects 
AMs resemble immature DCs (Guth et al., 2009).  On the other hand, AMs can also 
have immunosuppressive effects.  A least in vitro, AMs are able to inhibit mitogen 
induced proliferation, suppress mixed lymphocyte reactions and restrain tumoricidal 
effects of natural killer (NK) cells and lymphocyte activated killer (LAK) cells (Rich 
et al., 1991, Nicod et al., 1989, Bordignon et al., 1982, Roth and Golub, 1989).  
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AMs also respond to T cell products.  They become activated during acute lung 
infection (probably due to the influx of T cells into the airways) and exhibit 
alterations in chemotaxis, cytotoxicity, phagocytosis and secretion of 
nitrogen/oxygen intermediates, TNFα, IFN and PGE (Holt et al., 1982, Johansson et 
al., 1997, Chandler et al., 1988, Chandler and Brannen, 1990, Steinmuller et al., 
2000, Bilyk et al., 1988, Wizemann and Laskin, 1994, Liu et al., 1997).   
The unique function of AMs, relative to macrophages from other sites and tissues, 
has also been documented using gene expression analysis (Ge et al., 2005, Freeman 
et al., 2012, Heng and Painter, 2008, Khattra et al., 2007, Gautier et al., 2012, Hume 
et al., 2010, Mabbott et al., 2010, Kapetanovic et al., 2013). Recent studies compared 
the expression profiles of AMs with those of blood and marrow-derived cells in the 
pig (Kapetanovic et al., 2013, Freeman et al., 2012).  The AMs were clearly distinct 
in both basal gene expression and response to bacterial LPS. In particular, AMs 
constitutively expressed a range of C-type lectin receptors implicated in 
phagocytosis. Interestingly, the genes that were unique to the AMs were apparently 
not expressed by intestinal macrophages. These findings further support the theory 
that AMs have a unique profile compared to other types of tissue macrophages. 
 
1.6 The equine macrophage and the immune system 
 
1.6.1 Equine bone marrow derived and monocyte derived 
macrophages 
In mice, macrophages are routinely generated in vitro from bone marrow progenitors 
for functional studies (Corraliza et al., 1995, Raza et al., 2008).  This approach has 
recently been extended to the pig, expedited by an ability to freeze cells and culture 
them following recovery (Kapetanovic et al., 2012), but has not yet been applied to 
horses. Bone marrow colony assays have been described, and used to study the 
transforming actions of equine infectious anaemia virus (Swardson et al., 1992).  
Furthermore, a macrophage cell line (e-CAS cells) has been derived from equine 
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bone marrow cells (Werners et al., 2004) and subsequently shown to have phagocytic 
capabilities and responsiveness to CSF2 and LPS.    
In the horse, blood is more easily accessed than bone marrow. Consequently, there 
have been several studies on equine monocytes derived from peripheral blood 
mononuclear cells (PBMCs) and their ability to produce proinflammatory cytokines, 
such as TNFα and IL1, after LPS stimulation (May et al., 1990, Morris, 1991). 
Compared to AMs, equine PBMCs appear more sensitive to low concentrations of 
LPS, potentially consistent with desensitization of AMs by chronic low level 
stimulation (Grunig et al., 1991). Moreover, another study also revealed transforming 
actions of equine infectious anaemia virus on equine blood monocytes (Raabe et al., 
1998). 
In humans and mice, the macrophage response to LPS can be mediated via two 
different pathways; a myeloid differentiation primary response gene 88 (MyD88) 
dependent pathway which induces an inflammatory response and/or a MyD88 
independent pathway which stimulates the induction of type I IFN and IFN inducible 
genes (Kawai et al., 2001, Kawai and Akira, 2007). These pathways appear to be 
conserved in horses.   TNF, IL1β, IL6 induction in equine macrophages/monocytes 
was linked to activation of the MyD88 pathway, while interferon alpha (IFNα), 
interferon gamma-induced protein 10 (IP10) and regulated on activation, normal T 
cell expressed and secreted (RANTES, also known as CCL5) induction were related 
to the TIR-domain-containing adapter-inducing interferon-β (TRIF) dependent 
signaling pathway (Figueiredo et al., 2009, Bjorkbacka et al., 2004, Hirotani et al., 
2005). Even high concentrations of LPS did not significantly activate TRIF-
dependent gene expression of INFα, IP10, RANTES or TNF receptor-associated 
factor 1 (TRAF1) in equine monocytes, suggesting that, in contrast to other studied 
mammalian-derived cells, the response of equine monocytes to LPS mainly occurs 
via the MyD88 pathway (Figueiredo et al., 2009).  
As demonstrated in other mammalian-derived cells, TLR2 ligands induce a mild 
inflammatory response by equine PBMCs, compared to the much greater response to 
TLR4 agonists (Fureix et al., 2012, Gombart, 2009).  Equine monocytes are also 
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responsive to TLR3 stimulation with double stranded RNA [polyinosinic 
polycytidylic acid (Poly IC)] (Kwon et al., 2010), which is dependent upon the TRIF 
adaptor.  In contrast, horse monocytes do not apparently express TLR5, which 
explains their lack of response to flagellin (Kwon et al., 2011).  
 
1.6.2 Equine peritoneal macrophages 
The peritoneal cavity is another major source of macrophages for functional studies 
in rodents, in many cases following injection of an irritant or infectious agent 
(Nomura et al., 2000).  It has also been used as a source of human macrophages 
(Halme, 1989) and pigs (Paul et al., 1979). The function of peritoneal-derived 
macrophages is unclear; although it is likely to be influenced by their proximity to 
the gastro-intestinal organs and may act as a defence against any breach of the 
integrity of the intestinal wall which may result in exposure to microflora and various 
bacterial-derived products (Qin et al., 2010). Equine peritoneal macrophages 
stimulated with LPS produced a significant amount of prostanoids and 
proinflammatory cytokines (Morris and Moore, 1987, Morris et al., 1990, Morris et 
al., 1992), but did not produce NO (Hawkins et al., 1998). The LPS-induced response 
could be suppressed by high concentrations of dexamethasone (100 µM), as well as 
by the anti-inflammatory cytokine IL10 (Morris et al., 1991, Hawkins et al., 1998). 
Interestingly, LPS-induced TNF production from PMs harvested from healthy horses 
was significantly increased compared to PMs derived from horses with acute 
gastrointestinal disease, leading to the suggestion that PMs harvested from 
endotoxaemic horses are likely to exhibit early endotoxin tolerance (Barton et al., 
1996).  
 
1.6.3 Macrophages of the equine lung 
Bronchoalveolar lavage in horses is a practical and commonly used method of 
obtaining macrophages without causing harm to the animal. Consequently, there are 
several published studies of AMs in this species.  Bacteria such as Streptococcus 
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zooepidemicus, Streptococcus pneumoniae and Pasteurella/Actinobacillus species 
constitute opportunistic pathogens in the equine airway, triggering the respiratory 
immune system and inducing inflammation (Wood et al., 1993, Burrell et al., 1996). 
LPS, a significant component of organic dust derived from equine bedding and 
forage, is considered a major factor for the induction of airway inflammation in 
stabled horses (Andonegui et al., 2003).  
Werners and Bryant (2012) reviewed the limited literature relating to structure-
function relationships amongst pattern recognition receptors in horses (Werners and 
Bryant, 2012).  Early studies found that equine AMs produced large amounts of 
TNFα in response to LPS, but were significantly less responsive to bacterial LPS 
than blood monocytes, requiring 100-fold higher concentration to induce 
procoagulant activity (Grunig et al., 1991). Suri et al (2006) demonstrated that 
TLR4, but not TLR2, is constitutively expressed in healthy horse lungs, with TLR2 
being induced by LPS in interstitial macrophages (Suri et al., 2006), a finding also 
reported in murine, human and porcine macrophages (Schroder et al., 2012, Henneke 
et al., 2002, Fairbairn et al., 2011). Recently, Waldschmidt et al (2013) reported that, 
in contrast to equine skeletal muscle tissue cells, equine AMs responded efficiently 
to TLR2, 3, and 4 ligands (Waldschmidt et al., 2013). TLR9, the receptor that 
recognizes unmethylated CpG oligodeoxynucleotide DNA (Rutz et al., 2004) is 
expressed by equine lung cells including interstitial and alveolar macrophages and its 
expression is also upregulated by LPS stimulation (Schneberger et al., 2009). 
Similarly, TLR9 is expressed in mouse and human lung macrophages and enhanced 
by LPS (Rutherford et al., 1993, Schneberger et al., 2013).   
Lung macrophages may be the primary or secondary site of infection and/or the 
source of inflammatory cytokines in several important viral diseases including 
equine arteritis virus, equine influenza, and equine herpesvirus 2 (Schlocker et al., 
1995, Moore et al., 2003). Both interstitial and alveolar macrophages are thought to 
contribute to airway inflammation in recurrent airway obstruction (RAO), a common 
environmental respiratory disease in adult horses. Certain hay dust-derived 
components, including endotoxin and fungal spores, activate macrophages and 
induce chemokines such as IL8 and macrophage inflammatory protein 2 (MIP2) or 
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CXCL2 (Laan et al., 2006, Aharonson-Raz and Singh) and subsequent neutrophil 
recruitment (Baggiolini, 1992, Yan et al., 1998, Geiser et al., 1993, Thomsen et al., 
1991, Watanabe et al., 1991, Franchini et al., 2000, Franchini et al., 1998). The 
neutrophil accumulation in turn leads to free radical and protease-mediated tissue 
damage, a process also seen in human studies (VanWetering et al., 1997, Dallegri et 
al., 1995, Cavarra et al., 1996).   
There is some debate as to whether NO is amongst the free radicals produced by 
horse macrophages.  NO, a product of inducible nitric oxide synthase (iNOS), is a 
major effector secreted by activated macrophages in rodents, but is not produced by 
human or porcine macrophages (Kapetanovic et al., 2012, Schneemann et al., 1993). 
Human and porcine macrophages stimulated with LPS instead metabolise tryptophan 
through the induction of indoleamine dioxygenase (encoded by the IDO gene), 
kynurenine hydroxylase and kynureninase (KYNU), while mouse macrophages do 
not use this pathway (Silva et al., 2002, Mellor and Munn, 2004, Kapetanovic et al., 
2012). Whilst Hammond et al (1999) reported an increase in iNOS mRNA in equine 
AMs after LPS challenge and suggested that the enzyme might be a therapeutic 
target (Hammond et al., 1999a), others did not reproduce this finding (Johnson et al., 
1997).  
Whereas normal mouse and human lungs have no PIMs, they are detected in the 
capillary endothelium of horses and other species such as cattle, pig and sheep and 
are recognized as a member of the MPS (Aharonson-Raz and Singh, Singh and de la 
Concha-Bermejillo, 1998, Schneberger et al., 2012). Equine PIMs are considered as 
proinflammatory cells that play a critical role in equine lung inflammation, since they 
phagocytose LPS and secrete the proinflammatory cytokines TNFα and IL1β in 
response to LPS (Parbhakar et al., 2005). Depletion of equine PIMs by gadolinium 
chloride resulted in a decreased severity of LPS-induced lung inflammation, reflected 
in a reduced mean pulmonary arterial pressure and lower IL1β production in PIM-
depleted horses compared to controls (Parbhakar et al., 2005). Furthermore, 
depletion of PIMs in horses affected with RAO resulted in a reduction in both 
clinical symptoms and lung inflammation, characterised by a reduced airway 
neutrophil count and a decrease in IL8 and TLR4 mRNA detected in airway-derived 
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cells (Aharonson-Raz et al., 2012). Equine PIMs have been shown to express TLR9 
and TLR4 and the expression of TLR9 and 2 was augmented after LPS treatment 
(Schneberger et al., 2013, Suri et al., 2006).PIMs could have a unique role in 
pulmonary immunity since they are capable of directly responding to inflammatory 
stimuli within both the airway and intravascular compartments and may partly 
explain the recognised susceptibility of the horse to endotoxaemia (Schneberger et 
al., 2012). Although PIMs are not observed in healthy humans, there is evidence of 
their existence in patients with liver disorders, whereby it has been suggested that 
they are involved in the hypersensitivity of the airways in response to endotoxaemia 
(Schneberger et al., 2012). 
 
1.7 Horse as an animal model for human disease 
research 
The mouse is the most widely used animal model for studying human disease, but 
there are many differences between murine and human pathophysiology 
(Schneemann et al., 1993, Schneemann and Schoeden, 2007, Junhee et al., 2013). In 
addition to obvious environmental, anatomical, pathophysiological and genetic 
differences between mice and humans, there are many distinctions in their innate 
immune responses (Kapetanovic et al., 2012, Schneemann and Schoeden, 2007, 
Schneemann et al., 1993, Heinz et al., 2003, Schroder et al., 2012) with specific 
relevance to mechanistic differences in common inflammatory conditions such as 
trauma, burns or endotoxaemia (Junhee et al., 2013).Hence, there is an increasing 
demand for novel animal models (e.g. pig), which more closely resemble human 
pathophysiology than rodents (Lunney, 2007, Spurlock and Gabler, 2008, Fairbairn 
et al., 2011), to facilitate research into various human diseases.  
Horses have already been used as models for several human diseases, including 
metabolic syndrome, allergy, chronic obstructive pulmonary disease (COPD), 
musculoskeletal diseases cancer and even autoimmune uveitis (Turlej et al., 2001, 
Seltenhammer et al., 2004, Deeg et al., 2007, Hodavance et al., 2007, Koch and 
Betts, 2007). Although the practical and financial costs associated with equine 
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research (through feeding, housing and handling) are considerable compared to 
rodent research and the investigation of large sample populations is problematic, 
there are significant advantages associated with the use of the horse as a model for 
human research (Table 1.5) (Turlej et al., 2001, Snapper, 1986, Bureau et al., 2000). 
Many genes involved in immune function are more closely related between human 
and horse, than between human and mouse (Milenkovic et al., 2002, Steinbach et al., 
2005, Tompkins et al., 2010). Milenkovic and others (2002) identified 113 conserved 
segments between equine and human genome (Milenkovic et al., 2002). For 
example,  IL2 showed 72% identity with human and both IL23 and IL17 showed 
greater nucleotide sequence identity with human (89% and 84%, respectively) than 
mouse (77% and 75%, respectively) (Tompkins et al., 2010). Similarly, equine IFNγ-
induced chemokine CXCL9 has 86% homology with human, but only 74% with the 
mouse (Hudgens et al., 2011). With specific relevance to macrophages, the equine 
CSF1R is similar to the human CSF1R, containing 21 exons which code a 968 amino 
acid protein within a 30kb region (Roberts et al., 1988, Yarden and Ullrich, 1988, 
Beck et al., 2005). In addition, Steinbach et al (2005) demonstrated both the capacity 
for equine CSF2 to induce proliferation of a human TF-1 cell line and cross-
reactivity of antihuman monoclonal antibodies against CD14, CD163 and CD206 
with horse PBMCs (Steinbach et al., 2005).  
Chowdhary et al (2003) were the first to study the radiation hybrid map of the horse 
genome and found the level of human-horse synteny (preserved order of genes on 
chromosomes of related species which results from descent from a common 
ancestor) to be greater than the level of mouse-horse synteny (Chowdhary et al., 
2003). Interestingly, almost half the number of horse chromosomes showed 
conserved synteny to one human chromosome (Wade et al., 2009). Several other 
comparative genome studies have shown high conservation between horse and 
human chromosomes (Raudsepp et al., 1996, Raudsepp et al., 2002, Roenne, 1992). 
For example, Raudsepp and colleagues (1996) found that the majority of equine 
chromosomes show homology to human chromosomes, whereas later (2002) the 
same group demonstrated high conservation of gene order between horse and human 
chromosome X. 
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Despite extensive research on equine inflammatory diseases, specific information on 
the equine MPS is lacking, largely due to the limited availability of appropriate 
molecular reagents. Consequently, many previous studies have relied on the 
successful use of cross-reactive human reagents (Steinbach et al., 2005, Ibrahim et 
al., 2007). With the development of genomic/transcriptomic resources for the horse 
(http://www.affymetrix.com, http://www.uky.edu/Ag/Horsemap) (see more 
discussion below) and emerging data from numerous other large mammals (human, 
pig, cattle, sheep), it is now increasingly possible to address what is known, and what 
is not known, about the innate immune system of the horse in comparison to other 
species.   
Horses are valuable animals requiring considerable investment from their owners.  
This is particularly true of racing Thoroughbreds, in which morbidity of any kind can 
result in substantial financial losses.  Horses can suffer from an extensive range of 
infectious and inflammatory diseases, some of which are zoonotic, others of which 
share certain clinical and pathological features with equivalent human diseases 
(Couetil et al., 2007, Sitterle et al., 2012, Traversa et al., 2012).  More than 100 
equine hereditable conditions may serve as models for human disorders, including 
inflammation, muscular or fertility disorders, osteoarthritis and even depression 
(http://omia.angis.org.au, 2009, Carnevale, 2008, Fureix et al., 2012). Furthermore, 
racehorses resemble elite human athletes and can suffer similar consequences in 
terms of repetitive injuries and exercise-associated pathology, including arthritis and 
respiratory tract infections. Therefore in using the horse as an appropriate model for 
human disease, there is the likelihood that discoveries will have direct benefits for 
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Table 1.5 : Comparisons of horse and mouse models for human diseases. 
 
Comments Horse Mouse References 
General Body, organ, liter size Closer to human Less (Ibrahim et al., 2007, 
Steinbach et al., 2005) 
Breeding costs High Low 
Sample population, possible 
experiment repetition 
Small Big 
Availability of immunological 
tools/reagents 
Limited High 
Genetic Homology of protein coded genes 
with human 
High Low (Milenkovic et al., 
2002, Chowdhary et al., 
2003, Raudsepp et al., 
1996, Raudsepp et al., 
2002) 
Human CD16 is replicated Replicated Not replicated 
Syntenies with human High Low 
Chromosome  conservation with 
human 
High Low 
Genome annotation Poor High 
 Macrophage 
Biology 
CD14+CD16+ monocytes observed in 
humans 
Detected Not detected (Fingerle et al., 1993, 
Sunderkotter et al., 
2004, Noronha et al., 
2012, Hawkins et al., 
1998, Weinberg et al., 
1995, Ito et al., 2005) 
No nitric oxide but  indoleamine-
pyrrole 2,3-dioxygenase production 
by human macrophages   
Similar Less similar 
Diseases >100 hereditary conditions served as 
models for humans 
Yes No (Morrison and Ulevitch, 
1978, Morris, 1991, 
http://omia.angis.org.au, 
2009, Capomaccio et 
al., 2011, Langley and 
Morris, 2009, Koch and 
Betts, 2007, Fureix et 
al., 2012, Turlej et al., 
2001, Shin et al., 2009, 
Hodavance et al., 2007) 
Musculoskeletal disorders-
osteoarthritis 
Common Less common 
Human endotoxaemia -sepsis 
pathophysiology 
Similar Less similar 
Asthma – Chronic obstructive 
pulmonary disease pathophysiology  
Similar Less similar 
Human exercise pathophysiology / 
immunology 
Similar Less similar 
Human infectious diseases   Similar Less similar 
Human depression Similar Less similar 
Human metabolic diseases  Similar Less similar   
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1.7.1 Genome and microarray analysis in the horse 
The development of useful transcriptomic resources for the horse was dependent 
upon genomic sequences.  Efforts to sequence the equine genome started in 1995 
with the Equine Gene Mapping Workshop (Ramery et al., 2009). In 2006, an attempt 
was made to derive a high quality genome sequence from a female thoroughbred 
(http://www.board.mit.edu/mammals/horse). Almost 2.7 billion bp of genome 
sequences were released by the Broad Institute 
(http://www.broad.mit.edu/mammals/horse).  Some parts of the horse genome 
remained difficult to sequence (Ramery et al., 2009) and the assembly remains a 
work in progress.  Approximately 95% of it has been anchored to chromosomes 
(autosomes 1-31 and X) with the rest concatenated into a virtual chromosome 
‘’chrUn’’ separated by gaps of 1,000 bp (http://genome-euro.ucsc.edu/cgi-
bin/hgGateway?db=equCab2&redirect=auto&source=genome.ucsc.edu). Gene 
annotation is currently in progress by the equine genome research community 
(www.uky.ed/Ag/Horsemap). The need for establishing commercial and reliable 
genomic technologies such as microarrays or next generation sequencing for equine 
gene expression experiments, as well as proteomics, led to the improvement of the 
level of horse annotation, since it is a prerequisite for deriving valuable information 
from these studies. However,  hitherto the field equine genomic annotation remaines 
challenging (www.affymetrix.com) (Bright et al., 2009).  
Earlier studies of the equine transcriptome relied on “home-made” gene expression 
arrays. A study of synoviocytes was based upon 3000 provisionally annotated genes 
(Gu and Bertone, 2004). LPS treatment on synoviocytes induced 84 inflammatory 
and noninflammatory genes (Gu and Bertone, 2004). Based on these results and a 
few studies that followed, a master genelist was developed and facilitated gene 
annotation (Santangelo et al., 2007, Colenman S.J et al., 2007, Noschka et al., 2009, 
Mienaltowski et al., 2008). An early attempt to construct a multi-tissue gene 
expression atlas followed (Huang et al., 2008b) along with efforts to both correlate 
gene expression with pathology in equine osteoarthritis [using microarray technology 
(Smith et al., 2006)] and to identify markers of osteogenic differentiation in horses 
induced by bone morphogenic proteins 2 and 6 (Zachos et al., 2006).  All of these 
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studies were limited by the extent and annotation of the available expression arrays at 
the time. 
Human and mouse microarrays have been applied in several equine studies (Ing et 
al., 2004, Michelle R. Mouse et al., 2002, Barrey et al., 2006). Clearly, some probes 
fail to hybridise but the annotation of probesets on the arrays is superior. Several 
studies used this approach to provide a rather limited view of nucleated cells derived 
from peripheral blood (Barrey et al., 2006), airways of horses with RAO (Ramery et 
al., 2008) and normal or pathologic tendon tissue (Nomura et al., 2007). Murine 
microarrays have also been employed to study gene expression in healthy equine 
muscles (Mucher et al., 2006). Both human and mouse microarrays were used on 
mRNA extracted from equine blood cells in order to shed some light on how exercise 
affects the physiology and metabolism of the horse (Barrey et al., 2006). Around 
12,000 horse-human orthologues have been identified, which enables a comparative 
approach to assessing the significance of changes seen in association with disease in 
horses (Glaeser et al., 2009). Capomaccio et al (2010) studied the effect of intense 
exercise on racehorses and investigated the gene expression on PBMCs before, 
immediately after and 24h following racing using equine/murine oligonucleotide 
microarray (Capomaccio et al., 2010). This microarray was established based on the 
combination of the home made equine long oligonucleotide microarray and the open 
access of human and mouse long oligonucleotide arrays as described in an earlier 
horse study (Barrey et al., 2009). They found an exercise-associated difference in 
gene expression, related mainly with inflammatory and immunological mechanisms 
(Capomaccio et al., 2010). Recently, horse microarrays were also used for 
investigating the gene profile of equine immature and mature DC subsets, confirming 
the hypothesis that they consist of two clearly distinct populations (Moyo et al., 
2013). 
Moreover, short RNA-seq sequences were used to detect extended period of exercise 
induced genes in equine skeletal muscles (McGivney et al., 2010), while recently, 
RNA-seq analysis was successfully used to study exercise related gene in equine 
blood and muscle and interestingly, three exercise involved genes were related with 
the evolutionary history of Thoroughbreds (Park et al., 2014). RNA-seq has also 
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been used to study horse development by screening the horse blastocyst (Iqbal et al., 
2014) and sperm transcriptome (Das et al., 2013). Other RNA-seq studies have been 
performed to explore several equine disorders, including congenital stationary night 
blindness and leopard complex spotting in the horse (Bellone et al., 2013), 
osteoarthritis (Peffers et al., 2013) and in order to assess the Corynebacterium 
pseudotuberculosi strain transcriptional activity. RNA-seq also represents a valuable 
tool for improving the annotations of species that have incomplete annotation , such 
as the horse (Coleman et al., 2013).  
A few equine studies have already used proteomics to investigate the pathogenesis of 
equine diseases, such as arthritis (Williams et al., 2013, Chiaradia et al., 2012), 
equine recurrent uveitis (Hauck et al., 2012, Degroote et al., 2012, Hauck et al., 
2010, Deeg, 2009, Deeg et al., 2007), endometritis (Wolf et al., 2012), RAO (Racine 
et al., 2011), Potomac horse fever (Gibson et al., 2011), exertional rhabdomyolysis 
(Bouwman et al., 2010) and Trypanosoma evansi infection (Roy et al., 2010). 
Interestingly, proteomics were also used to investigate the presence of 582 proteins 
in cell free equine BALF and showed that major homeostatic processes, such as 
carbohydrate metabolism and cell to cell signalling or function take place in the 
alveoli (Bright et al., 2011). 
 
1.8 The horse as an elite athlete 
The horse is an excellent athlete. Horses evolved living on ancient prairies, where 
they had to possess sufficient endurance to travel long distances in order to seek 
water and food whilst maintaining the ability to undertake short episodes of high 
speed to escape predators (Hinchcliff and Geor, 2004). Over numerous generations, 
enhancement of their speed was extremely important for their survival (Hinchcliff 
and Geor, 2004). After their domestication by humans, these attributes (speed and 
endurance) and other attributes (strength, size), were improved and modified by 
selective breeding, dependent on the intended purpose of use (Hinchcliff and Geor, 
2004). Heavy breeds were bred for strenuous work, like pulling burdens, and lighter 
ones for transportation and later for racing. The athletic ability of horses is a result of 
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numerous physiological characteristics; some are independent of training, such as 
lung size, and others are training dependent, such as blood volume (Hinchcliff and 
Geor, 2004). Horses also have a greater aerobic capacity compared to other 
domesticated animals (goat, cows and dogs), a greater ability for intramuscular 
storage of energy substances (e.g. glycogen), higher intramuscular mitochondrial 
volume and a great efficiency of thermoregulation. Besides, they have an extensive 
surface for gas exchange within their large lung, and a high oxygen-carrying capacity 
in the blood, which can be enhanced during exercise by splenic contraction 
(Hinchcliff and Geor, 2004). This superior capacity to transport oxygen from inhaled 
air to muscles is vital in exercise.  
 
1.8.1 Pathophysiological changes during exercise 
During exercise, numerous physiological changes occur in the horse (Table 1.6). 
Muscle contraction requires large amounts of adenosine triphosphate (ATP); thus the 
metabolic rate is raised to replace spent ATP. ATP synthesis is based on substrate 
and oxygen supplies, with the substrate mainly derived from carbohydrates in muscle 
(glycogen) and blood (glucose). These energy supplies are regulated by a variety of 
hormonal changes that occur during exercise; in particular, a decrease in blood 
insulin concentration and an increase in catecholamine, cortisol and glucagon 
concentrations. Hepatic glycogenolysis and gluconeogenesis generates only a small 
portion (<10%) of the carbohydrates required during intense exercise; the rest is 
obtained from muscle glycogen stores. Oxygen transportation is also essential during 
training and is achieved by the coordination of the respiratory and cardiovascular 
systems. Alveolar ventilation, blood oxygen concentration, splenic contraction and 
regulation of heart rate constitute the main determinants of oxygen delivery to the 
tissues, all of which are affected by the intensity of exercise. Muscle contraction also 
leads to increases in body temperature which, during an acute bout of exercise, may 
exceed 42
0
C, leading to heat shock and morbidity. Furthermore, exercise results in 
the synthesis of many functional and structural proteins, which have definable effects 
on the immune system (Kenneth and Raymond, 2008). These will be discussed in the 
next section (Section 1.8.2). 






Recovery Period References  
Heart rate ↑ ↓ (Kenneth and Raymond, 2008) 
PCV ↑ Recovered 1h post race (Robson et al., 2003) 
Body temperature ↑ ↓ (Kenneth and Raymond, 2008) 
Metabolism ↑ ↓ (Kenneth and Raymond, 2008) 
Oxidative capacity ↑ ↓ (Kenneth and Raymond, 2008) 
Oxygen 
consumption 
↑ ↓ (Kenneth and Raymond, 2008) 
Blood cortisol ↑ Recovered 1h post race (Robson et al., 2003, Wong et al., 
1992) 
 ↑ Recovered 11.30h post 
exercise 
(Rossdale et al., 1982) 
 ↑ Recovered 5 days post 
exercise 
(Huston et al., 1986) 
 ↑ Recovered 1 day post 
exercise 
(Adamson and Slocombe, 1995) 
Blood 
catecholamines 
↑ Recovered 30 min post 
exercise 
(Adamson and Slocombe, 1995) 
BALF cortisol  ↑ Not available (Huston et al., 1986) 
BALF lipid ↑ Remained high even 5 
days post exercise 
(Huston et al., 1986) 
Blood glucose ↓ Recovered 1h post race (Robson et al., 2003) 
Plasma glutamine ↑ ↓ and recovered  24h post 
race  
(Routledge et al., 1999) 
 No change No change (Robson et al., 2003) 
Total blood protein  ↑ Recovered 1 day post race (Robson et al., 2003) 
BALF protein No change No change (Huston et al., 1986) 
BALF surfactant ↑ Remained high 5 days 
post exercise 
(Huston et al., 1986) 
 
Table 1.6: Physiological changes in response to exercise. 
 
1.8.2 Exercise immunology  
Stress is an important factor that may induce numerous pathophysiological changes 
in the body. Four main stress induced pathways are described to affect the immune 
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system in athletes: namely, (1) the direct effect of cytokine production, such as IL6, 
by muscle cells; (2) the activation of the well described hypothalamic-pituitary-
adrenal axis (HPA); (3) the extra-adrenal pathways associated with neuropeptides 
and neurotransmitters; (4) autonomic nervous system [ANS] activation (Figure 1.6) 
(Horohov, 2004, Griffin, 1989). 
 
HPA activation is initiated by the secretion of the corticotropin releasing hormone 
(CRH) and vasopressin by the brain, resulting in adrenocorticotropic hormone 
(ACTH), growth hormone (GH) and β endorphin production by the anterior pituitary 
gland. ACTH subsequently results in cortisol, encephalin and catecholamine release 
by the adrenal cortex.  Increased cortisol release, a chronic response to exercise 
stress, can cause a decrease in blood lymphocyte numbers and neutrophilia, while 
increased catecholamine release, an acute response to exercise stress, regulates 
neutrophil activity in association with growth hormone (Pedersen et al., 1997, Chao 
et al., 2005).  Glucocorticoids also induce gluconeogenesis, a metabolic pathway that 
produces glucose from non-carbohydrate carbon substrates essential for central 
nervous system function, as well as for other activities in the body (Chao et al., 2005, 
Griffin, 1989).  
 
Under stress, there is activation of the sympathetic nervous system, a phenomenon 
known as the ‘’fight or flight syndrome’’. Stressors acting via the cerebral cortex of 
the brain and the hypothalamus result in the activation of the ANS with subsequent 
catecholamine release, either directly via norepinephrine secretion from sympathetic 
nerve endings or indirectly via epinephrine secretion from the adrenal gland 
following HPA axis stimulation (Griffin, 1989, Axelrod and Reisine, 1984). 
In turn, this catecholamine release produces vasoconstriction and splenic contraction, 
leading to splenic-derived erythrocyte and leukocyte release into the circulation 
(Cross et al., 1988).  
 
Finally, the extra adrenal pathway is less clearly understood (Davies and MacKenzie, 
2003).  Locally, the release of corticosteroids has both autocrine and paracrine 
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Figure 1.6: The response of the immune system to exercise.  
The effect of exercise on the immune system results from the autonomic nervous system and 
hypothalamic-pituitary-adrenal axis activation, the extra adrenal pathway, as well as from the direct 
cytokine production by the muscle cells. CRH: corticotropin releasing hormone, GH: growth 
hormone, ACTH: adrenocorticotropic hormone. 
 
1.8.2.1 Beneficial effect of exercise  
Exercise immunology has been a rapidly expanding area of research over the past 40 
years, with its subsequent development as a specific discipline with its own 
international society and dedicated journal (http://www.isei.dk/, Walsh et al., 2011). 
Moderate and regular physical activity clearly has beneficial effects on humans. For 
example, a positive effect of exercise on various chronic inflammatory conditions 
such as cardiac and respiratory disorders, type II diabetes, atherosclerosis and several 
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types of cancer is consistently reported (Woods et al., 2009, Blair et al., 2001, 
Troosters et al., 2005). Furthermore, a better prognosis and a lower risk of coronary 
heart disease, stroke, cardiovascular disease and colon cancer are reported in more 
physically active individuals (Blair et al., 2001). Numerous studies have detected a 
relationship between inactivity in both young and elderly individuals and intermittent 
claudication associated with a low level of systemic inflammation (Abramson and 
Vaccarino, 2002, Geffken et al., 2001, Tisi et al., 1997). In elderly individuals this 
phenomenon has been termed inflammaging (Franceschi et al., 2000) and physical 
activity has been shown to affect this low grade inflammation (Tisi et al., 1997, 
Geffken et al., 2001, Abramson and Vaccarino, 2002).  Even though similar studies 
have not been performed on horses, a beneficial effect of exercise on equine athletes 
is likely to occur. 
 
The inflammatory effect induced by moderate exercise may involve IL6, a cytokine 
with both proinflammatory and anti-inflammatory properties (Tilg et al., 1997, 
Starkie et al., 2003, Gabay, 2006, Petersen and Pedersen, 2005). IL6 is highly 
expressed by contracting muscle cells during exercise and its expression is further 
enhanced by low muscle glycogen levels; thus this cytokine is considered a potential 
regulator of hepatic glucose metabolism (Keller et al., 2001, Steensberg et al., 
2001a). IL6 controls lipid metabolism, induces lipolysis and fat oxidation 
independent of circulating hormonal changes and without causing 
hypertriacylglyceridemia (Petersen et al., 2005, van Hall et al., 2003). Furthermore, 
exercise-associated IL6 secretion by skeletal muscle cells inhibits the production of 
TNFα, a cytokine involved in a number of pathogenic conditions such as insulin 
resistance and atherosclerosis (Blair and Brodney, 1999, Starkie et al., 2003). Even 
after exposure to endotoxin, TNFα release in human subjects was inhibited by either 
physical exercise or rhIL6 infusion at physiological concentrations (Starkie et al., 
2003). IL6 can also trigger cortisol release and the production of anti-inflammatory 
cytokines (e.g. IL1RA and IL10) and delay C reactive protein secretion (Steensberg 
et al., 2003). The low lymphocyte counts detected during the recovery period 
following exercise may partly be attributed to elevated plasma cortisol levels, 
induced by IL6 (Steensberg et al., 2001b, Steensberg et al., 2003). IL6 has also been 
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shown to induce the production of soluble TNF receptor (sTNFR), a principal 
inhibitor of TNFα activity (Tilg et al., 1994) (Figure 1.7).  
 
 
Figure 1.7: IL6 activities during exercise.  
During physical activity IL6 is produced by skeletal muscle cells in high levels. IL6 plays an 
important role in glucose homeostasis and is an important modulator of fat metabolism as it induces 
lipolysis and fat oxidation. IL6 triggers the production of the anti-inflammatory cytokines IL1RA, 
IL10, sTNFR and inhibits the production of TNFα. Figure adapted from Marie et al. 2005. 
 
 
Epinephrine also contributes slightly to IL6 production. However the suppression of 
endotoxin-induced TNFα release observed in humans pre-exposed to epinephrine 
(vanderPoll et al., 1996) is considered to be independent of IL6 (Steensberg et al., 
2001b, Petersen and Pedersen, 2005). In a comparative study of humans and horses, 
the level of IL6 mRNA expression by PBMCs was found to be greater in both 
species during training (Capomaccio et al., 2011, Colahan et al., 2002),while IL6R 
was more so in horses, which may thereby have superior means of responding to 
exercise (Capomaccio et al., 2011). 
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Antioxidants are another potential anti-inflammatory mechanism induced by exercise 
(Leeuwenburgh and Heinecke, 2001, Abramson and Vaccarino, 2002). Although 
exercise can result in oxidative stress, long term training results in antioxidant 
production thus preventing any oxidant-induced chronic tissue damage 
(Leeuwenburgh and Heinecke, 2001, Leeuwenburgh et al., 1999, Powers et al., 1994, 
Robertson et al., 1991). The benefits of exercise may also partly relate to its effect on 
lung surfactant (van Iwaarden et al., 1990, Huston et al., 1986, Rooney, 1985).  In 
horses, BALF surfactant levels increase significantly following training, remaining 
elevated even after five days (Huston et al., 1986).  
 
1.8.2.2 Deleterious effect of exercise  
Where moderate exercise improves immunity in humans, especially in the elderly, 
long-term strenuous exercise has the opposite effect (Bruunsgaard and Pedersen, 
2000, Field et al., 1991, Fitzgerald, 1991). The same is apparently true in horses.  
Histopathological lesions have been observed in the lungs of racehorses, reflective of 
conditions such as exercise-induced pulmonary haemorrhage (EIPH), and pulmonary 
inflammation (McKane and Slocombe, 2002, Collins et al., 1994). The phenomenon 
of overtraining has been widely studied in humans.  There are several inconsistencies 
in the terminology used and accurate diagnostic markers for this syndrome remain to 
be identified (Purvis et al., 2010, Meeusen et al., 2013).  The diagnosis is mainly 
based on the athlete’s psychological profile (McKenzie, 1999) although clinical 
symptoms might reflect sympathetic or parasympathetic nervous system alterations, 
including severe loss of appetite, fatigue, performance decrements, insomnia, 
excitability, anxiousness, weight loss, muscle and joint pain, hypoglycemia in non-
diabetic athletes, lack of concentration and enthusiasm for the sport, apathy and 
depression (Purvis et al., 2010, Meeusen et al., 2013). Since psychological status and 
mood cannot easily be estimated in horses, the diagnosis is based on other measured 
parameters such as performance decrements, weight loss and reduced oxygen 
consumption (Hamlin et al., 2002). Recently, new analytical technologies, such as 
microarrays and proteomics, have been proposed as potential tools for the detection 
of subclinical performance or even a means by which the training status of the horse 
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can be monitored (te Pas et al., 2013, Scoppetta et al., 2012). Unfortunately, no 
reliable biomarkers have been identified to date.  
 
Exercise-induced immunosuppression has been studied in humans (Cox et al., 2007, 
Abbasi et al., 2013, Cox et al., 2008) and laboratory animals (Davis et al., 1997, 
Leeuwenburgh et al., 1999, Woods et al., 1997) and to a lesser extent in horses 
(Raidal et al., 2000, Wong et al., 1990) and dogs (McKenzie et al., 2007, Clark et al., 
1997). Much of the data applied to the field of human exercise immunology have 
been derived from a number of animal studies (Kakanis et al., 2010, Keast et al., 
1988, Raidal et al., 2000).  Such studies have helped to identify a variety of 
immunological derangements associated with both acute and chronic exercise, 
including exercise-associated effects on cell migration and margination, mucosal IgA 
secretion, cellular function and cell surface receptor expression (Walsh et al., 2011). 
The recognition of such alterations has in part helped to reveal the mechanisms 
which may lead to an exercise-associated increased susceptibility to opportunistic 
infection, commonly referred to as the “open window” theory (Figure 1.8) (Walsh et 
al., 2011).  
 
 
Figure 1.8: The immune response to exercise and the “open window’’ theory.  
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Intense exercise can increase the risk of upper respiratory tract infections in humans 
and augment latent infections (MacKinnon, 2000, Nieman, 1994). Humans and 
horses may differ with respect to the impact of exercise on respiratory tract infections 
and the results obtained in published studies in both species are often contradictory 
(Cox et al., 2008). This can partly be attributed to differences between studies with 
respect to the training protocols applied, the sampling time points (e.g. during or 
after active exercise or during a prolonged “training period”), the types of samples 
collected and the experimental methodologies used (Robson et al., 2003, Huston et 
al., 1986). Such differences in study design can significantly impact on the value of 
inter-study data comparisons due to the numerous physiological changes, mainly 
neuroendocrine and metabolic, that occur during physical activity (Jonsdottir, 2000, 
Venkatraman and Pendergast, 2002).  
 
1.8.2.3 The effect of exercise on leukocyte distribution and function 
During exercise, muscle contraction results in hyperthermia and sympathoadrenal 
activation, which leads to immune cell redistribution (Rhind et al., 1999). Therefore, 
most equine studies have focussed on the distribution of blood cellular components 
(monocytes, neutrophils, lymphocytes) (Rossdale et al., 1982, Jensen-Waern et al., 
1999, Robson et al., 2003) and those looking at the response of the innate immune 
system using in vitro assays to measure phagocytic or oxidative burst activity of 
neutrophils/monocytes (Horohov, 2004, Hines et al., 1996). Limited studies on the 
effect of exercise on the adaptive immune response have investigated lymphocyte 
proliferation and function (Horohov et al., 1999, Hines et al., 1996). The effect of 
exercise on the innate immune system, first appearing at the beginning of the 
workout, seems to be biphasic in both humans and horses (Kakanis et al., 2010, 
Rossdale et al., 1982). Short exercise-induced changes in the immune system include 
a transient increase in both neutrophil and lymphocyte numbers (Rhind et al., 1999, 
Robson et al., 2003, Kakanis et al., 2010) followed, in both humans and horses, by a 
decrease in circulating lymphocytes below normal levels approximately one to two 
hours after exercise, a phenomenon attributed to high plasma cortisol levels (Nesse et 
al., 2002, Pedersen et al., 1997).  Results of various studies are summarised in Table 
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1.7.  The level of leukocytosis depends on the magnitude of the physical activity, 
with more intense exercise resulting in a greater increase in leukocyte numbers post 
exercise (Brenner et al., 1998). 
 
 Post  
exercise  
Recovery Period References  
Lymphocytes  ↑  ↓ Recovered 1h post race (Rossdale et al., 1982) 
Not available  ↓ did not recover 16h post exercise (Nesse et al., 2002) 





 T cell  ↓ Not available (Hines et al., 1996) 
Monocytes  ↑ Recovered 1h post race (Robson et al., 2003) 
No change No change (Jensen-Waern et al., 1999) 
Neutrophils ↑ Recovered 3 days post race (Robson et al., 2003) 
↑ Recovered 8 days post race (Jensen-Waern et al., 1999) 
 
Table 1.7: The effect of exercise on leukocyte distribution in horse blood. 
 
In addition to exercise induced blood cell redistribution, changes have also been 
reported in BALF cell counts. The exercise-associated increase in total BALF cell 
count has been attributed to increases in both neutrophils and eosinophils, potentially 
in response to the release of the proinflammatory platelet-activating factor in the 
airway (McKane et al., 1993, Michelotto et al., 2010). In comparison, other studies 
have reported either a reduction in the number of total BALF cells after 10 weeks of 
training (Clark et al., 1995) and three days following exercise (Huston et al., 1986) or 
no changes in cell number (Wong et al., 1990, Ainsworth et al., 2003a, Raidal et al., 
2000). 
 
Leukocyte function may also change in response to exercise (Raidal et al., 2001, 
Robson et al., 2003).  Overall, initial activation of immune cells both during and 
shortly after training is followed by general suppression of the immune system in 
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several human and horse studies (Kakanis et al., 2010, Cox et al., 2008, Cox et al., 
2007, Gleeson et al., 1999, Robson et al., 2003).  In particular, lower immune cell 
numbers (lymphocytes) and impaired cellular function (phagocytosis, oxidative burst 
activity) develop in the recovery period following an acute bout of endurance 
exercise (Kakanis et al., 2010, Robson et al., 2003, Nesse et al., 2002). There have 
been multiple reports focusing on suppressed function in macrophages in response to 
exercise, which is linked potentially to lower respiratory tract infections in the horse 
(Wong et al., 1990, Folsom et al., 2001). The current literature on equine immune 
cells with emphasis on macrophages/monocytes is summarised in Table 1.8. 
 
Strenuous exercise resulted in impaired phagocytosis of equine blood monocytes, an 
effect which persisted even three days following exercise (Wong et al., 1990).  A 
suppression of AM phagocytic activity during exercise is also documented by several 
studies (Huston et al., 1986, Wong et al., 1990, Raidal et al., 2000). However, a large 
degree of inconsistency exists in the literature with respect to reported results (Raidal 
et al., 2001, Adamson and Slocombe, 1995), a phenomenon which may be explained 
by the common occurrence of EIPH (McKane et al., 1993). In EIPH, the RBCs tend 
to form rosettes around AMs and impair phagocytosis, potentially by blocking cell 
receptors on the AM membranes (Commins et al., 1990). Furthermore, RBC 
internalization by both alveolar and peritoneal macrophages neutralizes reactive 
oxygen metabolites, thus potentially impairing their oxidative burst activity 
(Adamson and Slocombe, 1995, Hand and Kingthompson, 1983).  
 
There are many other variables in these studies which may also partly explain the 
inconsistent results, including the duration, nature and season of training, the nature 
of inhaled particles, the age of the horses and the inter-individual variation in 
macrophage function.  It is therefore likely that vigorous exercise can be either pro- 
or anti-inflammatory in the lung, depending on a variety of circumstances. These 
results further support the theory that intense exercise may have a negative impact on 
the pulmonary system of the horse, either directly or via immunosuppression, with a 
subsequent increase in susceptibility to opportunistic infections. 
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Activity Cell type Finding References 
Viability Blood leukocytes  No change post strenuous exercise (Adamson and 
Slocombe, 1995) 
 BALF cells ↓ after the training period, but no change was 
observed post exercise 
(Raidal et al., 2000) 
 Alveolar macrophages ↓ till 5 days post exercise (Adamson and 
Slocombe, 1995, 
Huston et al., 1986) 
Morphology Blood granulocytes No change post strenuous exercise (Adamson and 
Slocombe, 1995) 
 Alveolar macrophages No change post strenuous exercise (Adamson and 
Slocombe, 1995, 
Huston et al., 1986) 
LAK cell 
activity 
LAK cells  ↑ 20min after intense exercise but returned to 
resting levels 2h post exercise 





↓ and did not captured even 3 days post 
exercise 
(Robson et al., 2003) 
 Blood neutrophils, 
lymphocytes 
↑ and during prolonged training decreased (Raidal et al., 2001) 
 BALF granulocytes ↓ 30min post strenuous exercise (Adamson and 
Slocombe, 1995) 
 BALF derived 
lymphocytes 
↑ post strenuous exercise (Raidal et al., 2000) 
 BALF derived 
lymphocytes 
No change (Raidal et al., 2001) 
 Alveolar macrophages ↑ 30min post strenuous exercise (Raidal et al., 2000) 
 Alveolar macrophages  Varied during the study (Raidal et al., 2001) 
 Alveolar macrophages ↓ at race trained horses compared to those at 
rest 
(Michelotto et al., 2010) 






















↓ and did not captured even 3 days post 
exercise 
(Wong et al., 1992) 
 Alveolar macrophage ↓ and recovered at day 3 post exercise (Huston et al., 1986) 
 Alveolar macrophage ↓ (Wong et al., 1990) 
 Alveolar macrophage ↓ 30min post exercise of the training period (Raidal et al., 2000) 
 Alveolar macrophages No change (Raidal et al., 2001) 
 Alveolar macrophages ↓ at race trained horses compared to those at 
rest 
(Michelotto et al., 
2010) 
 Blood neutrophils ↓ after 4-7 weeks of intense training (Buschmann and 
Baumann, 1991) 
 Blood neutrophils  ↓ even one day post race (Jensen-Waern et al., 
1999) 
 Blood neutrophils ↑ at intense exercise and decreased at 
overtraining 
(Raidal et al., 2001) 
 
Table 1.8: The effect of exercise on equine immune cells, with emphasis on the monocyte / 
macrophage.  
LAK = lymphokine activated killer. 
 
1.8.2.4 Cytokines and other substances in the response to exercise 
As noted in the previous section, the short term effect of exercise on leukocyte 
distribution may resemble an LPS challenge (Rhind et al., 1999). There are several 
studies focusing on the cytokine expression of immune cells during and after 
exercise in man, horses and other species (Moldoveanu et al., 2000, Liburt et al., 
2010, Keller et al., 2004, Wakshlag et al., 2010). In addition to IL6 (discussed 
above), IL1, IL8, IL1RA, TGFB1 and TNFα have been detected in human plasma 
following an acute bout of endurance exercise (Moldoveanu et al., 2000, Abbasi et 
al., 2013). Similarly, in horses, several proinflammatory (TNFα, IL1β, IL6, IL6R, 
IL8, IL12) and anti-inflammatory (IL6, IL10, IL1RA) cytokines and the acute phase 
protein C-reactive protein, were found to be released in high levels following 
exercise (Horohov, 2004, Liburt et al., 2010, Barton et al., 2003, Capomaccio et al., 
2011, Cappelli et al., 2007).  The response of PBMCs to racing has been analysed 
using gene expression arrays (Capomaccio et al., 2010).  A list of 132 genes was 
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induced transiently, but declined to basal levels after 24h (Capomaccio et al., 2010). 
The induced genes included both proinflammatory and anti-inflammatory genes, 
such as TNFα, IL18, IL8, IL1β, SOCS3 and CCL3 (Capomaccio et al., 2010). The 
same group used next generation sequencing and reported similar results, but 
identified a number of novel candidate regulators (Capomaccio et al., 2013). 
Recently, another study examined the effect of training, as opposed to acute exertion.  
In particular TLR3 mRNA expression was downregulated in both AM and monocytes 
and did not normalise during the recovery period (Frellstedt et al., 2014). Moreover, 
viral challenge of AMs resulted in low levels of TNFα and IFNβ expression, further 
supporting the existence of an exercise-associated increased susceptibility to viral 
infections (Frellstedt et al., 2014).   
 
The high levels of circulating endotoxin observed in both athletes and racehorses 
after strenuous exercise might explain the release of TNFα by immune cells 
(macrophages/monocytes) post exercise (Barton et al., 2003, Jeukendrup et al., 
2000). Because of sympathetic stimulation during intense exercise, blood flow is 
diverted from the gastrointestinal tract, potentially resulting in intestinal 
hypoperfusion and a compromised integrity of the mucosal barrier. Furthermore, 
increases in body temperature and changes in vessel permeability may also 
contribute to an increase in endotoxin levels in the circulation (Barton et al., 2003). 
Moreover, the cytokine release observed in the circulation following strenuous 
exercise might partly reflect cytokine secretion in tissues resulting from exercise-
associated tissue damage (Smith et al., 1992, Woods and Davis, 1994).  
 
1.9 Inflammatory Airway Disease 
Inflammatory airway disease (IAD) is a nonspecific inflammatory condition of the 
equine airways, which is recognized as the most common respiratory disorder in 
young racehorses in the UK (Wilsher et al., 2006, Wood et al., 2005b). Its prevalence 
in racehorses has been estimated between 11.2 and 50% (Wood et al., 2005b, Wood 
et al., 2005a, Burrell et al., 1996). Although young racehorses (2-4 years old) are 
more prone to develop the disease, under the current diagnostic definition, it can also 
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present in nonracehorses of any age (Chapman et al., 2000, Wood et al., 1993, 
Robinson et al., 2006). 
The most common clinical signs of IAD are chronic and intermittent coughing and 
poor racing performance (Chapman et al., 2000). The presence of mucopurulent 
tracheal secretions with an elevated neutrophil concentration is considered to be the 
hallmark of IAD (Moore et al., 1995, Sweeney et al., 1992). Pulmonary dysfunction 
due to lower airway inflammation may also occur (Robinson, 2003) and airway 
hyper-responsiveness and impaired blood gas exchange are also present according to 
the disease phenotype proposed by the American College of Veterinary Internal 
Medicine consensus panel members in October 2003 (Robinson, 2003).  
Due to the relatively nonspecific nature of the clinical signs of IAD, diagnosis can 
often be difficult and is based primarily on cytologic examination of BALF, mainly 
characterized by either a mild neutrophilia, eosinophilia or mastocytosis or a 
combination of these (Couetil et al., 2001, Hoffman, 2008). Recently, IAD cases 
have been subdivided into three main subtypes, depending on their BALF cytological 
profiles; namely, neutrophilic, mast cell or both (Beekman et al., 2012). Abnormal 
BALF cytology results have been related to poor performance in all horse types 
(Fogarty and Buckley, 1991, Moore et al., 1995, Richard et al., 2010b). The BALF 
differential cell count (DCC) is sometimes used to discriminate between diseases of 
the horse lung. For example the cytological profile of horses affected with RAO is 
characterised by a substantial increase in neutrophil ratio in the BALF, usually much 
higher than in horses with IAD (McGorum et al., 1993, Robinson, 2003). Ultimately, 
the distinction between these clinically related conditions can only be achieved by 
other diagnostic means, including lung function tests, environmental manipulation 
and careful consideration of the history (Couetil et al., 2001). In contrast to RAO 
cases, no increased respiratory effort is observed in horses affected with IAD at rest 
(Robinson, 2003), and such an increased effort cannot be induced by exposure to 
mouldy hay (Dixon et al., 1995). 
A characteristic feature of IAD is also a subtle decline in pulmonary function with 
resultant gas exchange abnormalities during exercise (Sanchez et al., 2005). The 
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results of standard lung mechanics testing are normal in IAD (Ocallaghan et al., 
1987), although impulse oscillometry, a noninvasive method of assessing pulmonary 
mechanics, can be useful for the early detection of subclinical cases of airway 
inflammation (Richard et al., 2009). Unfortunately, more sensitive pulmonary 
function tests are not widely available to clinicians (Couetil et al., 2001). Finally, 
airway hyper-responsiveness, bronchoconstriction and cough are linked with 
abnormal BALF profiles in horses with IAD (Hare and Viel, 1998, Hoffman et al., 
1998). Interestingly, increased serum concentration of SPD was found in horses 
affected with IAD (Richard et al., 2012), as well as with experimental bacterial 
airway infection (Hobo et al., 2007), suggesting that SPD could be used as a serum 
biomarker for lower airway inflammation in the horse. 
Although the exact aetiopathogenesis of IAD is not completely elucidated, a variety 
of infectious and noninfectious causes have been proposed and reported (Pirrone et 
al., 2007, Wood et al., 2005a, Holcombe et al., 2001). Training at a young age is an 
important risk factor for IAD in racehorses (Malakides M and Hodgston, 2003) and 
stress from transportation, interaction with other horses and housing in poorly 
ventilated places may contribute to its development (Wilsher et al., 2006, Cardwell, 
2009). A strong correlation exists between IAD and high levels of airborne 
endotoxins from dust sources, poor ventilation and certain meteorological conditions, 
such as high evaporation level, humidity, high temperatures and wind (Malakides M 
and Hodgston, 2003). These factors likely increase the load of inhaled 
proinflammatory agents in the lower airways. Furthermore, increased ventilation 
during intense exercise also will result in a greater likelihood of inhaling pharyngeal 
and environmental pathogens or airborne foreign substances (Gordon and Read, 
2002, Kakanis et al., 2010).  
The incidence of infection with Streptococcus pneumoniae and the prevalence of 
IAD decreases with age (Wood et al., 2005a). Virus infections do not seem to be 
highly associated with the pathogenesis of IAD (Wood et al., 2005a, Burrell et al., 
1996), although the number of viruses tested was not extensive. However, IAD could 
result from viral-induced immunosuppression, subsequently followed by 
opportunistic bacterial infections (Burrell et al., 1996, Hannant et al., 1991).  
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A few studies have been performed to investigate whether a polarised T cell response 
is involved in the aetiopathogenesis of the disease (Table 1.9). Horses with IAD 
have an increased expression of proinflammatory cytokine mRNA (TNFα, IL1β and 
IL23) within BALF derived cells, reflecting an innate immune response, likely to 
inhaled antigens. In keeping with this interpretation, there was no clear evidence of a 
polarised T cell response (Hughes et al., 2011).  By contrast, another group found 
both IL4 and IFNγ mRNA in BALF cells (Lavoie et al., 2011), results which were 
suggestive of both a Th1 and Th2 response in the cases investigated (Lavoie et al., 
2011, Lasky and Brody, 1997). Similar findings have also been reported in relation 
to RAO, an asthma-like obstructive airway disease in horses, suggesting that a 
common pathologic mechanism may exist between these two diseases (Ainsworth et 
al., 2003b, Giguère et al., 2002, Lavoie et al., 2011).  
By contrast, another group indicated a more Th2-type response of BALF cells 
derived from horses affected with IAD (Beekman et al., 2012). However, different 
IAD subtypes may be associated with different immunological mechanisms 
(Beekman et al., 2012). For example, BALF eosinophilia, common in horses with 
IAD and mastocytosis, is associated with airway hyperactivity, whereas BALF 
neutrophilia is associated more with coughing (Hoffman et al., 1998, Bedenice et al., 
2008). Interestingly, IL4 was detected only in the mast cell IAD group suggesting 
that Th2 cytokines and IgE may participate in this disease subtype (Beekman et al., 
2012), whereas the neutrophil chemoattractant IL17 was detected only in the 
neutrophilic IAD. Hence, there seems to be a correlation between cytokine 
production by BALF cells and BALF cytologic profile and, even though both Th1 
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IAD type  Finding  References 
IAD and exercise intolerance TNFα, IL1β,  IL4 and IFNγ (Lavoie et al., 2011) 
IAD TNFα, IL1β and IL23 (Hughes et al., 2011) 
IL1β,  IL5, IL6, IL8 and IL10 (Beekman et al., 2012) 
Neutrophilic IAD  IL1β, IL5, IL6, IL8 and IL17. 
IL1β, IL5 and IL8 were higher 
compared to the mast cell IAD   
(Beekman et al., 2012) 
Mast cell IAD IL1β, IL4, IL5, IL6, IL8 and 
low IL12p35 
(Beekman et al., 2012) 
 
Table 1.9: Summary of cytokine mRNA expression by BALF cells derived from horses with IAD. 
 
At present, therapeutic options for the treatment of IAD are limited. These are based 
primarily on environmental modifications, and anti-inflammatory and antibiotic 
medication (Bertone, 1997). The aim of the environmental modifications is to reduce 
exposure of the respiratory system to various potentially proinflammatory airborne 
antigens. Improving the ventilation system of the stable and using feed and bedding 
that produce low levels of airborne dust is considered extremely important (Woods et 
al., 1993, Pirie et al., 2002). 
The use of inhaled corticosteroids (e.g. fluticasone or beclomethasone) is a frequent 
anti-inflammatory therapeutic approach (Rush et al., 2000, Couetil et al., 2005). 
Although systemic corticosteroid therapy (e.g. dexamethasone or prednisolone) is 
also commonly used, the risks of undesired side effects are greater compared with 
the inhalation route of administration (Rush et al., 1998). Additional therapeutic 
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approaches have included inhaled sodium cromoglycate, a mast cell stabilizer which 
improves clinical appearance and decreases airway hyper-responsiveness (Hare et al., 
1994) and oral IFNα, which has been shown experimentally to reduce respiratory 
inflammation in Standardbred racehorses with IAD (Moore et al., 1997). Due to the 
subclinical form of the disease at rest, re-examination of the patient is needed before 
training recommences (Couetil et al., 2007). 
 
1.10 Preventive measures for exercise induced 
dysregulation of the immune system 
 
1.10.1 Dietary measures 
Glutamine, an amino acid mainly produced in muscle cells and essential for immune 
cell function and preservation, is decreased in the plasma of both marathon runners 
following racing or during overtraining (Parry-Billings et al., 1992) and in racehorses 
following exercise (Routledge et al., 1999). Glutamine oral administration in human 
athletes resulted in lower risk for infection compared to the control group, suggesting 
that glutamine dietary supplements are beneficial for the immune system during 
exercise (Castell et al., 1996). Another nutritional supplement that is suggested to 
enhance the immune activity in horses is ascorbic acid (Vitamin C) (Snow et al., 
1987). Short term supplementation of horses with Vitamin C after long-lasting stress, 
is beneficial to immune function, although long term supplementation is not 
recommended (Ralston and Stives, 2012).   
1.10.2 Macrophage regulation 
Many infectious or autoimmune diseases encountered in veterinary and human 
medicine are associated with an excessive inflammatory response of immune cells 
and several methods have been employed to therapeutically or prophylactically 
suppress or inhibit such responses, particularly targeting macrophages (Nathan, 
2002, Ainsworth et al., 2003b). For instance, TNF converting enzyme (TACE) 
inhibition showed a significant reduction in proinflammatory cytokine (TNF, IL1β 
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and IL6) production by both equine and human macrophages in vitro (Wijnker et al., 
2004). Parbhakar et al (2005) also used gadolium chloride and successfully depleted 
equine pulmonary intravascular macrophages and showed a decrease in the severity 
of LPS-induced lung inflammation (Parbhakar et al., 2005). Additionally, IL4, IL13 
and IL10 are shown to be critical for maintaining the balance between Th1 and Th2 
immune responses to several infectious pathogens (Barnes, 1998, Bogdan and 
Nathan, 1993). Jackson et al (2004) showed that horse AMs cultured in recombinant 
equine IL4 produce less mRNA of the proinflammatory cytokines IL8 and IL12 p40 
after LPS stimulation than LPS treated cells, indicating that IL4 can modulate AM in 
response to LPS (Jackson et al., 2004). Conversely, the enhancement of macrophage 
function could produce therapeutic and/or prophylactic clinical benefits (Tzianabos, 
2000). For instance the use of polysaccharides, poly-( 1-6)-P-glucotriosyl-( 1-3 )-P-
glucopyranose -glucan and Bacteroides fragilis polysaccharide A in a rat model with 
experimental intra-abdominal sepsis resulted in reduced mortality and abscess 
formation (Tzianabos et al., 1998).  
Many studies have investigated the regulatory mechanisms of macrophage 
polarisation. Recently, it was shown that M2 polarization was induced in Bruton’s 
tyrosine kinase (Btk) deficient mice after treatment with LPS, an M1 stimulus (Ní 
Gabhann et al., 2014), since Btk activates NFκB via TLR4 (Horwood et al., 2006). 
Many earlier studies investigated the regulation of macrophage activation, including 
the effect of several molecules, such as members of the SOCS family, members of 
interferon regulated factors (IRFs), members of the signal transducers and activators 
of transcription (STAT) family and several signaling pathways (Spence et al., 2013, 
Sica and Mantovani, 2012, Zhou et al., 2014). For example, SOCS2 induces M2 
polarisation, SOCS3 the classical phenotype (Spence et al., 2013) and STAT3 and 
STAT6 the alternative macrophage activation pathway (Sica and Mantovani, 2012). 
Thus, modulation of macrophage function may provide new insights in order to 
facilitate treatment measures for infectious and non-infectious respiratory diseases in 
horses, in particular for infections resulting from antibiotic resistant organisms, 
autoimmune or nonspecific inflammatory diseases.  
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One approach to alleviating the effect of exercise would be to adopt the use of 
immunomodulators (Ziebell et al., 1997, Klier et al., 2011). For example, 
parapoxvirus ovis (PPOV) is a virus belonging in the Poxviridae family which 
infects humans, goats and sheep, presenting mainly with acute skin lesions (Haig and 
Mercer, 1998).  Its inactivated form (iPPOV) has been shown to induce both 
immunostimulatory and immunosuppressive actions (Fachinger et al., 2000). Its 
immunostimulatory properties include the promotion of antigen presentation, 
phagocytosis and inflammatory related cytokine production (TNFα, IL2, IL6 IFN), 
whereas its immunosuppressive properties include the induction of anti-
inflammatory cytokine production, such as IL4 and L10 (Fachinger et al., 2000, 
Friebe et al., 2004, Knolle et al., 1998).  Thus, iPPOV has been proposed as an 
efficient antiviral drug, potentially offering new perspectives in antiviral therapeutic 
options. Its effects on cells derived from several species share many similarities and 
several studies on its immunomodulating properties have been reported in the 
literature (Ziebell et al., 1997, Fachinger et al., 2000, Friebe et al., 2004).  PPOV acts 
as a superantigen on porcine PBMCs and was found to induce a MHC II dependent T 
cell proliferation (Fachinger et al., 2000). In a clinical trial on horses, iPPOV 
efficiently reduced the severity of respiratory clinical signs resulting from stress and 
viral and bacterial infections (Ziebell et al., 1997). It is currently marketed under the 
tradename Zylexis® by Zoetis. 
Cytosine phosphate guanine oligodeoxynucleotides (CpG-ODNs) are another 
immunostimulant widely studied in mice which acts by suppressing the Th2 response 
and enhancing a Th1 shift, thus providing defence against asthmatic inflammation 
(Kline, 2007). In horses, a similar immunostimulatory effect of CpG-ODNs on 
BALF cells was reported and characterised by both IL10 and IFNγ release after 
CpG-ODN administration (Klier et al., 2011).  A subsequent in vivo study performed 
by the same group demonstrated that inhalation of biodegradable, biocompatible and 
nontoxic gelatin nanoparticle bound CpG-ODN 2216 resulted in enhanced IL10 
release by BALF cells (Klier et al., 2012). The reported IL10 release may relate to T 
reg cell activation, a process shown to inhibit neutrophil infiltration (Montagnoli et 
al., 2006). Moreover, the stimulation of IL10 and IFNγ release by T reg cells has also 
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been shown to be protective against the development of airway hyperactivity (Stock 
et al., 2004). 
 
1.11  Rationale and aims of the study 
As early as 300BC, Aristotle commenced his investigation of animal biology and 
suggested that horses and humans have many biological similarities. Moreover, he 
tried to characterise many equine respiratory syndromes. Since then, the evolution of 
veterinary medicine has resulted in the extensive investigation of the 
pathophysiology of many equine diseases. Nonetheless, hitherto the mechanisms of 
equine innate immunity are far from completely elucidated. 
IAD is one of the most common performance limiting pulmonary disorders in young 
racehorses in training. Although the precise aetiopathogenesis is poorly understood, 
proposed mechanisms include opportunistic bacterial infections and/or sub-optimal 
air-hygiene. Since AMs are the main cells responsible for bacterial and particulate 
clearance within the lungs, it was hypothesised that they represent an appropriate 
therapeutic target-cell for the disease. Therefore, acquiring a better understanding of 
macrophage biology is of paramount importance in addressing this issue. This thesis 
focuses on the role of AMs in the immune system of the equine lower respiratory 
tract.  
Although all types of tissue macrophages might derive from the same progenitor 
cells, they develop a function and phenotype that is highly dependent on their milieu. 
Therefore, the aim of this study was to characterize the function and phenotype of the 
equine AM and by making comparisons with PMs, to help further define the 
influential role of the microenvironment.  
As mentioned above there is a great demand of animal models that more closely 
resemble human pathophysiology. Therefore, comparisons are made between the 
data obtained from horse-derived cells and that published in relation to human, 
porcine and murine-derived cells, with particular focus on their LPS induced 
inflammatory status. 
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Finally, an additional aim was to perform a genome-wide gene expression scan on 
AMs isolated from Standardbred racehorses prior to and after commencement of 
competition race training in order to identify any exercise-associated gene expression 
modulation and to determine whether any mechanisms and biofunctions could be 
identified which might reflect a training-associated inflammatory response and/or 
immunological derangement which may increase susceptibility to opportunistic 
infections.  
The next section (Chapter 2) describes the methodology followed in this thesis, 
while Chapter 3 presents the series of the experiments performed. The findings of 
this section will be discussed in Chapter 4, along with future perspectives of this 
project. Overall, it will be shown that there is evidence for using horse as an 
appropriate animal model for human studies, since abundant number of 
monocytes/macrophages can be isolated from a single individual which, specifically 
in relation to AMs, show a similar response to LPS. Moreover strong differences 
between AMs and PMs are presented, highlighting the microenvironmental effect on 
determining macrophage diversity. Finally, it will be revealed that training, in 
addition to other factors, may have a significant effect on the respiratory immune 
system of the horse, specifically in relation to the AM, which represents the first line 
of cellular immune defence in the lungs.  
Together, the information provided here sheds more light on equine macrophage 
biology, with emphasis on the AM, and provides a first step in understanding its role 
in IAD, and its potential as a therapeutic target cell. Moreover, the results presented 
within this thesis form a platform on which future studies can be generated aimed at 
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Chapter 2: Materials and methods 
 
2.1 Animals used in the study 
 
2.1.1 Euthanised horses 




 SEM), range: 4-22 years)] were 
admitted to the Equine Hospital at the Royal (Dick) School of Veterinary Studies for 
elective euthanasia. The Veterinary Ethical Review Committee of the School of 
Veterinary Medicine, University of Edinburgh approved all the protocols involving 
the use of post-mortem material from these animals. Horses were euthanised by the 
intravenous (i.v.) administration of cinchocaine hydrochloride (25mg/mL) and 
secobarbital sodium (400mg/mL) (Somulose
TM
, Arnolds/Dechra, UK), via a pre-
placed 14 gauge i.v. jugular catheter. All animals were systemically healthy and 
17/18 had no history of chronic or immediate respiratory disease while one was 
diagnosed with RAO prior to euthanasia (Horse 7). Post-mortem examination 
confirmed the absence of gross lung pathology in 17/18 horses. One horse had gross 
evidence of previous EIPH (Horse 4), and another was identified with airway 
eosinophilia after a differential cell count (DCC) was performed on its BALF (Horse 
9).  
Samples derived from horses diagnosed with a respiratory condition were not used in 
the experiments that investigated functional and phenotypic characteristics of the 
macrophages. The following samples were obtained from these subjects: BALF 
(n=14), peritoneal lavage fluid (PLF) (n=11), spleen (n=8) and venous blood (n=12). 
The retrieved samples were immediately placed on ice and processed within 1h of 
collection at the Roslin Institute. Animals used are detailed in Table 2.1. 
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Horse ID Age Sex Reasons of Euthanasia  Sample 
Horse 1 20 F Elective euthanasia BALF 
Horse 2 15 F Suspected protein losing enteropathy with 
poor weight gain-elective euthanasia 
BALF, PLF 
Horse 3 22 F Elective euthanasia BALF, PLF 
Horse 4 11 F Orthopaedic problem- elective euthanasia BALF, PLF 
Horse 5 7 F Elective euthanasia BALF, PLF, Spleen 
Horse 6 12 F Elective euthanasia BALF, PLF, Spleen 
Horse 7 10 F RAO-elective euthanasia BALF, PLF, Spleen, Blood 
Horse 8 4 F Elective euthanasia BALF, PLF, Spleen, Blood 
Horse 9 13 F Elective euthanasia BALF, Spleen, Blood 
Horse 10 16 F Blood bank horse-elective euthanasia BALF, Spleen, Blood 
Horse 11 16 F Blood bank horse-elective euthanasia BALF, PLF, Spleen, Blood 
Horse 12 16 F Blood bank horse-elective euthanasia BALF, PLF, Spleen, Blood 
Horse 13 22 M Blood bank horse-elective euthanasia BALF, PLF, Blood 
Horse 14 22 F Blood bank horse-elective euthanasia BALF, PLF, Blood 
Horse 15 16 M Blood bank horse-elective euthanasia Blood 
Horse 16 12 M Blood bank horse-elective euthanasia Blood 
Horse 17 13 F Blood bank horse-elective euthanasia Blood 
Horse 18 10 F Blood bank horse-elective euthanasia Blood 
 
Table 2.1: Details of euthanised horses. 
 
2.1.2 Standardbred racehorses 





SEM) and age range: 3-6 years, from a racing yard under the care of 
the Nantes Veterinary School Equine Clinic were included in this study. The 
Veterinary Ethical Review Committee of the College of Veterinary Medicine at 
Nantes approved all the protocols involving the use of these animals. Horses were 
treated according to standard welfare procedures and informed owner consent 
obtained. All eight horses were clinically healthy. Clinical examination by two 
clinicians (Dr Anne Courouce-Malblanc and her resident student Marianne 
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Depecker) was performed in all the Standardbred racehorses prior to sample 
collection. 
BALF samples were collected at two different time points: prior to the 
commencement of intense training (T0, end of the rest period) and during a period of 
training (T1). Horse BU8 was sampled only at timepoint T1. All samples were 
collected early in the morning between 0600 and 0700, before feeding. The time 
lapsed between the previous training session and the sample collection was at least 
24h. Animals used are detailed in Table 2.2. The standard training programme 
consisted of  an initial three week period of light work (jogging), followed by an 
increase in work intensity to also include two days per week of aerobic exercise, 
which continued until the blood lactate concentration reached 3-4mmol/L. Apart 
from horses BU2, BU4 and BU5 which were sampled following an identical 1.5 
week period of light work (jogging), the remaining horses had all been in a 
standardised full training program for a period of 7 weeks. The period between the 
T0 collection and the initiation of training varied between horses. 
Horse ID Age 
(years) 
Sex T0 (at rest) T1 (post rest training period in weeks ) 
BU1 4 F 2 weeks rest 7 weeks in full training, raced 8 days before sampling 
BU2 5 F 6 weeks rest 1.5 week in light training 
BU4 5 M 6 weeks rest 1.5 week in light training 
BU5 3 F 6 weeks rest 1.5 week in light training 
BU6 6 F 6 weeks rest 7 weeks in full training, raced 2 weeks before sampling 
BU8 4 M sampling not 
available 
7 weeks in full training 
BU11 3 F 2 weeks rest 7 weeks in full training 
BU12 3 M 2 weeks rest 7 weeks in full training 
 
Table 2.2: Details of Standardbred racehorses. 
 
Characterisation of the equine macrophage/monocyte 
 63 
2.2 Sample collection and cell isolation 
 
2.2.1 Bronchoalveolar lavage fluid (BALF) 
Post-mortem: Following euthanasia, the trachea was exposed, transected and 
occluded proximally to prevent blood contamination of the lungs. The thorax was 
opened and the lungs, with trachea attached, were removed and transferred to a clean 
working area. The trachea was further transected at a level approximately 15cm from 





D1408, Sigma-Aldrich, USA) were instilled into the lungs, either directly into the 
trachea or via a cuffed endotracheal tube. Following gentle massage of the lungs, the 
BALF was retrieved by gravity following elevation of the lungs above the level of 
the distal trachea. 
Field work: BALF was collected by Dr Anne Courouce-Malblanc and Marianne 
Depecker as previously described (Depecker et al., 2014). A flexible 3.2 m long, 12.8 
mm tip diameter videoendoscope (Optomed) was inserted in the left nostril, guided 
through the laryngopharynx into the trachea and afterwards introduced into the left or 
the right mainstem bronchus till it wedged in a more distal bronchus. 
A volume of 250mL sterile isotonic saline solution was infused into the bronchus 
during endoscopy. Initially, the endoscopic channel was filled with 20mL of saline. 
Afterwards a 125mL bolus of saline was instilled via two 60mL syringes and 
immediately retrieved by manual aspiration. The initial 20mL of retrieved fluid, 
representing the dead-space volume of the endoscope biopsy channel, was discarded 
and the remaining fluid collected. This process was repeated using a further 125mL 
bolus of saline. Following this procedure, the endoscope instrument channel was 
flushed with 30mL isotonic saline and the same process repeated in the contralateral 
lung. The BALF recovered from each lung was transferred separately from metallic 
bowls into sterile plastic beakers and kept on ice until processed later in the lab. 
Sedation was required only in horse BU8, which received intravenous administration 
of romifidine iv (10 mg/l, Sedivet, Boehringer Ingelheim Ltd, St. Joseph, MO, USA).  
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2.2.2 Peritoneal lavage fluid (PLF) 
For post-mortem peritoneal lavage, an incision was made in an aseptically prepared 
area of the ventral abdominal midline down to the level of the linea alba, through 
which a catheter with luminal trocar was inserted into the peritoneal cavity. 
Following removal of the trocar, 6 L of sterile PBS was infused into the peritoneal 
cavity by gravity. Following abdominal ballottement, the horse was hoisted by the 
pelvic limbs and the peritoneal cavity opened carefully. The instilled fluid, which 
had gravitated to a level immediately caudal to the liver, was visualised and retrieved 
by siphoning through a 1 m length of sterile tubing. 
2.2.3 Cell isolation from BALF and PLF 
First the fluid was filtered (100μm cell strainer) and decanted into 500mL falcon 
tubes and centrifuged at 400g for 10min at 10
0
C. Supernatant was removed carefully 
and the cell pellets re-suspended in PBS and transferred to a 50mL falcon tube which 
was further centrifuged at 400g for 5min at 10
0
C. The cell pellet was resuspended in 
1 mL of RPMI-1640 (Sigma-Aldrich, UK) and cells were counted using a 
haemocytometer. Viability was assessed by adding Trypan blue 0.4%. When grossly 
visible blood contamination was evident, 5mL of sterile red cells lysis buffer (10mM 
KHCO3, 155mM NH4Cl, 0.1mM EDTA pH 8.0) was added for 5min, after which 
cells were washed once with PBS and centrifuged at 400g for 10min.  
2.2.3.1 Differential cell count (DCC) of BALF and PLF 
An aliquot of each cell suspension was retained for cytological analysis as described 
previously (Hughes et al., 2003, Pickles et al., 2002). Cell numbers were adjusted to 
5x10
5 
cells/mL by the addition of a calculated volume of PBS. From this aliquot,two 
cytospin slide preparations were prepared per lavage (cytocentrifuged at 1000g for 
3min), stained (Leishman stain; L/1815L/PB05, Fisher Scientific, Leicestershire, 
UK) and a DCC calculated under light microscopy by counting 500 cells (Hoffman, 
1999). Each type of cell was presented as a percentage of total counted nucleated 
cells. Epithelial cells were not included in the calculations. DCC of the BALF from 
Standardbred racehorses was performed at the Frank Duncombe Laboratory, in 
France, by counting 300 cells. Horses were considered free of inflammatory airway  
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disorders based on the following DCC cut off values: neutrophils ≤ 10%; mast cells 
<5%; eosinophils ≤ 2% (Hare and Viel, 1998, Koblinger et al., 2011, McGorum and 
Dixon, 1994, Wasko et al., 2011, Depecker et al., 2014, Richard et al., 2010a). 
 
2.2.4 Spleen cell isolation  
A sample (approx. 15g) of horse spleen was collected following euthanasia, 
immediately transferred into a sterile beaker with PBS and stored on ice. After 
several washes with PBS to remove peripheral blood contamination, the sample was 
sectioned into pieces and smashed with a syringe plunger in sterile petri dishes. 
Spleen tissue was incubated with collagenase (100µg/mL, Sigma C9263-25mg) for 
1h in a shaking incubator, following which collagenase activity was inhibited by the 
addition of EDTA (Sigma E8008, dilution 1:100). The sample was then filtered 
(100μm cell strainer) and transferred to a sterile 50mL falcon tube. Splenic cells were 
layered on top of 15mL of Lymphoprep (Axis-Shield, Norway) and centrifuged at 
1,100g for 25min with the brake disengaged, following which the distinct layer of 
separated splenic cells was removed, the cells washed twice with PBS and 
centrifuged at 600g for 10min and 400g for 10min. Supernatant was discarded and 
the cell pellet resuspended in 2mL PBS and counted prior to cryopreservation. 
2.2.5 Isolation of peripheral blood mononuclear cells 
(PBMCs) 
Blood was collected into sodium heparin vacutainer tubes via a pre-placed 14 gauge 
i.v. jugular catheter immediately prior to euthanasia. Approximately 80 mL whole 
blood per horse was collected. After blood was mixed with the same volume of 
RPMI, 35mL of this suspension was layered on top of 15mL of Lymphoprep (Axis-
Shield, Norway) and centrifuged at 1,100g for 25min with the brake disengaged. 
PBMCs were separated into a distinct layer which could easily be harvested. This 
was washed twice with PBS and centrifuged at 600g for 10min and 400g for 10min. 
Supernatant was discarded and the cell pellet resuspended in 2mL PBS and counted 
prior to use or cryopreservation. 
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2.2.6 Cryopreservation 
Cells not used on the day of sampling were cryopreserved for later use by the gradual 
addition of freezing medium (FCS 90%, DMSO 10%) (Sigma-Aldrich, USA). Cells 
were aliquoted at 5x10
7
cells/mL per cryovial. The cryovials were stored overnight in 
an isopropanol freezing unit at -80
0
C (Nalgene, Denmark), facilitating a slow 
reduction in temperature. The following day, cells were transferred to a -155
0
C 
freezer for long-term storage. When thawing, cells were pre-warmed for 5min in a 
waterbath at 37
o
C. Thawed cells were washed with PBS, added dropwise to 
minimise osmotic shock. Cells were then centrifuged at 400g for 5min, the 
supernatant carefully discarded and the cells resuspended in 1mL RPMI for cell 
counting. Viability of the cells was assessed using Trypan blue 0.4%. 
 
2.3 Cell culture 
Cells were seeded in six well plastic plates (Nunc, Thermo Scientific, Wilmington, 
USA) at 1x10
6 
cells per mL in complete medium: RPMI-1640 medium supplemented 
with GlutaMAX™-I Supplement
 
(Invitrogen Ltd, Paisley, UK), 
penicillin/streptomycin (Invitrogen Ltd, Paisley, UK) and 10% heat-inactivated FCS 
(FCS - PAA Laboratories GmbH, Austria) or 10% heat-inactivated Horse Serum (HS 
- Sigma Aldrich, cat no: H1138). The response of AMs and PMs cultured in the 
presence of both horse serum and the more commonly used FCS was compared to 
further assess whether inter-species differences in macrophage responses to pathogen 
challenge are due in part to serum proteins, as suggested by Warren et al (2010) 
(Warren et al., 2010). Plates were incubated at 37
0
C in 5% CO2 overnight. The 
following day, nonadherent cells were removed. New complete medium was added 
and adherent cells were stimulated with different agonists: LPS (10ng/mL and 
100ng/mL) from Salmonella enterica serotype Minnesota Re 595 (source strain: 
ATCC 49284, L9764, Sigma-Aldrich, USA), heat killed Salmonella enterica; 







Poly IC (Invitrogen, San Diego, USA) (2µg/mL). Supernatant from the plates was 
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collected at various time points (0, 2, 6 and 24h) following stimulation and stored at -
20
0
C until further analysis.  
Ten million PBMCs were incubated in petri dishes (w/2mm Grid 430196, 
60mmx15mm style, Corning Incorporated NY 14831) in complete medium: RPMI-
1640 medium supplemented with GlutaMAX™-I Supplement
 
(Invitrogen Ltd, 
Paisley, UK), penicillin/streptomycin (Invitrogen Ltd, Paisley, UK) and 10% heat-
inactivated horse serum (HS - Sigma Aldrich, cat no: H1138), supplemented with 
recombinant human (rh) CSF1 (1mg/mL) and incubated at 37
0
C, 5% CO2 for six 
days. Additionally, the same experiment was performed in the absence of rhCSF1 
and a higher concentration of HS (30%). 
For the endotoxin tolerance experiment, AMs and PBMCs were cultured in the same 
complete medium as described above in the presence of HS and stimulated with two 
consecutive LPS (100ng/mL) doses. Twenty four hours following stimulation with 
the first LPS dose, supernatant was collected, the medium refreshed and cells re-
stimulated with the same dose of LPS. Supernatant was collected 24h later and stored 
at -20
0
C until further analysis by enzyme linked immunosorbent assay (ELISA).  
 
2.4 Enzyme linked immunosorbent assay 
Equine TNFα and IL10 protein concentrations in cell culture supernatants were 
measured using the DuoSet ELISA kit (R&D systems, Minneapolis) according to the 
manufacturer’s instructions and a few optimisations. After diluting the capture 
antibody (Part 841816, 0.4µg/mL for TNFα and Part 842605, 0.8µg/mL for IL10) in 
PBS, a 96 well microplate was coated with 50µl of capture antibody per well. The 
plate was sealed and incubated at room temperature overnight. The following 
morning, the plate was washed three times with 200µl of wash buffer (0.5% Tween
R
 
20 in PBS, catalog number WA126, R&D systems, Minneapolis). The liquid was 
carefully removed on each occasion and following the final wash, the plate was 
turned upside down and tapped on clean papers towels.  
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Afterwards the plate was blocked with 150µl of Reagent diluent (1% bovine serum 
albumin in PBS, 0. 2µl filtered, catalog number DY995, R&D systems, Minneapolis) 
and incubated at room temperature for 1h. Following the wash step, cell culture 
supernatant samples were diluted in Reagent diluents for TNFα and for IL10 (50µl 
final dilution). The maximum standard concentrations for TNFα and IL10 were 
2000pg/mL and 3000pg/mL, respectively, and a standard curve consisting of seven 
concentrations prepared by 1:2 serial dilutions in reagent diluent was prepared. The 
samples were incubated for 2h at room temperature, followed by a repetition of the 
wash step. Duplicates were assayed for each sample and standard dilution. Control 
dilutions, called BLANK, were also assayed in duplicate.  
Following the wash step, 50µl of diluted Detection antibody (Part 841817, 200ng/mL 
for TNFα and Part 842607, 100ng/mL for IL10) in reagent diluent were added to 
each well, the plate was covered and incubated at room temperature for 2h. After the 
wash step, Streptavidin – HRP (Part 890803, 05% in Reagent diluent) was added and 
the plate covered to avoid light exposure and left for 20 min at room temperature. 
Following a final wash step, 100µl of Substrate Solution (1/1 mixture of colour 
reagent A (H202) and colour reagent B (Tetramethylbenzidine) (catalog number 
DY999, R&D systems, Minneapolis) were added per well. The plate was kept in the 
dark for approximately 6 min. Stop Solution (50µl/well, 1N HCl) was then added to 
discontinue the reaction. Optical density was read on a Multiskan v2.6 (Thermo 





2.5 Nitrite assay 
Nitric oxide (NO) is unstable and is rapidly converted to nitrite. Thus, nitrite was 
measured as the end product of NO, using the Griess reaction as previously described 
(Gross and Levi, 1992). Positive and negative controls were obtained by using 
murine RAW-274.1 cells treated with LPS (10 and 100ng/mL) for 6h, since it is well 
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established that mouse macrophages produce NO in high levels (Haskó et al., 1996). 
Duplicates were used for each time point. Briefly, nitrite concentration was assayed 
against standards by incubating 50μL of supernatant/standard with 50μL Greiss 
reagent (0.1% α-napthyl-amine, 1% sulfanilimide, 2.1% phosphoric acid) for 10 min. 
Optical density was read on a Multiskan v2.6 (Thermo Scientific, Wilmington, USA) 
at 450 nm and data analyzed using Ascent software. Geneious software 
(http://www.geneious.com) was used to investigate the conservation of the inducible 
nitric oxide synthetase (iNOs) promoter sequences between human, mouse and horse 
with a Pustell DNA matrix (Pustell and Kafatos, 1986). 
 
2.6 Flow cytometry assay 
 
2.6.1 CD14, TLR4 and CD163 cell surface expression 
Cells were seeded onto cell culture plates at a concentration of 10
6
/mL, as previously 
described (Section 2.3), and left overnight. The following morning nonadherent cells 
were washed away and remaining adherent cells were gently detached using cell 
scrapers. One million
 
cells were used per vial. After 30 min incubation at 4
0
C in the 
dark with high-block solution (PBS, 0.1% NaN3, 2% FCS, 0.1%BSA), cells were 
washed with low-block solution (PBS, 0.1% NaN3, 0.2% FCS, 0.1%BSA) and 
centrifuged twice at 400g for 5min.  
Cells were then incubated for 30 min in the dark with 100µl of low-block solution 
and stained with either mouse monoclonal anti-equine CD14 IgG1 Ab, goat 
polyclonal anti-human TLR4 antibody or a mouse anti-human macrophage surface 
Ag monoclonal antibody targeting CD163. After three washes with low-block 
solution and centrifugation at 400g for 5 min, a F(ab') 2 goat anti-mouse secondary 
IgG was used for the CD14 and CD163 Ab staining, while a donkey secondary anti-
goat (Alexa-Fluor 633, Life A21082) was used for the TLR4 staining in 100µl of 
low-block solution. The cells were incubated for 30 min at 4
0
C in the dark (Table 
2.3). Cells were then washed, resuspended in 500µl of PBS and analysed using 
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CyAn™ ADP Analyser (Beckman Coulter, High Wycombe, UK) and Summit v4.3 
software (http://summit1.software.informer.com/4.3/ ). Sytox Blue 0.1% (Invitrogen, 
Catalogue No S34857) was added to exclude any dead cells from analysis. Non-
specific binding was controlled by using the secondary antibody only and all 
centrifugation steps were performed at 4
0
C. Data were acquired on approximately 
10,000 events. 
Antibody Concentration Source 
Mouse anti-equine CD14 1:100 Clone 105, Wagner Laboratory, Cornell 
University 
Goat anti-human TLR4 1:100 M-16:sc-12511, Santa Cruz Biotechnology, Inc 
Mouse anti-human 
CD163 (AM-3K) 
1:100 KT013, Gentaur 
Goat anti-mouse IgG 
F(ab') 2 
1:100 SATR105PE, RPE AbD Serotec,  
Donkey anti-goat IgG 1:200 Life A21082, Alexa-Fluor 633,  
 
Table 2.3: Antibodies used in flow cytometry. 
 
2.6.2 Phagocytosis assay 
Cells were seeded in duplicate (1x10
6
cells/mL), in petri dishes (w/2mm Grid 430196, 
60mmx15mm style, Corning Incorporated NY 14831) in complete medium 
(supplemented only with HS) and left overnight at 37
o
C, 5% CO2. The following 
morning, two plates were incubated at 4
0
C for at least 30min. The 4
0
C condition was 
incorporated to reveal the presence of surface adherent bacteria only, as phagocytosis 
is inhibited at this temperature. Medium from all plates was refreshed with warm and 
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cold cell culture media (as above), respectively; thus, removing nonadherent cells. 
Heat-killed Escherichia(E.) coli bioparticles (E2861, K-12 strain, 10mg, Life 
techonogies, Molecular probes
R
) were added at a ratio of 10 bacteria per cell in one 
plate at 37
0
C and one at 4
0






plates; these were incorporated to control for autofluorescence. Paired plates were 




C, respectively, to allow particle uptake. All cells 
were washed twice with cold PBS and were gently collected with cell scrapers. Cells 
were then centrifuged at 400g for 5min, resuspended in 500 mL of cold PBS and 
analysed on a CyAn™ ADP Analyser, as above. 
 
2.7 RNA analysis 
 
2.7.1 Total RNA extraction  
Total RNA from both AMs and PMs was extracted using RNA-Bee (Amsbio, 
Abingdon, UK) according to the manufacturer’s instructions. After carefully 
removing the supernatant of the cell culture plates, 1mL of RNA-Bee was added for 
the cell lysis, since at least 0.2 mL of RNA-Bee per 10
6
 cells was indicated by the 
protocol. Then 0.2 mL chloroform was added per 1 mL of RNA-Bee. The sample 
was shaken vigorously for approximately 30 sec and left on ice for 5 min. 
The homogenate was centrifuged at 12,000g for 15 min at 4
0
C. Afterwards, the 
sample formed a lower blue phenol-chloroform phase, an interphase, and an upper 
colourless aqueous phase. The aqueous phase contained the RNA and had almost 
50% of the volume of the RNA Bee used, plus the volume of the sample. After 
transferring it to a clean tube for the precipitation step, 0.5 mL of isopropanol was 
added, the sample stored for 30 min at room temperature and then centrifuged at 
12,000g for 15 min at 4
0
C.  
Following centrifugation, the supernatant was removed, the RNA pellet washed once 
with 75% ethanol and then centrifuged for 10 min at 7,500g at 4
0
C. At least 1 mL of 
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ethanol solution was used per 1 mL of RNA-Bee used for the initial homogenization. 
Finally, the RNA pellets were air-dried for 10 min, then dissolved in 50 µl of RNase-




2.7.2 RNA quality assessment  
RNA concentration and purity was measured using ND-1000 Nanodrop 
spectrophotometer (Thermo Scientific, Wilmington, USA) by measuring absorbance 
at 260 and 280 nm (A260, and A280 respectively). Purity of RNA was determined 
using the A260/A280 ratio. A ratio close to two is indicative of pure RNA. RNA 
integrity was confirmed with RNA 6000 Pico Assay (Agilent Technologies). RNA 
integrity number (RIN) greater than seven as considered appropriate for qPCR and 
microarray use (Schroeder et al., 2006). 
 
2.7.3 cDNA synthesis 
One microgram total RNA was converted to complementary DNA (cDNA) using the 
NanoScript reverse transcription kit (RT –NanoScript, Primerdesign, Southampton), 
according to the manufacturer’s instructions. A 10µl final solution contained 1µg of 
RNA, 1µl of random nonamer primer and RNAase/DNAase free water. Solutions 
were heated for 5min at 65
0
C and then stored on ice. The transcription mix contained 
2µl of nanoScript 10x Buffer, 1µl of 10mM  dNTP, 2µl of 100mM DTT, 1µl of 
NanoScript enzyme and 4µl RNAse/DNAse free water to make a final volume of 
10µl. 10µl of the transcription mix was added on each of the samples stored on ice. 
Negative controls were included by omitting the NanoScript enzyme in order to 
check for genomic contamination (NRT control). The samples were incubated for 5 
min at room temperature, then for 20 min at 55
0
C and finally at 75
0
C for 15 min. 
cDNA was stored at -20
0
C until further use in the RT qPCR reaction.  
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2.8 Real time quantitative polymerase chain reaction 
(RT qPCR) 
All the RT qPCR reactions were carried out using the Stratagene Mx3000p qPCR 
System following the manufacturer’s instructions. RT qPCR with SYBR Green 
chemistry was performed according to the custom designed real time PCR assay 
from Primerdesign. Each sample was tested in triplicate. A negative control, 
containing no reverse transcriptase, produced during cDNA synthesis (NRT control) 
(Section 2.7.3), and a second negative control containing no cDNA (NT control), 
which reveals possible contamination problems, were always included in each assay. 
Primers for the genes of interest were provided by Primerdesign. Primer details are 
shown in Table 2.4. 18S ribosomal RNA (18S) was selected as a housekeeping gene 
according to the results of the GeNorm kit used in the current study (Section 2.8.1).  
The cDNA of the samples (LPS treated and untreated) was diluted in RNA/DNAase 
free water to a concentration of 5ng/mL. Five microliters of each sample was added 
to 1µl primer mix, 10µl Primerdesign Precision SYBRgreen 2X qPCR Mastermix, 
0.5µl ROX reference dye (Invitrogen, Catalogue No 12223-012) and 3.5µl 
RNA/DNAase free water, in order to make a final volume of 20µl. RT qPCR cycling 
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Primer Name Sequence (5’-3’) Tm (
0
C) Product Length 
TNFα sense ATCTACTCCCAGGTCCTCTTC 55.9 129 
TNFα antisense CGTGTTGGCAAGGCTCTT 55.7  
IDO sense ATCAAAGAAATTCCGTTATATTCAA 54.1 94 
IDO antisense TGCGTAGACAAGAAGAAGTTATATCAAT 55.6  
STAT 4 sense TCAGTAGAATTTCGCCATTTGC 56.2 119 
STAT 4 antisense ATCTGTGTCTCAAAGGTTATGGA 55.9  
IL7R sense TCCTCCGCAACTAGATGATTC 55.5 109 
IL7R antisense CTCTCCTCCGAAAGTTTTTGG 55.1  
CYP27B1  sense AGTTGTCAGCCTCGTCCAT 56.3 96 
CYP27B1 antisense GTTCATACAGCCCAAGAGAG 56.7  
TNIP3 sense CATGGCACATTTTGGACAGG 55.7 95 
TNIP3 antisense AGTTCTTTCTTCTTGATGATTGAGT 55.8  
18S sense CGGACAGGATTGACAGATTGATA 56.8 118 
18S antisense TGCCAGAGTCTCGTTCGTTA 56.8  
ACTB sense GGCATCCTGACCCTCAAGT 56.7 194 
ACTB antisense GCTCGTTGTAGAAGGTGTGG 56.6  
B2M sense AGGACTGGTCTTTCTATCTTCTG 55.8 111 
B2M antisense ACTTAACTATCAGGGGGTCTTTG 56.3  
GAPDH sense GGAGTCCACTGGTGTCTTCA 56.9 91 
GAPDH antisense AGCAGAAGGAGCAGAGATGAT 56.8  
SDHA sense GGACAGAGCCTCAAGTTTGG 56.5 116 
SDHA antisense GTATCATATCGTAGAGACCTTCCATA 56.6  
HPRT1 sense CTGAGGATTTGGAAAAGGTGTTTAT 56.9 89 
HPRT1 antisense TCCCATCTCCTTCATCACATCT 56.8  
 
Table 2.4: Oligonucleotides used in RT qPCR analysis 
 










Table 2.5: RT qPCR reaction thermal profile 
Real time qPCR data were analysed with the Stratagene MxPro qPCR Software 
according the standard curve method as previously described (Winer et al., 1999). 
Expression level values were first derived from the standard curve equations and 
were normalised to the reference gene 18S rRNA, as described in Section 2.8.2 by 
applying the following formula: 
 
 
2.8.1 Primer efficiency  
The efficiency of the primers was determined by analysing standard curves for each 
set of primers. Standard curves were run for each RT qPCR plate. Examples are 
presented  in Appendix I. Five serial two fold dilutions of cDNA reaction mixtures 
Step Time Temperature Number of cycles 
Enzyme activation 10 min 95
0
C 1 
Denaturation 15 sec 95
0
C  
40 Annealing and extension 1 min 60
0
C 
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from 1:10 to 1:160 were made and RT qPCR reactions were performed in triplicate 
for each primer mix separately.  
The cycling threshold (Ct) values of each of the dilutions were plotted against the 
cDNA dilutions and the slopes calculated from the graphs. Graphs with a high 
correlation coefficient (Pearson’s correlation coefficient r≥0.90) and high linearity in 
the investigative range are representative of high primer efficiency. One hundred 
percent efficiency corresponds to a perfect doubling of template during every cycle, 
however, the conventional range is 90-110% for assay validation, which corresponds 
to standard curve slopes of -3.1 to -3.6.  
 
2.8.2 Reference gene selection 
The establishment of the optimal reference genes was performed by using the 
geNorm
TM 
reference gene selection kit (Primerdesign), according to manufacturer’s 
instructions. The genes tested were the 18S, Glyceraldehyde 3-phosphate 
dehydrogenase (GAPDH), Beta-actin (ACTB), β2 microglobulin (B2M), Succinate 
dehydrogenase complex, subunit A (SDHA) and Hypoxanthine-guanine 
phosphoribosyltransferase (HPRT1). 
In order to select an appropriate reference gene, cDNA of the samples (4 LPS treated 
and 4 untreated) was diluted in RNAse/DNAse free water to a concentration of 
5ng/mL and RT qPCR assay was performed as described above (Section 2.8). 
qBase
PLUS
, a real time data analysis software, was used for the analysis of the results. 
Genorm M and V analysis was performed (http://www.biogazelle.com/). The M 
value indicates the average expression stability value of the reference genes; the 
lower it is, the more stable the gene. The V value determines the optimal number of 
reference genes required in each experiment by illustrating the variation in average 
stability of the reference genes. This calculation is known as pairwise variation, 
V(n/n+1). The threshold of the V value is 0.15. 
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2.9 Statistical analysis 
Descriptive statistics were performed using Mini Tab 16 statistical software (Minitab 
Ltd., UK). After testing for normality, a one-sample Wilcoxon test was employed to 
identify differences in protein production/gene expression production between (a) 
untreated cells (controls) and cells incubated for 2h, 6h, 24h following multiple 
antigen challenge stimulation, (b) cells incubated with FCS and HS, (c) low and high 
dose of endotoxin (d) fresh and cryopreserved cells and (e) before [T0] and during 
the training period [T1], and to compare the DCC between timepoints T0 and T1. A 
Mann-Whitney test was performed to identify any statistical significance in the 
protein production between AMs and PMs and to compare the DCC findings 
between the racehorse and nonracehorse groups. A two sample t-test was performed 
to identify any statistically significant differences in the BALF DCCs between both 
healthy and diseased horses and racehorses and nonracehorses. Statistical 
significance was assumed at p<0.05. Numeric results are presented as mean
+ 
SEM. 
All the experiments were performed using different biological replicates.  
 
2.10 Microarray analysis 
Microarrays were processed by ARK Genomics (Centre for Comparative and 
Functional Genomics) at the Roslin Institute. Total RNA (50ng) was amplified by the 
Nugen Pico SL kit (Agilent, the Netherlands). Two and a half micrograms (2.5µg) of 
the cDNA produced was biotin labelled using the Nugen Encore labelling kit. Biotin 
labelled transcripts were prepared for hybridisation following the Nugen protocol for 
Gene Titan hybridisation (Affymetrix, Santa Clara, CA), using the Affymetrix Gene 
Titan Hybridization Wash and Stain Kit for WT Array Plates (PN 901622). The 
samples were hybridised to Equine Gene 1.1 and 1.0 ST Array Strips from 
Affymetrix, including 30,559 probe sets, using the appropriate Hyb-Wash Scan 
protocol and the Gene Titan Hyb-Wash Stain Kit for the reagents (Affymetrix, Santa 
Clara, CA). The arrays used were oligonucleotide microarrays that consisted of 
probes corresponding to exons along the whole length of each transcript (25 probes 
sets per transcript). However, 41.3% of the transcripts included in the arrays were 
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missing gene symbol information, due to the poor annotation of the horse genome. 
The microarrays also included a small number of duplicate transcripts (183 out of 
17,929 annotated transcripts), that correlated during the analyses. 







Software (AGCC) version 3.0.1. For the 
quality control, Affymetrix Expression Console Software was used. Expression 
values were normalized according to the RMA algorithm within the Expression 
Console Software (Irizarry et al., 2003). Equine Gene 1.1 ST Affymetrix Array Strip 
(Affymetrix, Santa Clara, CA) was used for the first batch of horses (horses 1-3, LPS 
treated and controls).  After this, due to lack of availability of this strip from 
Affymetrix, Equine Gene 1.0 ST Affymetrix Array Strip was used for the remaining 
samples. Comparisons between the two array strips were feasible since the same 
group of probesets (30,559 probesets) was used in both array types. 
 
2.10.1 Partek microarray analysis 
CEL files were imported to Partek Genomic Suite 6.6 software (North America 
Partek Incorporated, St. Louis, Missouri) for the microarray data analysis, using 
default parameters. The resulting data were expressed in Log2. Principal-component 
analysis (PCA) was performed to detect outliers and assess whether batch effects or 
other parameters significantly affected the data.  
 A two way ANOVA (random effect: array type; fixed effect: cell type) was 
used for the microarray analysis to compare untreated AMs and PMs in the 
Section 3.2.6. In this case the gene list was created by using an adjusted p 
value <0.01 and a fold change of 9.  
 Data from untreated AMs at 0h were compared with the LPS treated AMs at 
the 6h time point (Section 3.3). A three way ANOVA (random effect: array 
type and horse ID; fixed effect: LPS treatment) was executed to compare 
differential expression in LPS treated and untreated AMs. A gene list was 
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created with a cut off adjusted p value <0.05 and a fold change of two for the 
LPS treated AMs.  
 The same statistical analysis was performed in Section 3.3.1, however in that 
case the array type was not included in the analysis, since only one type of 
arrays was utilised for that experiment. The microarray datasets used here 
derived from a human Reynier et al (2012) study (GDS4419, platform: 
GPL570: [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 
Array). 
 In Section 3.4.3 a two way ANOVA (time point: fixed effect; horse ID: 
random effect) test was performed in order to identify differentially expressed 
genes between the two groups of standardbred racehorses at rest and during 
the training period (p< 0.05, fold change of two).   
 In the final experiment described in the Section 3.4.4, a two way ANOVA 
with horse type as a fixed effect and scan date as a random effect, statistical 
significance 0.05 and fold change of two was performed in order to detect 
any differentially expressed genes between young racehorses and elderly 
nonracehorses. 
FDR (False discovery rate) or adjusted p-value using the Benjamini and Hochberg 
test for correction was used in all the experiments. Fold changes of at least two were 
used in all the experiments. These cutoff values are widely used in microarray data 
analysis. The only case in which more strict values were applied was in the 
comparison between AMs and PMs. In that case the vast difference between these 
two groups resulted in a very long gene list, that allowed the use of more firm cutoff 
points.Upregulated transcripts were represented with positive values, whereas 
negative values were used for the downregulated transcripts.For the validation of the 
microarray results, RT qPCR was performed in the same samples utilised for the 
microarray experiments. The same protocol as described in Section 2.8 was followed 
to target sequences of the genes of interest.   
 
2.10.2 Biolayout microarray analysis 
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A network analysis of the expression data was performed in BioLayout Express
3D
 
(Freeman et al., 2007). With this software pairwise Pearson correlation coefficients 
were calculated and a threshold of r>0.9 was chosen for the transcript to transcript 
comparison across the array samples. The resulting network graph consists of nodes 
that represent transcripts and the edges that represent expression correlations above 
the threshold (r>0.9) between the transcripts. The markov cluster algorithm (MCL) 
graph based algorithm was used to identify groups of tightly co-expressed genes, 
with an inflation value of 2.2 (van Dongen and Abreu-Goodger, 2012). Lowly 
expressed transcripts, with dynamic range ≤1.5, were filtered out.  
 
2.10.3 Functional annotation  
Initial annotation used the most recent Affymetrix annotation file imported in Partek 
software or identified in the Affymetrix Netaffx site and additional annotation was 
achieved by cross-mapping the non-annotated sequences to the human sequence 
using BLAT in the Ensembl browser (Couture et al., 2009, www.affymetrix.com).  
DAVID (Database for Annotation, Visualisation, and Integrated Discovery) 6.7 
software, as well as Partek Genomic Suite 6.6 software were used to determine the 
biological processes of the genes included in the gene lists. The enrichment score of 
the DAVID package is a modified Fisher exact p value calculated by the software, 
while in Partek software it is measured by a chi-square test comparing the proportion 
of the genelist in a group to the proportion of the background in the group tested. The 
higher the enrichment score is, the more enriched the cluster is. An enrichment score 
of greater than one means that the functional category is over expressed. A value of 
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Chapter 3: Extensive studies on the equine 
macrophage/monocyte 
The overall goal of the current study was to characterise the equine monocytes/ 
macrophages with a view to understanding their functions in homeostasis and 
pathology, as well as comparing them with macrophages from other, better 
characterised, mammalian species such as human, mouse and pig. 
  
3.1 Establishing a protocol for horse macrophage 
isolation and activation 
The horse is a valued and valuable animal, so it was important to achieve maximum 
utility from each animal euthanised. Therefore the first stage of this project was to 
establish the conditions for isolation, preservation, culture and stimulation of 
macrophages from different locations in the horse.  
 
3.1.1 Monocytes / macrophages can be isolated in high yield 
from the lungs, peritoneal cavity, spleen and peripheral 
blood from a single horse. 
Sample collection from different anatomical sites is essential not only for disease 
diagnosis and health status assessment, but also for research purposes, both in human 
and veterinary medicine (Hoffman, 1999, Mezhir et al., 2013, Zhang and Morrison, 
1993).  In particular, BALF, peritoneal fluid and blood samples are routinely used for 
diagnostic purposes by equine veterinarians (Hoffman, 1999, Harrold et al., 2000, 
Richard et al., 2010b).  Contrary to mice, where small volumes (circa 10mL)  of 
blood and lung and PLF can be isolated from a single animal (Zhao et al., 2005), 
horses represent an abundant source of different types of immune cells.  Isolation 
protocols for equine macrophages/monocytes from blood, lungs and peritoneal cavity 
of live horses have been reported (Laan et al., 2005, Morris and Moore, 1987, Raabe 
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et al., 1998) while one study on post-mortem on BALF retrieval in an abattoir is 
published (Hammond et al., 1999a).  
However, a greater volume of BALF and PLF, and consequently cell yield, can be 
obtained from horses following euthanasia. For example 75-250mL of PLF per horse 
can be obtained from live horses (Hawkins et al., 1998, Massoco and Palermo-Neto, 
2003) , compared to 1.5-3L per horse obtained following euthanasia. Similarly, circa 
250-300mL is routinely instilled into the bronchus of a live horse (Lavoie et al., 
2011, Laan et al., 2006), while in the current study a volume of 2L was instilled into 
the trachea. These volumes and associated cell retrieval values represent 2-3 orders 
of magnitude greater than can be obtained from rodent models.  
The present study used a series of 18 horses euthanised for a variety of reasons 






) cells were isolated from the 








42) from the spleen 




9) from the peripheral blood (approximately 80ml) 
(Figure 3.1.1.A). A greater cell yield was obtained from the lung compared with 
peritoneal cavity. Although this finding may reflect the relatively greater surface area 
of tissue lavaged, it may also reflect a difference in cell density (per unit surface 
area) between these anatomical sites. Due to the extensive lung surface area, which is 
continuously exposed to numerous inhaled pathogens and pro-inflammatory agents; 
there is likely a greater requirement for an abundance of immune cells in the lungs 
compared to the peritoneal cavity. The yield of cells from lungs of horses with 
evidence of pulmonary disease was statistically significantly lower than that from 
healthy individuals (Figure 3.1.1.B), potentially due to airway narrowing and fluid 
retention in the distal airways. In the cadaver, this airway narrowing may be due to 
disease-associated mild structural changes as previously reported in horses affected 
with EIPH (McKane and Slocombe, 2002), as opposed to bronchospasm resulting 
from airway hyper-responsiveness in the live horse, a mechanism cited as the cause 
of low fluid retrieval in horses with a high percentage of metachromatic cells (Lavoie 
et al., 2011).  
 





Figure 3.1.1: Cells harvested from different anatomical regions of the horse and from the lungs of 
horses with and without respiratory disease.  
Total cell recovery (x10
6
) from (A) the lungs, peritoneal cavity, spleen and blood of healthy horses 
and (B) the lungs of horses with and without a suspected pulmonary inflammatory disorder. Results 
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3.1.2 Cryopreserved monocytes/macrophages can be 
recovered from storage and retain their activity 
Given the high yield of cells, there are obvious economical and ethical benefits to 
harvesting and storing homogenous macrophage populations from a single donor, 
especially since this allows the cells to be used for repeated experiments 
incorporating multiple time points. The production and maintenance of cell lines has 
been proposed as one solution to this problem (Werners et al., 2004). However, 
continuous subculture may result in important genetic or epigenetic changes, yielding 
cell populations that do not represent their in vivo counterpart (Ho-Yeon et al., 2007).  
Several cryopreservation protocols utilizing different cryopreservatives, storage 
temperatures or containers have been tested for different animal species and cell 
types (Berz et al., 2007, Marim et al., 2010, Kapetanovic et al., 2012). In the current 
study, the widely used protocol of controlled freezing in DMSO (10%) and FCS 
(90%) was used for cell cryopreservation and cells were stored at -155
0
C 
(Kapetanovic et al., 2012, Marim et al., 2010).  Similar cryopreservation protocols 
have been used elsewhere for equine AMs, bone marrow monocytes, spleen 
macrophages and stem cells, but not for PMs (Werners et al., 2004, Martinello et al., 
2010, Moore et al., 2003, Raabe et al., 1998). 
Cell viability on the day of cell harvesting was greater than 90% as assessed by 
Trypan blue staining. Short-term (circa 1 month) and long-term (circa 6 month) 
cryopreservation caused little if any loss of cell viability, which remained higher than 
80% in all cases (Figure 3.1.2). This showed that cells from a single horse could be 
harvested, cryopreserved and stored for later use. 
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Figure 3.1.2: Cell viability.  
Cell viability (% live cells) was assessed using Trypan blue staining on fresh and cryopreserved (1 
month or 6 month storage) cells after thawing. Results are the mean of a minimum of 8 experiments 
+/- SEM. 
 
3.1.3 Differential cell counts on alveolar and peritoneal lavage 
The DCC in BALF and PLF provides useful information for the diagnosis of diseases 
of the lungs and abdomen (Hoffman, 1999, Barton et al., 1996).  Widely, reported 
DCC reference ranges in BALF are: 30-60% AMs, 30-70% lymphocytes, 0-5% 
neutrophils, 0.6-2% mast cells, 0-1.6% eosinophils (Mair et al., 1987, Moore et al., 
1995, Mazan et al., 2005, Couetil and Denicola, 1999), although others reported a 
greater number of mast cells, eosinophils or neutrophils in the BALF of healthy 
horses (Derksen et al., 1985, McGorum and Dixon, 1994, Richard et al., 2010b, 
Richard et al., 2010a). Reported differences in mast cell differential counts may be 
















Cell Viability (%) 
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technique used. Occasionally, gross blood contamination was observed in the PLF, 
making it difficult to assess the DCC by light microscopy. 
Results for DCCs of ex vivo BALF and PLF from healthy horses, as assessed by light 
microscopy (Figure 3.1.3), are summarized in Table 3.1.1 which shows that that 
PLF consistently yielded a lower proportion of macrophages and lymphocytes and 
higher proportion of neutrophils than BALF. The DCC of the three horses suspected 
as having a respiratory disorder revealed significant increases beyond the reference 
ranges in the percentages of haemosiderophages and granulocytes, which indicate the 
presence of respiratory disease (Table 3.1.2). The BALF cytology profile of the 
horse diagnosed with RAO was similar to that already reported in such cases and 
cytological analysis also revealed evidence of airway disease (eosinophilia and 
increased haemosiderophages) in two other horses without any preceding history of 
respiratory signs (Couetil et al., 2005, Bell et al., 2008, Michelotto Jr et al., 2011, 
Richard et al., 2010a, Hare and Viel, 1998). The horse with the increased 
haemosiderophages was a racehorse and this cytological finding was considered 








Figure 3.1.3: Photomicrographs of stained cytospin preparations of BALF and PLF.  
Cell numbers from the BALF (A) and PLF (B) were adjusted to 5x10
5
cells/mL by the addition of a 
calculated volume of PBS. Numerous erythrocytes surround the PMs in the PLF.  From this aliquot, 2 
cytospin slide preparations were prepared per lavage sample (1000g for 3min), stained with 
Leishman stain and a differential cell count determined under light microscopy by counting 500 cells. 






Characterisation of the equine macrophage/monocyte 
 88 
 
Table 3.1.1: DCCs (mean
+
SEM %) of BALF and PLF derived from healthy horses 
 
 
Table 3.1.2: DCCs (%) of BALF derived from horses (n=3) suspected as having a respiratory 
disorder. 
 
In order to confirm the differential counts calculated by light microscopy, cells from 
BALF were stained for CD14, the co-receptor for LPS, usually expressed on 
macrophages (Figure 3.1.4) (Kabithe et al., 2010). As discussed in the introduction, 
Section 1.2, CD14 is a co-receptor for the complex of LPS, LBP and TLR4 and is 
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The 60-70% of cells that showed high expression of CD14 (CD14
hi
 ) also showed 
greater side scatter during flow cytometric analysis, consistent with a population of 
macrophages (Region 1, R1), whereas the smaller and less granular CD14-negative 
cells were consistent with lymphocytes (Region 3, R3, 20-30%).  The remaining cells 





were likely a mixture of neutrophils, mast cells and monocytes.  
 
Figure 3.1.4: Flowcytometric characterization of the harvested BALF cells.  
BALF cells were stained with CD14 antibody. Median fluorescence intensity and granularity were 
measured by flow cytometry, using a total of 10,000 events. Region 1 (R1) represents cells with high 
expression of CD14 and high granularity (macrophages), R2 represents cells with low CD14 and high 
granularity (mix of monocyte/neutrophils) and R3 represents cells with no granules and no CD14 
(lymphocytes). These data are representative of three experiments. 
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3.1.4 Alveolar macrophages differ from peritoneal 
macrophages with respect to their morphology 
Macrophages of the lung have a distinct cellular phenotype in different species such 
as pigs, humans and mice, a finding considered to reflect the distinctive 
microenvironment of this cell and its “breath-by-breath” exposure to ambient air 
containing a variety of potential allergenic and pro-inflammatory components (Guth 
et al., 2009, Freeman et al., 2012, Ettensohn and Roberts, 1983). Following 
cryopreservation, both equine PMs and AMs retained a phagocyte-like morphology, 
including granularity and pseudopodia. There were clear differences in the cell 
morphology between AMs and PMs cultured in either FCS or HS. AMs were larger 
in size, had a greater number of granules within their cytoplasm and developed a 
greater number of pseudopodia compared to PMs (Figure 3.1.5). As shown earlier 
(Laan et al., 2005), following overnight culture and removal of nonadherent cells, 
more than 85% of adherent cells were identified morphologically as macrophages 
after performing a Leishman stain on the culture plates, for both AMs and PMs 
(Figure 3.1.6). The potential for minimal lymphocyte contamination could not 
entirely be excluded. However, such an occurrence was considered highly unlikely to 
affect the data derived from studies designed to investigate predominantly 










Figure 3.1.5: Morphological differences between alveolar and peritoneal macrophages.  
AMs and PMs recovered from cryopreservation were selected by an adherence step (overnight). Both 
cell populations show the usual stellate, adherent morphology of macrophages. The AMs (A) were 
larger in size, more granular in appearance and developed more pseudopodia compared to PMs (B). 









Figure 3.1.6: Leishman stain on cell culture plate of AMs (A) and PMs (B) for investigation of 
adherent cell differentiation (>90% were macrophages).  
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3.1.5 The response of equine macrophages to LPS is 
dependent on the type of serum used in the culture 
medium 
Serum is an essential component of cell culture media, and may be obtained from the 
autologous adult source (e.g. horse serum for equine studies) or from heterologous 
sources, commonly fetal bovine serum, newborn calf serum, adult human serum or 
pig serum (Werners et al., 2004, Okano et al., 2006, Fogelman et al., 1980, Pleau et 
al., 1977, Tenang and McCaldin, 1988). All sources of serum contain many basic 
nutrients, vitamins, growth factors, hormones and binding proteins, such as LBP and 
complement components, that augment the ability of the cells to respond to stimuli, 
opsonise particles and participate directly in various biological processes (Jochems et 
al., 2002, Zweigner et al., 2006). In particular, LBP is present in serum of healthy 
mammals and it enhances LPS binding to soluble, as well as cell membrane-bound 
CD14 of phagocytes in order to initiate the intracellular signaling pathway (Zweigner 
et al., 2006, Martin et al., 1992). Following stimulation with LPS, LBP is recruited to 
transfer LPS to CD14 on the surface of macrophages/monocytes, a process followed 
by formation of a complex with TLR4 and MD2, initiation of NFK signaling 
pathway, activation and cytokine production (Heumann et al., 1992, Steinemann et 
al., 1994, Miyake, 2004).  LBP enhances the cell sensitivity to LPS, permitting the 
detection of, and assessment of the response to, very low LPS concentrations 
(pg/mL) (Steinemann et al., 1994, Van Amersfoort et al., 2003). Serum, as a blood 
product, also contains complement, which might result in complement mediated cell 
lysis, an effect inhibited by heat inactivation. Heat-inactivated FCS has been a 
common serum of choice for cell culture experiments of murine and human cells 
(Heumann et al., 1992, Steinemann et al., 1994, Puddu et al., 1997).  One key 
molecule that is apparently absent from FCS, but normally present in adult serum, is 
CSF1. This factor is commonly assayed in the presence of FCS in many studies 
(Gow et al., 2012, Gow et al., 2013).   
Previous studies on horse macrophages have examined the importance of serum in 
monocyte responsiveness. Okano et al (2006) showed that LPS-induced pro-
coagulant activity by equine mononuclear cells was greater in the presence of FCS, 
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compared to serum free medium (Okano et al., 2006). Another study found that 
pooled commercial equine serum or autologous equine serum produced more 
consistent results from cellular assays of equine monocyte cultures compared to heat-
inactivated autologous equine serum or heat-inactivated FCS (Figueiredo et al., 
2008). Heat-inactivated autologous equine serum was found to have relatively low 
LBP activity, whereas FCS directly stimulated equine macrophages (Figueiredo et 
al., 2008). Moreover, commercial horse and autologous horse serum showed more 
consistent results between horses compared to FCS (Figueiredo et al., 2008). 
The relative merits of different sera were initially examined by comparing the 
response of freshly-isolated equine AMs and PMs to LPS in the presence of heat-
inactivated FCS versus heat-inactivated HS. The cells were plated at a concentration 
of 10
6
 cells/mL and left to rest overnight in heat-inactivated FCS or HS. The 
following day, medium was refreshed and cells were stimulated with two different 
concentrations of LPS.  There was no apparent morphological difference between the 
cells incubated in the two different sera.  The supernatant concentration of TNF 
was measured prior to and 2h and 6h following stimulation of cells with low 
(10ng/mL) or high (100ng/mL) LPS concentrations (Figure 3.1.7). LPS-induced 
TNF production by AMs was detected by 2h when cells were incubated with either 
serum, and was significantly higher in the presence of HS at this and the later time 
point (6h). The low concentration of LPS was almost maximally stimulatory to AMs.  
In contrast to AMs, PMs released TNF constitutively at similar levels when 
cultured in the presence of both HS and FCS, and there was no further induction in 
the presence of LPS, even at the higher concentration of 100ng/mL (Figure 3.1.7). 
The aim of the present study was to use appropriate conditions for studying equine 
AM biology in vitro. Since equine AMs showed a higher ability to respond to LPS 
while incubated with HS compared to FCS. Therefore, heat inactivated HS was used 
for the rest of the experiments performed in this thesis. 
 
 




Figure 3.1.7: TNFα (pg/mL) production from freshly harvested AMs and PMs in response to low 
(10ng/mL) (A) and high (100ng/mL) LPS doses (B) and different heat inactivated sera (HS and 
FCS).  
Alveolar and peritoneal cells were seeded at 10
6
 cells/mL and left to rest overnight. The next day non-
adherent cells were washed away and cell medium was refreshed with FCS or HS. Fresh AMs and 
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freshly harvested AMs and PMs in response to low (10ng/mL) (A) and high (100ng/mL) (B) LPS 
doses. Results are the mean of a minimum of 6 experiments +/- SEM (*p<0.05 versus control 0h). 
Macrophages stimulated with LPS also produce IL10, a well-recognized anti-
inflammatory cytokine, which exerts feedback inhibition of the signaling cascade 
(Bogdan et al., 1992). IL10 can be produced by Th2 cells and B cells, as well as 
macrophages and monocytes in mice (Mosmann and Moore, 1991, Ogarra et al., 
1990). Laan et al (2005) previously reported that LPS treated horse AMs produce 
mRNA for IL10 (Laan et al., 2005), and human IL10 significantly reduced the 
production of inflammatory mediators (Hawkins et al., 1998). It was considered that 
one possible explanation for the apparent refractoriness of PMs to LPS could be IL10 
production. However, IL10 levels remained almost undetectable in both AMs and 
PMs using a commercially available ELISA and were not increased by LPS in either 
FCS or HS (Figure 3.1.8). In all ELISAs performed throughout the study, a standard 
curve was generated for each assay according to the manufacturers instruction 
(Section 2.4). Results were only considered valid if the correlation coefficient (r
2
) 












Figure 3.1.8: AM and PM production of IL10 (pg/mL) in response to low (10ng/mL) and high 
(100ng/mL) LPS doses when incubated in different heat inactivated sera (HS and FCS).  
Alveolar and peritoneal cells were seeded at 10
6
 cells/mL and left to rest overnight. The next day non-
adherent cells were washed away and cell medium was refreshed with FCS or HS. Fresh AMs and 
PMs were stimulated with low (10ng/mL) (A) and high dose of LPS (100ng/mL) (B) for 0h, 2h and 6h. 
IL10 production was measured by ELISA on cell culture supernatants. Results are the mean of a 
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3.1.6 Cryopreserved AMs and PMs, following LPS 
stimulation, show a similar pattern of cytokine response 
as the freshly harvested cells  
Compared to fresh cells, AMs recovered following cryopreservation exhibited a 
reduction in the absolute magnitude of LPS-induced TNF release. However, there 
was no change in the time course of the LPS response, nor the relatively greater 
response in HS compared to FCS (Figure 3.1.9). Similarly, the PMs recovered from 
cryopreservation showed the same lack of response to LPS, as observed with fresh 
cells. The cryopreserved cells also failed to release detectable IL10 (Figure 3.1.10). 
Because IL10 is an anti-inflammatory cytokine, its production may be delayed, 
compared to TNFα, following exposure to a stimulus (Liese et al., 2001). To test this 
hypothesis, the time course of stimulation of AMs was extended to 24h.  At this time 
point, there was no further elevation in TNF production by the AMs, no detectable 
TNF production by PMs and the IL10 production by AMs and PMs remained less 












Figure 3.1.9: TNFα (pg/mL) production by cryopreserved AMs and PMs in response to low 
(10ng/mL) and high (100ng/mL) dose LPS in different sera (heat inactivated HS and FCS).  
Cells were cultured as previously described in Figure 3.1.8.  The y axis shows the TNFα production 
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Figure 3.1.10: IL10 (pg/mL) production by cryopreserved AMs in response to stimulation with low 
(10ng/mL) and high (100ng/mL) dose LPS, incubated in different sera (heat inactivated HS and 
FCS).  
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Figure 3.1.11: TNFα and IL10 production (pg/mL) at 24h.  
TNFα (pg/mL) (A) and IL10 (pg/mL) (B) production at 24h by AMs and PMs following stimulation 
with high dose (100ng/mL) LPS. Cells were incubated in medium supplemented with heat inactivated 
HS. The y axis shows the TNFα (A) and IL10 (B) production in pg/ml. Results are the mean of a 
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3.1.7 In contrast to LPS treated mouse macrophages, equine 
AMs and PMs did not produce NO  
Nitric oxide (NO) has been attributed many functions in host defense based largely 
on the results of studies performed in rodents. LPS stimulation of mouse 
macrophages increases arginine uptake and inducible nitric oxide synthase (iNOS) 
activity and stimulates production of NO (Ito et al., 2005, Takacs et al., 2012). 
Neither pig nor human macrophages produce NO in response to LPS (Kapetanovic et 
al., 2012, Schneemann et al., 1993).  There are some conflicting reports as to whether 
horse AMs produce NO (Hammond et al., 1999a, Johnson et al., 1997). Hammond et 
al (1999) reported that stimulation of equine lung macrophages with LPS induced 
iNOS and nitric oxide production. Conversely, Johnson et al (1997) failed to identify 
NO production by equine macrophages. To further address this question, nitrite 
production by fresh and cryopreserved AMs and PMs was measured following 
stimulation with LPS (10ng/mL and 100ng/mL) for 6h. The mouse macrophage cell 
line RAW 274.1, known to produce NO in response to LPS, was used as a positive 
control. Although, the LPS-stimulated RAW274.1 cells produced abundant nitrite, no 
nitrite was detected in the supernatant of LPS-stimulated equine AMs or PMs either 
before (Figure 3.1.12) or after cryopreservation (Figure 3.1.13). 
The mouse iNOS promoter is not conserved in the pig or human genome (Zhang et 
al., 1996, Kapetanovic et al., 2012). In order to investigate whether the differences in 
nitrite production between the species were controlled at a transcriptional level, 
iNOS promoter sequence alignment (2000bp in front of the start codon) was 
performed in the three species: human, mouse and horse (retrieved from the Ensembl 
database; www.ensembl.org). Using the Geneious software, the conservation of the 
sequences between species using a Pustell DNA matrix, was investigated 
(http://www.geneious.com). Human and horse promoters are well conserved as 
shown in Figure 3.1.14.A, whereas there is little alignment of the promoter 
sequences between mouse/horse (Figure 3.1.14.B) and mouse/human (Figure 
3.1.14.C).  




Figure 3.1.12: Nitrite production was induced in murine but not in fresh equine AMs and PMs.  
Mouse RAW274.1 macrophages and fresh horse macrophages were treated similarly with low 
(10ng/mL; A) and high (100ng/mL; B) dose LPS and nitrite (µM/mL) was measured in the 
supernatant using the Griess reagent as described in Materials and Methods Section. Results are the 
mean of a minimum of three experiments +/-SEM. 
A 
B 



















Figure 3.1.13: Nitrite was induced in mouse but not in cryopreserved equine macrophages.  
Mouse and cryopreserved horse macrophages were treated similarly with low (10ng/mL; A) and high 
(100ng/mL; B) dose LPS and nitrite (µM/mL) was measured in the supernatant using the Griess 
reaction. Results are the mean of a minimum of four experiments +/- SEM. 
A 
B 





Figure 3.1.14: Dot plots of  iNOs promoter sequences of human, horse and mouse.  
Promoter sequence of iNOS was compared between horse, mouse and human using Pustell graph. 
Sequence up to 2000bp 5’ of the starting codon of the three species were aligned pairwise; horse 
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3.1.8 Equine AMs and blood monocytes show endotoxin 
tolerance  
As discussed in the introduction (Section 1.4.1), a natural feedback mechanism, 
known as endotoxin tolerance, is recruited in cases of continuous exposure to LPS in 
order to provide some protection to the host against excessive inflammation and 
tissue damage. The role of macrophages/monocytes in this mechanism is critical and 
has been widely described in humans and mice (Hotchkiss and Karl, 2003, Karin et 
al., 2006, Biswas and Lopez-Collazo, 2009).   
To model the endotoxin tolerance in AMs, they were seeded at 10
6
 cells/mL and left 
to rest overnight. The next day nonadherent cells were washed away and the cell 
medium was refreshed (0h timepoint). AMs were stimulated with 100ng/mL of LPS 
and left to incubate for 24h. The following day, after the supernatant was collected 
for TNFα measurement, cells were re-stimulated with the same dose of LPS and 
incubated for another 24h (Figure 3.1.15). Controls were either not stimulated at all, 
or stimulated only on the first or second day. Supernatants were collected after the 1
st
 
(24h time point) and 2
nd
 (48h timepoint) day and kept frozen for subsequent TNFα 
measurement by ELISA. The same experiment was performed with horse 
monocytes.  
 
Figure 3.1.15: Experimental design of endotoxin tolerance experiment on AMs and monocytes.  
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The results of the sequential treatment are shown in Figure 3.1.16. AMs that were 
incubated in medium only (controls) did not produce high levels of TNFα throughout 
the experiment. In AMs that were treated with LPS on day 1 only, as expected, TNFα 
concentration was increased in the supernatant collected 24h following LPS 
stimulation. However, following a further 24h incubation in medium only, TNFα 
levels in the supernatant subsequently declined. In AMs which were cultured in 
medium only for the first 24h, then stimulated with LPS at this time point (24h), the 
TNFα concentration of the supernatant was elevated although to a lesser extent than 
in fresh cells, probably due to some loss of cells during cell culture. Finally, further 
(day 2) LPS treatment of AMs that were treated with LPS on day 1 did not 
restimulate TNFα production in the second 24 hours.  In fact, TNFα production was 
lower compared to AMs given medium alone on day 2.  Essentially the same pattern 
was seen in blood monocytes (Figure 3.1.16-B). Slight production of TNFα was 
observed when the cells were incubated with cell culture medium only, for 24h. This 
level was considered insignificant (less than 300pg/mL for AMs and 500pg/mL for 
monocytes) and might have been due to some interaction of the cells.  
Consistent with the previous experiments, AMs did not produce detectable IL10 
under any of the conditions studied (Figure 3.1.17). By contrast monocytes did 
produce a significant amount of IL10 when stimulated with LPS, thereby providing a 
positive equine control for the assay and supporting the conclusion that the previous 
failure to detect high IL10 was an AM specific defect.  The pattern of regulation of 
IL10 was different from TNFα.  Inducibility increased after 24 h in culture, and did 
not decline to the same extent following re-addition of LPS.  




Figure 3.1.16: TNFa (pg/mL) production by LPS tolerant AMs and blood monocytes.  
AMs (A) and blood monocytes (B) were treated with the same LPS dose (100ng/mL) on two 
consecutive days (0h and 24h) as shown in Figure 3.1.15. Cell culture supernatant was collected at 
24h and 48h and TNFα (pg/mL) production was measured by ELISA. Control cells were cultured in 
medium only, at all time points. Results are the mean of a minimum of three experiments +/- SEM. 
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Figure 3.1.17: IL10 production (pg/mL) by LPS tolerant AMs and blood monocytes.  
AMs (A) and blood monocytes (B) were treated with the same LPS dose (100ng/mL) on two 
consecutive days. Cell culture supernatant was collected and IL10 (pg/mL) production was tested by 
ELISA. The y axis shows the IL10 production in pg/ml.Results are the mean of a minimum of three 
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3.1.9 rhCSF1 and high concentration of HS induced 
differentiation of horse PBMCs to macrophages 
CSF1 is required for the differentiation and development of macrophages in 
embryonic and adult life (Chitu and Stanley, 2006, Gow et al., 2010, Hamilton and 
Achuthan, 2013). To establish an in vitro macrophage culture for the horse, 
monocytes were cultured for seven days in rhCSF1. As shown in Figure 3.1.18, by 
the end of the culture period, the majority of cells was larger, spread on the 
substratum and resembled mature macrophages. Differentiation of macrophages 
derived from several species such as human (Chinetti et al., 1998) and mice (Wiktor-
Jedrzejczak et al., 1982) can also be achieved by incubating monocytes in cell culture 
medium without CSF1 supplementation. In these experiments monocytes 
differentiated into macrophages only in the presence of only serum and cell culture 
medium. Likewise, in the current study, equine monocytes grown in medium 
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Figure 3.1.18: Equine PBMC-derived macrophages.  
PBMCs were stimulated with rhCSF1 at day 1 (A). Monocyte-derived macrophages at day six (B). 










Figure 3.1.19: Equine PBMC-derived macrophages.  
PBMCs were stimulated with 30% heat-inactivated HS at Day 1 (A). Monocyte derived macrophages 







Characterisation of the equine macrophage/monocyte 
 113 
3.1.10 CD14, CD163 and TLR4 are present on equine 
blood monocytes 
Blood monocytes have been more widely studied than other types of horse 
monocytes/macrophages, because they are relatively easy to collect (Watson et al., 
1990, Grunig et al., 1991). However, their characterisation has not been complete 
because of the lack of commercially available horse specific reagents.  Most studies 
have relied on the crossreactivity of several anti-human or anti-mouse antibodies 
against equine proteins (Steinbach et al., 2005, Ibrahim et al., 2007). The cell 
membrane proteins CD14 and CD163 are expressed by equine monocytes (Steinbach 
et al., 2005, Kabithe et al., 2010).  Kabithe et al (2010) have produced an equine 
specific CD14 antibody, which was used in the current study (Kabithe et al., 2010). 
However, TLR4 expression on equine blood monocytes has not been tested using 
flow cytometry. 
To test the available reagents, PBMCs were seeded at 10
6
 cells/mL and left to rest 
overnight. The next day nonadherent cells were washed away and the adherent cells 
were detached using a cell scraper and stained for flow cytometry. Size (FS) and 
granularity (SS) were used to distinguish different cell populations and their gating 
as shown in Figure 3.1.20-A. Figure 3.1.20.B-D, demonstrate that CD14, TLR4 and 
CD163 could be detected by flow cytometry on equine blood monocytes. The 
fluorescence intensity is shown in Figure 3.1.21. This provided an appropriate 
comparative dataset for results presented in Section 3.2 using the equine AMs and 
PMs. A continuum of CD163 expression was detected on the cells, although it was 
not fully established whether this reflected 2 distinct sub-populations, as described 
with porcine monocytes (Fairbairn et al., 2013b). Fairbairn and colleagues (2013) 









 that more closely resembled human monocyte populations than those of 
mice, as discussed in the introduction (Section 1.2). Wether this is the case in horse 
needs to be further investigated. 
 
 





Figure 3.1.20: CD14, CD163 and TLR4 expression on equine monocytes.  
After isolation PBMCs were seeded at 10
6
 cells/mL and left to rest overnight. The next day non-
adherent cells were washed away and cells were stained for flow cytometry. Size (FS) and granularity 
(SS) were used for cell distinction and gating (A). Cells were stained for CD14, TLR4 and CD163. 
Results are shown in figures B-D and respectively.  Isotype controls are represented by a non-hatched 
black curve and targeting antibody is represented by a coloured hatched curve. Figures are 













Figure 3.1.21: Median fluorescence intensity of CD14 (A), TLR4 (B) and CD163 (C) and 
appropriate isotype control (IC) expression on equine blood monocytes.  
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3.2 Equine alveolar macrophages differ in their 
function and phenotype from peritoneal 
macrophages 
As discussed in detail in the introduction (Section 1.5.2), there is considerable 
evidence from other species that AMs adapt to their environment in a unique way 
and are distinct from macrophages derived from other locations, a finding thought to 
reflect the distinctive microenvironment of this cell and its “breath-by-breath” 
exposure to ambient air containing a variety of potential allergenic and pro-
inflammatory components, as well as its different origin (Guth et al., 2009, Salez et 
al., 2000, Nibbering et al., 1987, Landsman and Jung, 2007). Therefore, it was 
considered essential to further characterize the basic function and phenotype of the 
equine AM by making specific comparisons with other tissue derived macrophages, 
such as PMs.  
 
3.2.1 AMs, but not PMs, respond to different inflammatory 
stimuli 
To investigate the relative responsiveness of AMs and PMs to LPS, cells were plated 
at a concentration of 10
6
 cells/ml and left to rest overnight in heat-inactivated HS, in 
the optimal conditions determined in Section 3.1.5. As previously shown (Section 
3.1.5), AMs, but not PMs, responded to LPS treatment. To determine whether the 
lack of responsiveness of PMs was specific to the TLR4 agonist, both AMs and PMs 
were stimulated with other agonists containing alternative ligands. Thus, after 
overnight culture, medium was refreshed and cells were stimulated with either heat-







Poly IC (20µg/ml), a TLR3 ligand. The doses of the stimulants used were similar 
with those tested in previous monocyte/macrophage experiments in different species 
including horse (Kapetanovic et al., 2012, Waldschmidt et al., 2013, Yusof et al., 
1993). 
Salmonella typhimurium is a serovar of the Salmonella enterica subsp. enterica, 
which is a member of the genus Salmonella (gram negative bacteria) and is a major 
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cause of food borne salmonellosis (Prescott et al., 1996, Voetsch et al., 2004). 
Salmonella typhimurium is also an important equine pathogen, resulting in enteritis 
and associated endotoxaemia, a clinical status which, in horses, carries an uncertain 
prognosis (Peet et al., 1980, Durando et al., 1994, Werners et al., 2005). The heat-
killed Salmonella typhimurium used in this study contains a mixture of TLR4 (LPS), 
TLR2 (peptidoglycan), TLR9 (CpG) and TLR5 (flagelin) ligands (Prescott et al., 
1996, Kwon et al., 2011).  
AMs produced TNFα in response to both heat-killed Salmonella typhimurium 
(Figure 3.2.1) and Poly IC (Figure 3.2.2). As previously noted following LPS 
stimulation, (Section 3.1.5), IL10 levels remained almost undetectable in both AMs 












Figure 3.2.1: TNFα (pg/ml) production of AMs and PMs in response to inflammatory stimuli. 
Alveolar and peritoneal cells were seeded at 10
6
 cells/ml and left to rest overnight. The next day non-
adherent cells were washed away and cell media was refreshed with HS. AMs and PMs were 







 cfu/ml) (B). The y axis shpws the TNFα (pg/ml) production of AMs and PMs in response to 
inflammatory stimuli. Results are the mean of a minimum of four experiments performed with samples 
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Figure 3.2.2: IL10 (pg/ml) production of AMs and PMs in response to inflammatory stimuli.  
Cells were treated as in Figure 3.2.1. AMs and PMs stimulated with 2µg/ml of Poly IC for 6h (A) and 






 cfu/ml) (B). The y axis shpws the IL10 
(pg/ml) production of AMs and PMs in response to inflammatory stimuli. Results are the mean of a 
minimum of 3 experiments +/- SEM (*p<0.05 versus control 0h). 
A 
B 
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3.2.2 Identification of suitable reference genes for RT qPCR 
assay in AMs 
RT qPCR is a widely used assay for reliable and quick quantification of gene 
expression under specific conditions (Arya et al., 2005, Peirson and Butler, 2007). 
The relative gene expression in different treated groups is quantified and normalised 
to a reference gene (Arya et al., 2005).  The reference gene should remain stable 
under different treatment protocols or disease conditions (Schmittgen and Zakrajsek, 
2000, Cappelli et al., 2008). Since the expression of reference genes is tissue 
dependent, optimal reference gene selection for the tissue studied is essential for 
reliable RT qPCR results (Zhang et al., 2009).  
Reference gene selection was based on widely published housekeeping genes used in 
several horse studies and was performed on four LPS treated and four untreated AM 
populations  derived from systemically healthy horses. GAPDH and ACTB were used 
in many studies on BALF derived cells of different species including horse (Laan et 
al., 2006, Perkins et al., 2008, Riihimaki et al., 2008, Reyner et al., 2009, Beekman et 
al., 2011, Hughes et al., 2011) and other genes such as HPRT1, SDHA, 18S, B2M, 
28S have been investigated in other equine tissue cells (Cappelli et al., 2008, Zhang 
et al., 2009). In order to select the most appropriate reference gene for the equine 
macrophage-based studies, the M-value, describing the variation of a gene compared 
to all other candidate genes, was used. The gene with the lowest M-value is 
considered the most stable (Vandesompele et al., 2002). Six candidate reference 
genes were ranked based on their M-value, as assessed using qBase
plus
 software. All 
reference genes had M-values less than 1.5, the threshold below which genes are 
considered to be stably expressed. 18S rRNA expression was found to be the most 
stable compared to B2M, ACTB, HPRT1 and SDHA (Figure 3.2.3.A). Interestingly, 
the commonly used GAPDH was the least stable gene of the group. If more than one 
housekeeping gene is required, the measurement of the GeNorm V value of the genes 
under review is considered a suitable way to determine the optimum number required 
for an expression study (Vandesompele et al., 2002). The pairwise variation between 
samples is decreased by the inclusion of more reference genes (Vandesompele et al., 
2002), thus indicating the number of genes required to achieve an arbitrarily selected 
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threshold of reference gene stability (Vandesompele et al., 2002). A V value of 0.15 
is considered a suitable threshold (Perez et al., 2008). In the current protocol, the 
optimal combination of reference genes that could be used had a V value of 0.15 and 
included the following genes; 18S, B2M and ACTB (Figure 3.2.3.B).  
 
 
Figure 3.2.3: Gene expression stability of candidate reference genes.  
qBase
plus
 software was used for the ranking of the six candidate reference genes based on their M-
value (A). The lower the M-value, the higher the stability of the gene.  qBase
plus
 software calculates 
the optimal number of reference genes that should be used in order to calculate the normalization 
factor (B). The lower the V value, the better the gene combination.  
A 
B 
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Results were consistent with the findings of Zhang et al (2009) who found no 
significant differences in expression of 18S and ACTB between equine colon, small 
intestine, heart, spleen, kidney, liver, lung and lymph nodes (Zhang et al., 2009). 
18S, selected in previous studies on equine pulmonary-derived and blood 
mononuclear cells (Ainsworth et al., 2003a), represented the most appropriate single 
reference gene here. In comparison, a recent study on equine AMs reported 60S 
ribosomal protein L32 (RPL32) to be the most stable single reference gene 
(Waldschmidt et al., 2013); however that study did not include 18S and the current 
study did not include RPL32 in the list of genes assessed. Although Beekman et al 
(2011) selected a different gene combination, including GADPH, HPRT, SDHA and 
RPL32, in a study on equine IAD, the analyses were performed on pooled BALF-
derived cells harvested from diseased horses and not isolated AMs from healthy 
horses, thus highlighting the potential influence of cell type and disease status on  
optimal housekeeping gene selection (Beekman et al., 2011).  
 
3.2.3 LPS-induced TNFα and IDO mRNA expression in AMs 
and PMs 
RNA was extracted from AMs and PMs at 0h and 6h following LPS (100ng/ml) 
stimulation, providing an average yield of 1.3µg of RNA /10
6
cells (± 0.3) for AMs 
and 0.4µg/10
6
cells (±0.01) for PMs.  As TNFα secretion can be regulated at multiple 
levels, including the activation of TNFα-converting enzyme (Mohan et al., 2002), the 
possibility remained that PMs respond transcriptionally to TLR agonists, but do not 
release TNFα.  However, consistent with the TNFα ELISA results, only AMs 
showed significant upregulation of TNFα transcript in response to LPS (Figure 
3.2.4.A). As shown in Section 3.1.7, equine AMs and PMs, like human and porcine 
macrophages, did not metabolise arginine to produce nitric oxide as do mouse 
macrophages. Instead human and porcine macrophages metabolise tryptophan 
through the induction of indoleamine dioxygenase (encoded by the IDO gene) 
(Section 1.6.3) (Silva et al., 2002, Mellor and Munn, 2004). This pathway was 
therefore investigated in equine macrophages.  IDO expression was significantly 
upregulated in LPS stimulated AMs, but not PMs (Figure 3.2.4.B). 




Figure 3.2.4: Relative gene expression of TNFα and IDO by LPS treated equine AMs and PMs. 
Quantitative PCR of TNFα (A) and IDO (B) transcripts, respectively, were performed on cDNA 
samples of both AMs and PMs and mRNA expression was normalized to 18S rRNA. Results are the 
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3.2.4 CD14, CD163 and TLR4 expression in AMs and PMs 
In an effort to explain the lack of LPS-responsiveness of PMs, the relative expression 
of various relevant cell surface markers was evaluated. These included the LPS 
receptor TLR4 and its co-receptor CD14. Equine CD14 antibody was recently 
produced by Kabithe et al (2010) and tested on equine PBMCs. Even though many 
horse studies have implied CD14 presence on AMs and PMs, its actual expression on 
these cells has not yet been shown (Laan et al., 2006, Morris and Moore, 1987). 
TLR4 is expressed by equine AMs (Waldschmidt et al., 2013).  The relative 
expression was compared to CD163, a scavenger receptor commonly used as a 
macrophage marker. The anti-human AM-3K antibody against CD163 cross reacts 
with horse AMs, as demonstrated by immunocytochemistry (Yamate et al., 2000).  
Cells were gated, as shown in Figure 3.2.5.A and B. Similar to the earlier light 
microscopy observations (Section 3.1.4), the forward light scatter profile of the AMs 
suggests that they were somewhat larger on average than the PMs. AMs showed high 
levels of surface CD14, TLR4 and CD163 expression (Figure 3.2.5.C-E).  The PMs 
were positive for both CD163 and TLR4, whereas the expression of CD14 was 
negligible (Figure 3.2.5.F-H). Despite the low CD14 expression by PMs, inclusion 
criteria for the macrophage characterisation included their ability to adhere to the 
plastic plates, their morphology as assessed by light microscopy and their large size 
and granularity (forward and side scatter, respectively) as determined by flow 
cytometric analysis (Grunig et al., 1991, Hawkins et al., 1998, Moore et al., 2003, 
Werners et al., 2004). Furthermore, upon consideration of the differential cell count 
of the peritoneal lavage fluid, the macrophage comprised the predominant cell 
population, followed by neutrophils, which could be easily distinguished by the 
aforementioned methods. The median fluorescence intensity from four experiments 
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Figure 3.2.5: CD14 (C and F), CD163 (E and H) and TLR4 (D and G) expression on equine AMs 
and PMs.  
AMs and PMs were seeded at 10
6
 cells/ml and left to rest overnight. The next day nonadherent cells 
were washed away and cells were stained for flow cytometry. Size (FS) and granularity (SS) were 
used for the cell differentiation and their gating (A, B). Alveolar (A) and peritoneal macrophages (B) 
were stained for CD14, TLR4 and CD163. Results of AMs are shown in figures C-E and from PMs in 
figures F-H.  Isotype controls are represented by a non-hatched black curve and targeting antibody is 

















Figure 3.2.6: Median fluorescence intensity of CD14 (A), TLR4 (B) and CD163 (C) expression on 
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3.2.5 AMs show higher phagocytic activity compared to PMs  
Both equine neutrophils and pulmonary alveolar macrophages have been shown to be 
efficient at bacterial phagocytosis (Raidal et al., 1998). The small, and less ruffled, 
appearance of PMs (Section 3.1.4) suggested that they might be less active 
phagocytes. Figure 3.2.7 presents a summary of the protocol used (Section 2.6.2) to 
investigate this possibility.  Compared to AMs, PMs actively bound and/or 
internalized a significantly lower number of FITC-labelled E.coli, thus indicating a 
relative deficiency in their phagocytic ability as shown in Figure 3.2.8.A-B. The 





is presented in Figure 3.2.8.C.  
 
 
Figure 3.2.7: Experimental design of phagocytosis assay by flow cytometry on equine AMs and 
PMs. 
Following adherence, one plate set was left at 4
0
C in order to inhibit phagocytosis while the other was 
left at 37
0
C for 30min. FITC-labeled E. coli  were added into the wells for 1h. Cells were then washed 




C, were included in the experiment 














Figure 3.2.8: AMs (A), but not PMs (B), can phagocytose bacteria.  
The pink and blue curves represent the fluorescence of the cells that were not treated with bioparticles 
of E.coli and were incubated at 4
0
C and 37 
0
C, respectively. The green curve represents the 
fluorescence of the cells that were treated with bioparticles of E.coli but kept at 4
0
C, while the red 
curve represents the fluorescence by E.coli treated cells at 37 
0
C. Mean of the median fluorescence 
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3.2.6 Microarray analysis of equine AMs and PMs 
As shown above, AMs and PMs differ greatly in their function and phenotype.  This 
difference was therefore investigated on a genome-wide scale by gene expression 
profiling. This kind of analysis has been conducted on macrophages from other 
species, including humans, mice and pigs (Freeman et al., 2012, Su et al., 2002). For 
example, Freeman et al (2012), by extensive microarray analysis of numerous 
porcine cell and tissue samples, identified a plethora of tissue/cell type differences in 
gene expression and considerably improved the functional genomic annotation of the 
pig (Freeman et al., 2012).  Microarrays have been used in equine studies but the 
available arrays were usually not horse-specific (Ing et al., 2004, Michelle R. Mouse 
et al., 2002). Graham and coworkers commenced the investigation of the horse 
transcriptome using human microarrays on three different equine tissues (brain, liver 
and articular chondrocytes) (Graham et al., 2010). Two further studies using 
microarray (Huang et al., 2008b) and RNA-seq (Coleman et al., 2010) investigated 
the equine transcriptome of different tissues and detected tissue specific expression 
profiles correlated with specialised tissue functions; however, these studies did not 
focus on differences at the level of macrophages from different origin. 
In order to identify differences in gene expression between the two different types of 
horse macrophages, BALF (AMs) and PLF-derived (PMs) cells were plated at 10
6 
cells/ml and left overnight. After nonadherent cell removal, total RNA was extracted 
from untreated AMs and PMs harvested from five and three horses, respectively and 
used for microarray analysis. As outlined in Section 2.10, two different types of 
arrays were used within the experiment, so subsequent analysis included the 
investigation of a possible batch effect. Both array types contained identical probes. 
No single sample was analysed using both array types, thus permitting the direct 
assessment of array type on the data generated. However, the AMs were analysed 
using both array types (3 with one array type and 2 with the other array type), 
whereas only one array type was used when analysing the PMs. Therefore, any 
difference between the cell types (AMs versus PMs) could not soley be attributed to 
a difference in the array type used. Using Partek Genomic Suite 6.6 software, any 
batch effect was removed and sources of variation were plotted in order to 
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investigate the contribution of each factor to the variation in the response variables 
(gene expression intensity values) across the whole arrays. As shown in Figure 
3.2.9, following batch removal (array type) the factor with the greatest effect on gene 
expression intensity was the cell type (AMs / PMs). The PCA showed distinct 
separation of the two different groups, AMs and PMs (Figure 3.2.10). No outliers 















Figure 3.2.9: Sources of variation plots.  
View of plots by Partek Genomic Suite 6.6 software before (A) and after (B) the batch effect of array 
type was removed. These plots present the average effect size across all the genes for each of the 
factors. The x-axis shows all the factors included in the analysis. The error column represents the 
noise or the variability of the data not explained by the rest of the factors. The y-axis represents the 
mean F Ratio (signal-to-noise) of all the genes. 
A 
B 




Figure 3.2.10: Principal component analysis of AMs and PMs.  
Blue spheres represent the PMs and red spheres represent the AMs. The relative difference in colour 
intensity for each group reflects the fact that a 3-dimensional image has been transcribed onto a 2-
dimensional figure. Analysis was performed by Partek Genomic Suite 6.6 software. This is a three 
dimensional presentation of the microarray experssion data. The proportions in each axis (PC#1, 
PC#2 and PC#3) represent the percentage of variance explained by each component. The percentage 
on the top of the graph (83.4%) represents the sum of these percentages. 
 
A two way ANOVA test was performed in order to identify genes that were 
differentially expressed between the two groups. Figure 3.2.9 depicts the factors 
used in the ANOVA. Of those factors, cell type was used as a fixed factor and the 
remainder as random factors. A list of 451 genes showing statistically-significant 
variance was created with a p value < 0.01 and a fold change of 9 or above, as shown 
in the hierarchical clustering (Figure 3.2.11). However, only 25 (5.5%) of genes of 
Characterisation of the equine macrophage/monocyte 
 133 
the total genelist of differentially-expressed genes were annotated, including 12/14 of 
those that had greater expression in AMs (Appendix II, S1).   
An attempt to annotate further the transcript description of the list was made, in order 
to gain more information regarding the genes involved in this analysis. Via the 
NetAffx Affymetrix database the annotation was improved to 31 genes (6.9%). From 
the 87 uncharacterised proteins included in the list, 31 (all upregulated in PMs) were 
manually annotated by reference to the human genome using the Ensembl database 
and via the NetAffx Affymetrix database derived sequences, as described in Section 
2.10.3 (Appendix II, S2). 195 genes were identified as pseudogenes and the rest 
were intronic normalisation controls, non-coding (nc) RNAs and small nuclear (sn) 
RNA or completely uncharacterised (Table 3.2.1). Intronic normalization controls 
are used for the calculation of certain quality control metrics in Expression Console. 
They are labelled as “controls”; however, their sequences are derived from genes 
originally identified from a dataset of hybridizations representing a large number of 
different tissues and cell lines (www.affymetrix.com). According to Affymetrix, 
those probe sets showed very low signal and were therefore included in the 
microarray. However, it is not feasible to test their specific level of expression for 
every tissue type and cell population. Consequently, some of these probe sets were 
retained in the current experiments. The relative difference in their expression 
between AMs and PMs likely reflects inherent differences in these cell populations; 
however, such differences did not affect the interpretation of other genes that were 
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Transcript description No of genes Percentage (%) 
Annotated 31 6.9 
Pseudogenes 195 43.3 
Missing information 113 25.1 
Uncharacterised proteins 87 19.3 
Intronic normalisation control 13 2.7 
ncRNA/snRNA 12 2.7 
Total genelist 451 
 
Table 3.2.1: Summary of the annotation details of the genelist 
Figure 3.2.11 shows the hierarchical clustering of the genes included in the genelist. 
This is a method of cluster analysis, which builds a hierarchy of clusters. In the 
following figure the horizontal dedongram represents the gene list, with the position 
of the genes relative to other genes reflecting their degree of correlation.The vertical 
dedongram represents the samples tested with the position of the sample relative to 
other samples reflecting their degree of correlation, in this case reflecting their 
response to LPS. Fourteen genes of the genelist had greater expression in AMs and 
437 in PMs. Genes that were higher in AMs are presented in Table 3.2.2. Only 13 
out of 437 genes that were higher in PMs were annotated and are shown in Table 
3.2.3., which also highlights the potential biological significance of these 13 
differentially expressed genes. However, in light of the fact that the significant 
majority  of differentially expressed genes were not annotated, it is highly likely that 
this list also contains genes which had a similar, if not greater, although 
undetermined biological significance. Due to the poor annotation of the gene list, 
further network analysis was performed using a different software (Biolayout 
Express
3D
) that confirmed the results obtained here.  
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Figure 3.2.11: Hierarchical clustering of differentially expressed genes.  
Hierarchical clustering of the 451 differentially expressed genes between AMs and PMs. In the main 
panel, the rows represent the samples, AMs are in light blue (A) and PMs in orange (P). The genes 
are represented in columns. In the horizontal scale, genes/probe sets with high expression are shown 
in red and those with low expression in blue. Those that remain stable are shown in grey. The 
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CYP7A1 Cholesterol homeostasis 1.03E-05 49.5 
15080122 Platelet glycoprotein 
4-like 
CD36 Cell adhesion molecule-






NAAA Degradation of bioactive fatty 
acid amides 
0.0001262 25.7 
15088442 Mucolipin 2 MCOLN2 Intracellular transport of 
membrane protein 
0.0001424 21.8 
15126979 Toll like receptor 8 TLR8 Innate and adaptive immunity 0.0003232 20.9 
14966871 Unknown Unknown Unknown 5.99E-05 17.1 
15134514 Unknown Unknown Unknown 0.0005121 16.2 
15051976 Prostaglandin 
reductase 1 
PTGR1 Metabolic inactivation of 
leukotriene B4 
4.70E-05 14.3 
15023455 Complement C1q 
subcomponent 
subunit B-like 
C1QB Complement component 1.23E-05 14.0 
15100625 Phospholipase B 
domain containing 1 
PLBD1 Defense against invading 
microorganisms 
0.0002308 11.7 
14943095 Early growth 
response 2 
EGR2 Transcription factor 0.0004786 10.7 
15023462 Complement C1q 
subcomponent 
subunit A-like 
C1QA Complement component 0.0003013 10.5 
14969419 Catalase-like CAT T cell and B cell growth 0.0005182 9.5 
15023458 Complement C1q 
subcomponent 
subunit C-like 
C1QC Complement component 3.13E-05 9.3 
 
Table 3.2.2: List of genes which have greater expression in AMs 
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Transcript ID Gene name  Gene symbol Biological process p Value Differential 
expression 
14939913  Ig kappa chain V-III 
region PC 2485 
LOC100291786 Unknown 2.15E-05 -29.3 
15011434 Pentraxin 3 PTX3 Innate resistance to 
pathogens 
0.000458788 -25.4 
14975354  Plasminogen 
activator inhibitor-1  
PAI-1 Ttissue homeostasis 0.000101477 -23.8 
14972820 Olfactory receptor 
476-like 











15060218 Lumican  LUM Major keratan 
sulfate proteoglycan 
0.000107293 -13.9 




15076479 Sema domain, 
immunoglobulin 
domain (Ig), short 
basic domain 




15030285 Olfactory receptor 
2W1-like 
OR2W1 Odorant receptor 
(potential) 
0.00020208 -11.4 
15030212 Histone H2A type 1-
like 
HIST1H2AG Core component of 
nucleosome 
0.000478705 -11.0 
15094905 Chemokine (C-X-C 
motif) receptor 7  
CXCR7 Activation of MAPK 
signaling pathway 
0.000278447 -10.3 
15120364 Transcription factor 
7-like 2 (T-cell 
specific, HMG-box) 





15103641 microRNA mir-7-2 MIR7-2 Post-transcriptional 




Table 3.2.3: List of annotated genes which have greater expression in PMs 
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Network analysis of the same normalised data was performed using Biolayout 
Express
3D 
software, with a MCL inflation value of 2.2, a Pearson correlation 
coefficient threshold (r) of 0.93 and the smallest cluster was set at three nodes. 
Transcripts with dynamic range less than 1.5 were removed from the analysis. The 
graph created 1,321 clusters consisted of a total number of 12,341 nodes, connected 
with 1,947,031 edges and provided a more in depth understanding of the gene 
expression profiles of the two cell types. Consistent with the results of the PCA, the 
network analysis (Figure 3.2.12) clearly distinguished two groups of clusters; one 
consisting of gene clusters with greater expression in AMs and one consisting of 
gene clusters with greater expression in PMs. The remainder of the genes showed 
similar expression in both cell types. Sample to sample variation within each group 
was not apparent when analysing the data using Biolayout express software to 
identify differentially expressed gene clusters. Due to the high number of clusters 
created (1,321) it was not feasible to present or critically interpret all of the data 
generated. Therefore more detailed analysis was targeted towards the 5 clusters of 
differentially expressed genes which contained the highest number of genes. The top 
clusters of transcripts with the greatest expression in AMs compared with PMs and 
PMs compared with AMs were numbers 2, 3, 4 and 5; and 1, 8, 15, 17 and 25, 
respectively. The numerical figure used to identify each cluster is inversely 
proportional to the number of genes within the cluster. For example, cluster 1 
contains the greater number of genes. Total gene lists of these clusters are presented 
in Appendix II, supplementary data S3 (total gene number: 3,212) and S4 (total 
gene number: 773) respectively. Genes previously identified using the Partek 
software as showing statistically significant differential expression between the 2 
groups (Tables 3.2.2 and 3.2.3) were also identified within the gene clusters 








Figure 3.2.12: Network analysis of genes differentially expressed in AMs and PMs.  
Graph was performed by the Biolayout Express
3D 
software (MCL 2.2, r=0.93).  Nodes with the same 
colour belong to the same cluster of co-expressed genes. On the left panel is shown the total graph 
created and in the middle, the clusters with the two different expression profiles. On the right  top is 
shown the expression profile of the genes more highly expressed in AMs and on the bottom right those 
more highly expressed in PMs. The x-axis shows each horse  and the y-axis shows the normalised 
relative intensity of expression in that horse. Horses 2, 5 and 12 were included in  the PM group 
whereas horses 1, 2, 3, 6 and 8 in the AM group, as depicted in order (left to right) on the x-axes. 
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Analysis of the genelists derived from clusters with greater expression in AMs 
demonstrated enhanced expression of genes involved in cellular metabolic processes, 
leukocyte/myeloid cell differentiation, immune response, cellular 
differentiation/development and RNA metabolic processes (Huang et al., 2008a, 
Huang et al., 2009). In particular, the genelists more highly expressed in AMs 
included genes specifically-expressed by macrophages or encoding proteins highly 
involved in macrophage differentiation, such as CSF1 and its receptor CSF1R, 
colony stimulating factor 2 receptor beta (CSF2RB), members of the scavenger 
receptor family [CD14, CD68, CD163, macrophage scavenger receptor 1 (MSR1)],  
sialic acid-binding immunoglobulin-type lectins (SIGLEC1), CD80, monocyte to 
macrophage differentiation protein (MMD), myeloid cell nuclear differentiation 
antigen (MNDA), cell differentiation protein RCD1 homolog (RCD1), forkhead box 
protein P1 (FOXP1), schlafen 5 (SLFN5)  and transforming growth factor beta 1 
(TGFB1) (Figure 3.2.13).  
Moreover, of transcripts that showed relatively greater expression in AMs, many are 
clearly related to immune response. This included genes such as Mannose receptor C 
type 1 (MRC1), genes that play a role in the NFKB signalling pathway [Mitogen-
activated protein kinase kinase kinase 2 (MAP3K2), Interleukin-1 receptor-associated 
kinase 4 (IRAK4)], several pattern recognition receptors (TLR3, TLR6, TLR7, TLR8), 
members of the TNF and TNFRS receptor superfamily (TNFRSF) (CD40, 
TNFRSF1A, TNFRSF13B), interleukin IL18 and interleukin receptors (IL6R, IL17R), 
as well as suppressors of cytokine signaling (SOCS4, SOCS6) (Figure 3.2.14).  
 
 





Figure 3.2.13: Expression profile of genes involved in macrophage differentiation. 
Selection of genes more higly expressed by AMs. These include genes which were either (a) located 
within the top 5 clusters of genes with  higher expression in AMs (Clusters 2, 3, 4) or (b) located 
A B C 
D E F 
G H I 
J K L 
M N O 
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within other smaller clusters, yet with a similar expression profile and considered to have potential 
biological significance (e.g.  CSF1, CD68, SIGLEC1, CD80, MMD, MNDA). The x-axis shows each 
horse  and the y-axis shows the normalised relative intensity of expression in that horse. Horses 2, 5 
and 12 were included in  the PM group whereas horses 1, 2,3, 6 and 8 in the AM group, as depicted in 
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Selection of genes presented here were more higly expressed by AMs These include genes which were 
either (a) located within the top 5 clusters of genes with  higher expression in AMs (Clusters 2, 3, 4) 
or (b) located within other smaller clusters, yet with a similar expression profile and considered to 
have potential biological significance (e.g TLR3, TNFRSF13B, IL18, SOCS4, SOCS6). The x-axis 
shows each horse  and the y-axis shows the normalised relative intensity of expression in that horse. 
Horses 2, 5 and 12 were included in  the PM group whereas horses 1, 2,3, 6 and 8 in the AM group, 
as depicted in order (left to right) on the x-axes. 
 
Analysis of the genelists derived from clusters with greater expression in PMs 
(Cluster 1 expression profile) demonstrated enhanced expression of genes involved 
in inflammatory/defense and immune response, intracellular signalling cascade, 
cellular metabolic processes and multicellular organismal development. Genelists of 
clusters higher in PMs included several chemotactic chemokines (CXCL1, CXCL3, 
CXCL6), chemokine receptor 7 (CXCR7), both pro and anti-inflammatory cytokines 
(IL1A, IL1B, IL6, IL8, IL10, IL11, IL23A) and interleukin receptors (IL1R, IL1RN, 
IL2RA,IL4R) (Figure 3.2.15).  
Additionally, the high expression of the acute phase protein pentraxin 3 (PTX3), 
NFκB, TLR9 and of several interferons (IFNA1, IFNA2) (Figure 3.2.16.A-E 
respectively) suggests that PMs are more activated compared to AMs, which might 
explain why the cells did not respond to several stimuli (LPS, Poly IC and heat killed 
bacteria of S. typhimurium). In effect, the PM cells could be considered LPS-tolerant, 
due to prior exposure to an LPS-like stimulus.  Genes encoding vascular endothelial 
growth factor A (VEGFA) and one of its receptors (FLT1), which play an important 
role in angiogenesis and vasculogenesis, were also observed in cluster 1 and showed 
relatively greater expression in PMs, compared to AMs (Figure 3.2.16.F and G). In 
the same cluster, CSF3 and its receptor were identified (Figure 3.2.16.H and I).  
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Selection of genes presented here were more higly expressed by PMs. These include genes which were 
either (a) located within the top 5 clusters of genes with  higher expression in PMs  (e.g. Clusters 1 
and 15) or (b) located within other smaller clusters, yet with a similar expression profile and 
considered to have potential biological significance (e.g IL6, IL1RN and IL2RA). The x-axis shows 
each horse  and the y-axis shows the normalised relative intensity of expression in that horse. Horses 
2, 5 and 12 were included in  the PM group, whereas horses 1, 2,3, 6 and 8 in the AM grou, as 
























Figure 3.2.16: Expression profile of immune associated genes (A-E), genes regulating angiogenesis 
(F-G) and cell differentiation-proliferation (H-I). 
Selection of genes presented here were more higly expressed by PMs. These include genes which were 
either (a) located within the top 5 clusters of genes with  higher expression in PMs  (e.g. Clusters 1 
and 17) or (b) located within other smaller clusters, yet with a similar expression profile and 
considered to have potential biological significance (e.g NFKB, TLR9, IFNA2, FLT1). The x-axis 
shows each horse  and the y-axis shows the normalised relative intensity of expression in that horse. 
Horses 2, 5 and 12 were included in  the PM group whereas horses 1, 2,3, 6 and 8 in the AM group, 
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3.3 Gene expression after LPS stimulation in equine 
AMs and their comparison with human LPS 
treated AMs 
As stated in the introduction (Section 1.5), AMs represent the principal cells 
responsible for clearance of particulate material within the lungs (Dixon PM and 
McGorum, 1997). Under normal conditions, they neither attack nor trigger other host 
cells; rather they eliminate and degrade inhaled particles and microorganisms via 
phagocytosis (Dixon PM and McGorum, 1997). When exposed to pathogens or 
antigens they become activated and induce inflammation (Dixon PM and McGorum, 
1997). In the horse, common infectious organisms such as Streptococcus 
zooepidemicus, Streptococcus pneumoniae, Pasteurella/Actinobacillus species may 
present as opportunistic pathogens, which trigger the equine respiratory immune 
system and induce inflammation (Wood et al., 1993, Burrell et al., 1996). 
Lipopolysaccharide, derived from gram negative bacteria, is considered a major 
factor for the induction of inflammation in the airways via the activation of 
macrophages, neutrophils and endothelium of various vascular beds (Andonegui et 
al., 2003). Interestingly, horses and humans are more sensitive to endotoxin induced 
cardio-pulmonary shock and have a high endotoxaemia-associated mortality 
compared to other mammalian species including rodents (Berczi et al., 1966, Warren 
et al., 2010, Werners et al., 2005). Although the precise mechanism for this 
phenomenon is not completely understood, equine pulmonary intravascular 
macrophages are able to endocytose LPS and produce TNFα and IL1β and depletion 
of  pulmonary intravascular macrophages decreases the pulmonary immune response 
to LPS (Parbhakar et al., 2005).  
Most previous studies of equine macrophage gene expression were based on reverse 
transcription quantitative polymerase chain reaction (RT qPCR), an approach 
restricted by the limited number of genes which can be assessed in a single assay 
(Moore et al., 2003, Jackson et al., 2004). Microarrays have rapidly become a widely 
used tool as they enable the simultaneous assessment of the expression of a large 
number of genes and provide a vast amount of information on diverse biological 
processes. The present study investigates gene expression in equine LPS treated AMs 
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using a whole transcript horse specific microarray. Figure 3.3.1 summarises the 
experimental protocol used for the analysis of the microarray data. 
 
 
Figure 3.3.1: Workflow for gene expression study in LPS treated horse AMs.  
BALF-derived cells were plated at 10
6
 cells/ml and incubated overnight. The following morning, 
supernatant was removed and adherent cells (AMs) were stimulated with LPS for 6h. Prior to 
microarray analysis, RNA yield and quality were checked and confirmation of an LPS-induced 
response was obtained by the measurement of TNFα in cell culture supernatants. Negative controls 
comprised cells which were cultured in the same way but not stimulated with LPS. 
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As with the comparison of AMs and PMs described above, a batch effect due to the 
different array types was also observed in this analysis (Figure 3.3.2.A).  Using 
Partek Genomic Suite 6.6 software, the batch effect was removed and sources of 
variation were plotted in order to investigate the contribution of each factor to the 
variation in the response variables (gene expression intensity values) across the 
whole arrays (Figure 3.3.2.B). Following removal of the batch effect (array type), 
both LPS treatment and the individual horse greatly influenced differences in gene 
expression.  
No outliers were observed and PCA classified the samples into two evidently 
different groups; one consisted of untreated and the other of LPS treated AMs 
(Figure 3.3.3). By using Partek software a gene list of 240 genes was created 
(p<0.05). Of those genes, 220 were upregulated in LPS treated AMs and 20 were 
downregulated as shown in the hierarchical clustering (Figure 3.3.4). 207 out of 240 
(86.2%) genes were already annotated in the Affymetrix annotation file imported in 
Partek software. The remainder of the genes were identified by using the Affymetrix 








Figure 3.3.2: Sources of variation plots.  
View of plots by Partek Genomic Suite 6.6 software before (A) and after the batch effect of array type 
was removed (B). These plots present the average effect size across all the genes for each of the 
factors (x-axis). The error column represents the noise or the variability of the data not explained by 
the rest of the factors. The y-axis represents the mean F Ratio (signal-to-noise) of all the genes. 
A 
B 
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Figure 3.3.3: Principal component analysis of LPS treated and untreated AMs. 
The relative difference in colour intensity for each group reflects the fact that a 3-dimensional image 
has been transcribed onto a 2-dimensional figure.Analysis was performed by Partek Genomic Suite 
6.6 software. This is a three dimensional presentation of the microarray experssion data. The 
proportions in each axis (PC#1, PC#2 and PC#3) represent the percentage of variance explained by 
each component. The percentage on the top of the graph (60.5%) represents the sum of these 
percentages. 
 
Figure 3.3.4: Hierarchical clustering of differentially expressed genes in LPS treated and untreated 
AMs.  
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Hierarchical clustering of the 240 differentially expressed genes between LPS treated AMs and 
controls. In the main panel, the rows represent the samples. LPS treated AMs are those in pink (6h) 
and the untreated AMs (controls, 0h) in yellow. The genes are represented in columns. In the 
horizontal scale, genes/probes with high expression are shown in red and those with low expression 
are shown in blue. Those that remain stable are shown in grey. The dendrograms of the samples and 
genes/transcripts are shown in the left and on top of the main panel.  
 
Numerous well-known inflammation- related genes were upregulated in LPS treated 
AMs (Figure 3.3.5). Based upon the gene ontology tool of the Partek Genomic Suite 
6.6 package, the principal biological process categories were identified as 
“inflammation” and “cell defence” (Figure 3.3.6). Genes involved in apoptosis were 
also detected, a phenomenon that has been described before in humans and mice 
(Joshi et al., 2003). The genes downregulated at 6h following LPS stimulation are 
shown in Table 3.3.1. 
 
Figure 3.3.5: Fold change of inflammatory related genes upregulated after LPS treatment.  
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The y-axis shows the fold change of a list of inflammation related genes upregulated in LPS treated 
AMs at 6h. PTX3, pentraxin 3; STAT4, Signal Transducer and Activator of Transcription; IL27, 
Interleukin 27; GBP5, guanylate binding protein 5; CSF3, colony stimulating factor 3; CCL22, C-C 
motif chemokine 22; IFIH1, Interferon induced with helicase C domain 1; IL2RA,  Interleukin 2 
receptor alpha; IL6, Interleukin 6; IDO1, indoleamine 2,3-dioxygenase 1; CXCL6, chemokine (C-X-C 
motif) ligand 6; RIN2, Ras and Rab interactor 2; IL1A, Interleukin 1 alpha; TNF, tumor necrosis 
factor; CD38, cluster of differentiation 38; TLR3, Toll like receptor 3; JAK2, Janus kinase 2; NFKB, 
nuclear factor kappa-light-chain-enhancer of activated B cells; SOCS3, suppressor of cytokine 
signaling 3; IL10, Interleukin 10, TRIM56, tripartite motif containing 56; TRAF3IP2, TRAF3 
Interacting Protein 2; CXCL3, chemokine (C-X-C motif) ligand 3; IFNB1, Interferon beta 1; CD40, 















Figure 3.3.6: Main gene functional groups induced by LPS treatment in horse AMs.  
Gene ontology analysis tool from the Partek Genomic Suite software, was used. The histogram shows 
the main gene functional groups affected by LPS stimulation (A) and in particular the immune related 








Gene name Gene 
symbol 
Biological process P value Differential 
expression 
14954767 Neutral amino acid 
transporter B(0)-like 





Apoptosis 0.00319022 -2,02089 
14945010 Apoptosis enhancing 
nuclease 
AEN Regulation of apoptosis 0.00203566 -2,06747 
14971846 Patatin-like phospholipase 
domain-containing protein 
2-like  
PNPLA2 Regulation of cellular process 0.00800983 -2,07838 
15068182 Wolframin-like WFS1 Regulation of apoptosis 0.00425089 -2,08333 
14967281 Solute carrier family 46 
(folate transporter), 
member  
SLC46A1 Intestinal proton-coupled high-
affinity folate and heme transporter 
0.00407444 -2,12738 
15026677 RIO kinase 1 (yeast) RIOK1 Unknown 0.00510916 -2,14655 
14932187 Intronic normalization 
control 
  0.00630691 -2,25422 
15064847 Phospholipase A2, Group 
XV 
PLA2G15 Transacylase and calcium-
independent phospholipase A2 
activity 
0.00253817 -2,34886 
15126975 Toll like receptor 7 TLR7 Immune defense/ response  0.00711464 -2,38297 
15095766  Protein tyrosine 
phosphatase, non-receptor 
type 6 
PTPN6 Apoptosis 0.00128212 -2,45451 
14972866 Leupaxin LPXN Signal transduction 0.00169939 -2,46798 
15106911 Arrestin, beta 1  ARRB1 Signal transduction 0.00635258 -2,47078 
15094354 2-acylglycerol O-
acyltransferase 1-like 
MOGAT1 Glycerol metabolism-Lipid 
biosynthesis/metabolism 
0.00101971 -2,59006 
15073546  Regulator of G-protein 
signaling 2, 
RGS2 Regulation of cellular process 0.00796698 -2,61257 




PPARG Immune defense/response and system 
process – anti-inflammatory action 
0.00176408 -2,88641 
15032122 Glutamate-cysteine ligase, 
catalytic subunit 
GCLC Regulation of apoptosis - regulation of 
cellular process 
0.00129169 -2,90054 
15124723 Src-like-adapter-like SLA Negatively regulates T-cell receptor 
signaling. 
0.00677987 -3,12657 








Table 3.3.1: Genes downregulated in equine AMs after LPS stimulation 




 software package was used to further analyse the gene 
expression of AMs in response to LPS stimulation. Data were normalised as 
described in Section 2.10 and afterwards was clustered using correlation of r=0.91 
and MCL of 2.2, generating a graph of 2,983 nodes connected with 690,178 edges 
that resulted in 22,778 clusters  (Figure 3.3.7.A). Analysis confirmed the results 
obtained by Partek Genomic Suite 6.6 software. LPS-regulated genes were found 
within several clusters (cluster 8, 11, 39, 62, 66) that followed a pattern similar to 
that of cluster 8 shown in Figure 3.3.7.C. Cluster 8 was the largest cluster of LPS-
induced genes, consisting of 119 genes (Figure 3.3.7C), while cluster 12 was the 
largest cluster of genes downregulated by LPS, consisting of 94 genes (Figure 3.3.7 
D), alongside clusters 20, 27, 52 and 59. These clusters included genes involved in 
RNA/DNA processes (DNA-directed RNA polymerase II subunit RPB4, tRNA-
splicing ligase RtcB homolog, ribosomal RNA small subunit methyltransferase 
NEP1, methionyl-tRNA formyltransferase, mitochondrial), signal transduction 
(LPXN), apoptosis (PTPN6, AEN) and other cellular processes (PLA2G15, 
SLC46A1). A number of these genes were already detected previously in Table 
3.3.1. The full genelists of the five larger clusters with genes that were up and 
downregulated in LPS treated equine AMs are presented in Appendix III, S2 and 
S3, respectively.The top five clusters of the downregulated genes were explored for 
gene ontology by DAVID annotation software (Table 3.3.2) and included genes 
involved mainly in cellular metabolic processes and synthesis or assembly of the 
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Annotation cluster Biological process Enrichment score Gene count 
1 Ribonucleoprotein complex 
biogenesis 
3.77 6-15 
2 Nucleic acid transport 2.39 5-6 
3 Cellular metabolic process 1.79 16-118 
4 Mitochondrion organization / 
protein transport 
1.2 3-33 
5 Cellular component biogenesis 1.07 4-35 
6 Ribonucleoside metabolic process 1.02 3-6 
 
Table 3.3.2: The top six annotation clusters with downregulated genes.  
The table shows the top 6 out of 40 annotation clusters created by DAVID software that were related 
with the list of 227 downregulated genes. The enrichment score is a modified Fisher exact p value 
calculated by the software and the higher it is the more enriched the cluster is. Each annotation 
cluster contains similar  biological subcategories 
(http://david.abcc.ncifcrf.gov/content.jsp?file=functional_annotation.html). Each biological 
subcategory contains a specific number of genes; therefore, it is possible for a group of differentially 
expressed genes to be related to a particular annotation cluster via one or more of these biological 
sub categories. The range of gene counts (right column) incorporates the different gene counts 
relating to each biological subcategory. 
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Figure 3.3.7: LPS regulated genes were grouped using Biolayout Express
3D
. 
Genes were clustered by Biolayout Express
3D
 and graph (A) was generated. Of the LPS regulated 
genes (B), five were upregulated and five downregulated. Cluster 8 (C) is the biggest cluster of 
upregulated genes and cluster 12 (D) the biggest of those down-regulated. On the right panel the x-
axis shows each horse  and the y-axis shows the normalised relative intensity of expression in that 
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Consistent with the Partek analysis, analysis of the genelist of the five largest LPS 
induced gene clusters (cluster 8, 11, 39, 62, 66), consisting of 319 genes in total, 
using the DAVID annotation tool, demonstrated enhanced expression of genes 
involved in immune system process, response to stimulus and positive regulation of 
cellular and biological process. These included PTX3, GBP5, CCL5, IFIH1, TLR3, as 
shown in Figure 3.3.8.A-L, in addition to others. As widely reported in the scientific 
literature, inflammation suppressor genes are also induced in response to LPS (Wells 
et al., 2005). Such genes include IL1RN and SOCS3, which were included in the 
LPS-induced gene list reported in the current study (Figure 3.3.8.M-N).  
The phenomenon of constant interaction between inflammation and apoptosis is well 
established and is vital for both homeostasis and the development of an immune 
response (Joshi et al., 2003). Consequently, the LPS-induced expression of many 
genes related to apoptosis and programmed cell death detected in the current study 
was consistent with this phenomenon. These included programmed cell death 1 
ligand 1 (PDCD1LG1, also known as CD274, death-associated protein kinase 
1(DAPK1), apoptosis regulator Bcl-2 (BCL2L1) and FADD-like apoptosis regulator 
(CFLAR), apoptotic peptidase activating factor 1(APAF1), various caspases (CASP4, 
CASP7, CASP8) and ubiquitin specific peptidase 37 (USP37) (Figure 3.3.9.A-I).  
Numerous transcription factors, such as STAT4, ETS variant 6 (ETV6), ETV7, 
transcription factors GATA-6, transcription factor EC (TFEC) and basic leucine 























































Characterisation of the equine macrophage/monocyte 
 162 
Selection of genes presented here were induced by LPS. These include genes which were  located 
within the top 5 clusters of upregulated genes   (e.g. genes 8, 11, 39 and 62). The x-axis shows each 
horse  and the y-axis shows the normalised relative intensity of expression in that horse. Horses 1, 2, 

















Figure 3.3.9: Expression profiles of genes associated with apoptosis-cell death   (A-I) and of 
transcription factors (J-O). 
Selection of genes presented here were induced by LPS These include genes which were either (a) 
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other smaller clusters, yet with a similar expression profile and considered to have potential 
biological significance (e.g  TFEC and BATF).  The x-axis shows each horse  and the y-axis shows the 
normalised relative intensity of expression in that horse. Horses 1, 2, 3, 6 and 8 were included in this 
analysis, as depicted in order (left to right) on the x-axes. 
 
A large number of genes responsible for the initiation and the maintenance of 
inflammation were detected among the five largest clusters and other clusters with a 
similar expression profile; for example members of the TNF and TNF receptor 
superfamily, (TNF, CD40, TNFSF13B), interleukins (IL1α, IL1β, IL6) and 
chemoattractant chemokines (CCL2, CCR5, CXCL1, CXCL6, CXCL9) (Gaur and 
Aggarwal, 2003). Moreover, IL7R, which plays a critical role in lymphocyte 
development, and the positive regulator of Th1 type cytokine expression, PHD finger 
protein 11 (PHF11) were also upregulated after LPS stimulation. The inducible gene 
list also included several secreted growth factors or their receptors, including 
Schlafen family member 5 (SLFN5), TGFB1, GM-CSF, colony stimulating factor 2 
receptor beta (CSF2RB) and CSF3.  Interestingly, even though IL10 protein was not 
detected in the cell culture supernatant at 6h and 24h follow LPS stimulation of AMs, 
IL10 gene expression was induced at 6h post LPS stimulation. Finally, BANK1 
expressed on B cells, CCL1, CD2, CD7 on T cells and CD5 expressed by both were 
also identified in different clusters, indicating some lymphocyte contamination, a 
phenomenon also observed in previous studies (Kapetanovic et al., 2012, 
Waldschmidt et al., 2013).  
 
3.3.1 Comparative analysis with human data sets  
Humans and horses are more sensitive to endotoxaemia compared to other species 
such as mice. Several studies have identified significant differences between human 
and murine responses to LPS which likely result from species-specific differences in 
pathophysiological characteristics (Fairbairn et al., 2011, Schneemann et al., 1993, 
Schneemann and Schoeden, 2007, Junhee et al., 2013, Schroder et al., 2012). For 
example, the difference in cell responses to bacterial infection has been partly 
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attributed to species-specific differences in serum proteins (Warren et al., 2010). LPS 
stimulation of macrophages (including AMs) incubated with mouse serum resulted in 
a lower expression of endotoxin induced proteins compared to cells incubated with 
human serum (Warren et al., 2010). As a result, it has been suggested that the horse 
may be an more appropriate animal model for human endotoxaemia compared to the 
widely used rodents. In order to address this hypothesis, a comparison was made 
between horse and human LPS treated AMs. 
LPS stimulated AMs have been profiled in several species, including humans. 
Reynier and colleagues performed microarray analysis on human AMs harvested 
from seven individuals 6h following LPS (4 ng/kg body weight) instillation into a 
lung subsegment (Reynier et al., 2012). Control samples were retrieved from the 
contralateral lung of the same subjects 6h following saline instillation (Reynier et al., 
2012).  As noted above, horse macrophages expressed several genes (IDO, IL7R) that 
are shared with humans and pigs, but not mice.  There is increasing demand for the 
development of novel animal models which more closely resemble human 
pathophysiology compared to mice (for example pigs). To assess whether the horse 
might be a good model for human inflammation, the published human microarray 
datasets derived from the Reynier et al (2012) study (GDS4419) (Section 2.10.1) 
were compared with those derived from the horse in the current study.  
The human arrays were normalised and analysed as described above for the horse, 
using Partek Genomic Suite 6.6 software. The PCA showed a distinct separation 
between the LPS treated and untreated AMs (Figure 3.3.10). In agreement with the 
equine AM-derived microarray data (Figure 3.3.2.B), the source of variance plot 
revealed “treatment” (LPS) and “human subject” to be the factors which had the 
greatest effect on gene expression (Figure 3.3.11).  
Using a two way ANOVA (p<0.05) and fold change of two or more, a gene list of 
1,085 genes that were statistically significantly different between the two human AM 
groups was created. A total of 966 out of 1,085 genes were upregulated and the 
remainder (118 genes) downregulated following LPS stimulation (Appendix III, 
S4). The upregulated genes included many proinflammatory genes (e.g. IL6, IL8, 
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IL1β, IL1RA), some of which were also upregulated in horse AMs in the current 
study following ex vivo LPS stimulation (Figure 3.3.5). The hierarchical clustering 
of the genelist demonstrated that gene expression between LPS and saline treatment 
(control) was clearly different (Figure 3.3.12).  
 
Figure 3.3.10: Principal component analysis of LPS treated and untreated human AMs.  
After 6h in vivo challenge of human AMs with LPS (4 ng/kg body weight) or saline, cells were isolated 
from BALF, RNA was extracted and microarray analysis was performed. This is the PCA of LPS 
treated and saline treated (control) human AMs. Blue spheres represent the LPS treated AMs and red 
spheres represent saline treated AMs (controls). The relative difference in colour intensity for each 
group reflects the fact that a 3-dimensional image has been transcribed onto a 2-dimensional figure. 
Analysis was performed by Partek Genomic Suite 6.6 software. This is a three dimensional 
presentation of the microarray experssion data. The proportions in each axis (PC#1, PC#2 and 
PC#3) represent the percentage of variance explained by each component. The percentage on the top 
of the graph (57.5%) represents the sum of these percentages. 
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Figure 3.3.11: Sources of variation plot.  
View of plots by Partek Genomic Suite 6.6. The histogram presents the average effect size across all 
the genes for each of the factors (x-axis). The error column represents the noise or the variability of 
the data not explained by the rest of the factors and the subject column represents the seven different 
human volunteers that took part on this experiment. The y-axis represents the mean F Ratio (signal-
to- noise) of all the genes. 
 
Figure 3.3.12: The hierarchical cluster diagram of gene expression profiles in LPS/saline treated 
AMs of seven individuals. 
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 The expression patterns between saline-control (yellow dendrogram) and LPS (orange dendrogram) 
samples. Each column shows the expression of 1,085 probe sets expressed by each sample. Red 
indicates genes that were upregulated and red those that were downregulated. 
 
Despite the fact that the annotation of the horse genome is not yet complete, the 
analysis revealed 66 orthologous genes between the horse and human total genelists. 
Comparison between horse and human AMs in response to LPS (Figure 3.3.13) 
revealed a marked similarity in gene expression, a finding which may partly explain 
the similarities between horses and humans with regard to their susceptibility to 
endotoxaemia (Moore and Barton, 1998, Kobayashi et al., 2013).   
Previous work has identified LPS-induced genes shared by human and porcine, but 
not murine, monocyte-derived macrophages (Kapetanovic et al., 2012, Kapetanovic 
et al., 2013, Schroder et al., 2012). Many of these were also induced in LPS treated 
equine AMs in the current study. These comprised genes already discussed above 
(STAT4, IDO1, IL7R, and BATF3), as well as G-protein coupled receptor 183 
(GPR183; involved in B cell activation and proliferation), CD80 (involved in T cell 
activation and proliferation), RNA binding motif, single stranded interacting protein 
2 (RBMS2), Rap guanine nucleotide exchange factor 2 (RAPGEF2), poly (ADP-
ribose) polymerase family, member 9 (PARP9); kynureninase (KYNU; involved in 
the IDO pathway) and the apoptosis inhibitor XIAP associated factor 1 (XAF1) 
(Figure 3.3.14).  
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Figure 3.3.13: The horse AM response to LPS was similar to that of human AMs.  
Fold change of gene expression between horse (current study) and human (GDS4419) microarray 
data derived from LPS treated and control AMs. Genes with fold change greater than 2, which were 





Figure 3.3.14: Expression profile of genes upregulated in LPS stimulated equine macrophages.  
These genes are shown to be also upregulated in human but not in mouse LPS treated macrophages. 
These include genes which were either (a) located within the top 5 clusters of upregulatedgenes   (e.g. 
11 and 62 or (b) located within other smaller clusters, yet with a similar expression profile and 
considered to have potential biological significance (e.g  GRPI83, CD80, KYNU and XAF1). The x-
axis shows each horse  and the y-axis shows the normalised relative intensity of expression in that 
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Transcripts for genes important for the NO pathway, such as GTP cyclohydrolase 1 
(GCH1), iNOS, argininosuccinate synthase 1 (ASS1), arginase 2 (ARG2), ornithine 
aminotransferase (OAT), argininosuccinate lyase (ASL), were included in the 
Affymetrix equine microarray strip. However they were not induced by LPS 
stimulation, further emphasising the distinctions between rodents and humans, horses 
and pigs (Appendix III, S1 and S2).  RT qPCR was also used to validate the equine 
microarray data regarding gene expression of IL7R , STAT4 and (TNFAIP3-
interacting protein 3) TNIP3 (Figure 3.3.15 ), as well as of TNFα and IDO, which 
were verified earlier (Figure 3.2.4). Their microarray gene expression is shown in 
Figure 3.3.16. 
The vitamin D3 pathway is shown to play an important role in protection against 
infections (Gombart, 2009) and the CYP27B1 gene, involved in this pathway, is 
induced by LPS in both porcine and human macrophages, but not in murine 
macrophages (Kapetanovic et al., 2012, Kapetanovic et al., 2013, Reynier et al., 
2012). In the current study on equine AMs, LPS-induced expression of this gene was 
very low (microarray fluorescence intensity <50 and dynamic range after LPS 
treatment <1.5), a finding verified by subsequent RT qPCR analysis (Ct values > 30, 
data not shown). Interestingly, the circulating concentration of vitamin D in horses is 
very low, and does not appear to play a key role in regulating calcium and inorganic 
phosphate [P(i)] in homeostasis (Breidenbach et al., 1998).  Thus, this may be a 
species-specific trait.  
 
 





Figure 3.3.15: LPS induced IL7R (A), STAT4 (B) and TNIP3 (C) in equine AMs. 
 Horse AMs were treated with LPS and incubated for 6h. RNA was extracted from the same samples 
used for the microarrays and reverse transcribed. mRNAs for IL7R (A), STAT4(B) and TNIP3 (C) 
were measured by RT qPCR. Results are representative of 5 experiments +/-SEM, using RNA from 5 
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Figure 3.3.16: The mean expression of (A) TNFα, (B) IDO, (C) IL7R, (D) STAT4 and (E) TNIP3 
probesets as estimated during the microarray analysis on LPS treated (6h) and untreated (0h) 
equine AMs. 
Results are representative mean of 5 experiments +/-SEM, using RNA from 5 different animals (horse 
1, horse 2, horse 3, horse 6 and horse 8 ). Statistical significance (*) was set at p<0.05 versus control 
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3.4 The effect of race training on the basal gene 
expression of AMs derived from Standardbred 
racehorses 
Several human studies have focused on the effect of exercise on circulating 
monocytes, with respect to numbers, population shifts, cell surface receptor 
expression and cytokine production (Okutsu et al., 2008, Krueger and Mooren, 2007, 
Lancaster et al., 2005, Hong and Mills, 2008, Starkie et al., 2001, Steppich et al., 
2000). Similarly, more limited studies in horses have utilized microarray technology 
to assess the effects of long duration, extended exercise on peripheral blood 
monocyte global gene expression (Barrey et al., 2006, Capomaccio et al., 2010). 
Although such work has provided valuable information on exercise-induced 
alterations in immunity, it is limited with respect to offering insights into exercise-
induced and/or training-associated changes in resident macrophage function and 
related immune responses at the tissue level (Walsh et al., 2011). Some studies 
investigating the effect of exercise on AMs have been conducted in humans (Fehr et 
al., 1989), mice (Ceddia et al., 2000, Woods et al., 1997, Kohut et al., 1998) and 
horses (Raidal et al., 2000) and have  demonstrated an exercise-associated reduction 
in MHC-II expression (Woods et al., 1997), antigen presentation capacity (Ceddia et 
al., 2000), phagocytic properties (Raidal et al., 2000) and impaired response to 
several stimuli (Kohut et al., 1998, Mignot et al., 2012). To date, no studies have 
investigated alterations in the overall gene expression profile of equine AMs in 
response to extended training. 
 
Accordingly, this section of work aimed to define the gene expression of AMs 
derived from eight standardbred racehorses prior to and following commencement of 
race training.  BALF from eight systemically healthy Standardbred racehorses was 
collected at two different time points: prior to entry into training (T0) and during the 
training period (T1). Inclusion criteria for T1 sampling included the requirement for 
the horses to have been in training for at least 10 days prior to sample collection. 
 
3.4.1 Cell recovery and populations  
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 for T1] were not statistically significant 
different between the two time points, although slightly increased during the training 
period. Differential cell counts of raw BALF were assessed and are shown in Tables 
3.4.1 and 3.4.2. A slightly greater neutrophil percentage was found in samples 
obtained from horses during the training period, as reported previously (McKane et 
al., 1993). The mean percent of haemosiderophages was also increased during the 
training period, consistent potentially with a previous episode of EIPH, a disorder 
commonly observed in racehorses undergoing training (Doucet and Viel, 2002). 
However, no statistical statistical significance was observed on these results.  
According to the formal definition of IAD (Robinson, 2003, Couetil et al., 2007), all 
horses from T0 apart from BU11 and all from T1 were affected with the disease. 
Since no clinical symptoms were observed on the horses in this study, the form of the 
disease was considered as subclinical. Following overnight culture and removal of 
nonadherent cells, more than 90% of adherent cells were identified morphologically 
as macrophages, by light microscopy. 
 
DCCs (%) (T0), n=7 BU1 BU2 BU4 BU5 BU6 BU11 BU12 Mean+/-SEM 
Macrophages 42.5 21.5 44 66 45 60 57.5 48.1+/-5.6 
Lymphocytes 32 26.5 39 23.5 27.5 34 34.5 31+/-2 
Haemosiderophages 5.5 29 - 1.5 9 1 - 6.6+/-3.9 
Neutrophils 11 5 12 5 5 4 2 6.3+/-1.4 
Eosinophils - 15.5 2 - 12 - - 4.2+/-2.5 
Mast cells 9 2.5 2 4 1.5 1 5.5 3.6+/-1.2 
Multinucleated giant 
cells and/or basophils 
- - 1 - - - 0.5 0.2+/-0.2 
 
Table 3.4.1: Differential cell count (%) of BALF derived from Standardbred horses prior to entry 
into race training (T0). 
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DCCs (%) (T1), n=8 BU1 BU2 BU4 BU5 BU6 BU8 BU11 BU12 Mean+/-SEM 
Macrophages 50 14 47 64 51 22 57 61,5 45.8+/-6.4 
Lymphocytes 31 19 33 30 19 31.5 35.5 27.5 28.3+/-2.2 
Haemosiderophages - 54 10.5 - 7 29,5 - 1 12.8+/-6.9 
Neutrophils 16.5 7 7.5 3.5 16.5 16 5.5 6 9.8+/-2 
Eosinophils 0.5 - - - - - 0.5 - 0.2+/-0.1 
Mast cells 1.5 6 1.5 2.5 6.5 1 1.5 3.5 3+/-0.8 
Multinucleated giant 
cells and/or basophils 
0.5 - 0.5 - - - - 0.5 0.2+/-0.1 
 
Table 3.4.2: Differential cell count (%) of BALF derived from Standardbred horses following 
initiation into (T1) race training.  
 
3.4.2 The effect of race training on TNFα and IL10 production 
by AMs derived from Standardbred racehorses 
As noted above, some previous studies suggest that intense exercise might affect the 
function of AMs (Wong et al., 1990, Raidal et al., 2000, Raidal et al., 2001). For 
example Raidal and colleagues found that strenuous exercise was associated with 
impaired phagocytosis and increased oxidative burst activity of AMs (Raidal et al., 
2001, Raidal et al., 2000). Exposure of macrophages to low levels of LPS can 
produce prolonged refractoriness to restimulation (Section 3.1.8).  Hence, a possible 
indicator of exposure in vivo to an LPS-like microbial stimulus during exercise 
would be a change in LPS-responsiveness ex vivo.  To address this possibility, TNFα 
in AM culture supernatant was measured by ELISA before and 6h following LPS 
stimulation.  The levels of basal TNFα production (0h) induced in AMs from 
racehorses were similar to those observed previously (Section 3.1.5). However, LPS-
induced TNFα production by AMs derived from racehorses during the training 
period (T1) was slightly greater than that at T0 (Figure 3.4.1). Consistent with 
previous results (Section 3.1.5), LPS treatment did not induce detectable IL10 
(Figure 3.4.2). 
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Figure 3.4.1: Supernatant TNFα concentration (pg/ml) in LPS treated AMs harvested from 
Standardbred racehorses prior to (T0) and following (T1) entry into race training.  
BALF from Standardbred racehorses was collected before and during the training period. After AM 
isolation, cells were seeded in plastic plates at 1x10
6
 cells and left overnight to adhere to the plastic. 
Next morning they were stimulated with 100ng/ml LPS for 6h, supernatant was collected and TNFα 
production was measured by ELISA. Results are the mean of a minimum of two experiments derived 
from different horses+/- SEM. 
 
Figure 3.4.2: Supernatant IL10 concentration (pg/ml) in LPS treated AMs harvested from 
Standardbred racehorses prior to (T0) and following (T1) entry into race training. 
 Cells were treated as described previously (Figure3.4.1). Results are the mean of a minimum of three 
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3.4.3 Transcriptomic analysis of equine AMs before and 
during the training period 
BALF was collected from eight Standardbred racehorses before and after the 
commencement of training as described in Section 2.1.2. After isolation of AMs by 
adherence, RNA was extracted at 0h and 6h following LPS (100ng/ml) stimulation, 
providing an average yield of 1.7µg of RNA /10
6
 cells (± 0.5). Untreated RNA 
samples from 0h time point and with RNA integrity number (RIN) greater than 7 
were used for microarray analysis (Figure 3.4.3). According to these criteria, RNA 
samples derived only from  horse BU1, BU2, BU4, BU5, BU6 and BU12 (n=6) from 
the Table 2.2 were used for the microarray screening. 
 
 
Figure 3.4.3: Workflow for studying the gene expression response of racehorse AMs to training.  
BALF samples were collected at 2 different time points: prior the training period (T0, n=7) and 
during the training period (T1, n=8). Retrieved fluid was processed and isolated BALF cells were 
incubated overnight. Next morning RNA was extracted. After RNA quality assessment samples were 
used for microarray analysis (n=6). Cell figure captured from the current study. 
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All expression data were normalised in the Partek Genomics Suite 6.6 software and 
analysis was performed as previously described (Section 2.9 and 3.2.6). The source 
of variation plot (Figure 3.4.4.A) depicts the average effect size of all factors 
included in the experiment. Removal of the horse ID as a batch effect revealed that 
training had a significant effect (Figure 3.4.4.B). Nevertheless, the largest variation 
detected was between horses, an observation also confirmed by the PCA (Figure 
3.4.5). Unsupervised exploration of gene expression by PCA displayed a separation 
of samples into two groups corresponding to the pre-training period (T0) and the 
intra-training period (T1) (Figure 3.4.5). Horses BU2, BU4 and BU6 were more 
tightly clustered together compared to the rest. Based on the information available on 
these horses (e.g. stage of training, gender), no common factor could be attributed to 
this grouping, with the exception of the fact that these horses represented the oldest 
in the group of 6 (Table 2.2). However, no definitive conclusions could be drawn 
from the available  information and  further work  on a larger dataset would be 
required to definitely address this question. A two-way ANOVA test (time point: 
fixed effect; horse ID: random effect) was performed in order to identify 
differentially expressed genes between the two groups. No statistically significant 
difference was observed between the two time points (T0 and T1) (p< 0.05, Fold 











Figure 3.4.4: Source of variation plot of AMs from 6 racehorses before and during the training 
period. 
View of plots by Partek Genomics Suite 6.6 software before (A) and after (B) the horse ID was 
removed as a batch effect. These plots present the average effect size across all the genes for each of 
the factors. The y- axis represents the Mean F-ratio (signal-to-noise) of all the genes, while the x-axis 
represents the factors influenced the gene expression. The error column represents the noise or the 
variability of the data not explained by the rest of the factors.  
A 
B 
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Figure 3.4.5: PCA of AMs from 6 racehorses before and during the training period. 
Yellow and pink ellipsoid-webs represent the AMs retrieved while the racehorses were at rest (T0) 
and during the training period (T1), respectively. Each individual is represented with a different 
coloured sphere. The relative difference in colour intensity for each group reflects the fact that a 3-
dimensional image has been transcribed onto a 2-dimensional figure. Analysis was performed by 
Partek Genomic Suite 6.6 software. This is a three dimensional presentation of the microarray 
experssion data. The proportions in each axis (PC#1, PC#2 and PC#3) represent the percentage of 
variance explained by each component. The percentage on the top of the graph (60%) represents the 
sum of these percentages. 
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Network analysis of the normalised expression data was conducted using Biolayout 
Express
3D
. Only transcripts that were differentially expressed by dynamic range ≥ 1.5 
were included in the analysis.  As discussed earlier, Biolayout Express
3D
 is a 
software package used for the analysis of microarray data that allows detection of 
groups of genes with a similar expression profile (Freeman et al., 2007). Using this 
tool, a Pearson correlation matrix (r≥0.9) of a transcript-to-transcript comparison was 
used to filter for correlated expression patterns across the samples. This created a 
graph of 12,860 nodes connected by 104,012 edges and 4,117 clusters . The nodes 
correspond to transcripts (microarray gene probes) and the edges indicate a 
correlation between them above the threshold (r≥0.9). The clustering algorithm MCL 
with an inflation value of 2.2 was used to identify groups of tightly co-expressed 
genes and create clusters containing a minimum of three nodes (van Dongen and 
Abreu-Goodger, 2012). 
Figure 3.4.6 shows the network graph of all the genes based on co-expression 
patterns (r ≥ 0.9, MCL inflation: 2.2), in which clusters of genes with greater 
expression at T0 and clusters of genes with greater expression at T1 were observed. 
Although there was evidence of interhorse heterogeneity in relation to the magnitude 
of expression of individual genes at each timepoint, within each horse, several 
inflammatory related genes (e.g. chemokine ligands, interferons and NFKB) were 
expressed to a higher degree at T0, compared to T1 (Figure 3.4.7). This was evident 
despite the relatively poor annotation of the current horse microarray. This may 
reflect relative downregulation of these genes during the training period, consistent 
with an immunosuppressive effect of exercise, as previously suggested (Robson et 
al., 2003, Raidal et al., 2001, Raidal et al., 2000).  
Genes associated in the different clusters were explored for GO annotation analysis 
(Biological processes) by DAVID software. A gene list of 76 annotated genes was 
created from the clusters of genes with higher expression at T0 (Cluster 2, 5, 16, 21, 
39, Appendix IV, S1). This group included genes involved in cell activation and 
immune system processes Table 3.4.3. The annotated genes upregulated at timepoint 
T1 are shown in Table 3.4.4 (full list in Appendix IV, S2) and are genes mainly 
related to cellular metabolic processes and to regulation of biological processes. 
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Clusters 9 and 25 (Figure 3.4.8) are representative of a number of clusters that 
produce the horse-to-horse variation seen also in the PCA and it shows that some 
horses have higher expression of a group of genes compared to others. 
 
 




The network graph (A) represents the gene expression of AMs from 6 racehorses at rest (T0) and 
during the training period (T1). Genes with a similar expression profile are clustered together. Image 
B shows just the nodes involved in the clusters with an expression profile shown in C and D. Graphs 
(C) and (D) show the pattern of the clusters of genes that were detected higher at timepoint T0 and 
T1, respectively. The x-axis represents the 6 different horses before (T0) and after (T1) the training 
period and the y-axis the normalised expression level based on microarray intensity. Horses BU1, 
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Figure 3.4.7: Expression profiles of immune related genes.  
Selection of genes presented here were downregulated during training. These include genes which 
were either (a) located within the top 5 clusters of genes with  higher expression in AMs (Clusters 2, 
5,16, 21 and 39) or (b) located within other smaller clusters, yet with a similar expression profile and 
considered to have potential biological significance (e.g.CXCL9, STAT4, CXCL12). The x-axis shows 
each horse and the y-axis shows the normalised relative intensity of expression in that horse . Horses 
BU1, BU2, BU4, BU5, BU6 and BU12, as depicted in order (left to right) on the x-axes were included 
in this analysis.  CXCL9, chemokine (C-X-C motif) ligand 9; NFKB, nuclear factor kappa-light-chain-
enhancer of activated B cells; STAT4, signal transducer and activator of transcription 4; CXCL12, 
chemokine (C-X-C motif) ligand 12; IFNA1, interferon alpha 1; IFNB1, interferon beta 1; IFN-omega 
1, interferon omega 1; TNFAIP3, tumor necrosis factor alpha-induced protein 3; GBP5, guanylate 
binding protein 5.  
 
 
A B C 
D E F 
G H I 
Characterisation of the equine macrophage/monocyte 
 186 
Annotation cluster Biological process Enrichment score Gene count 
1 Response to stimulus 7.92 50-58 
2 Immune system process 2.7 11-17 
3 Immune system development 2.68 3-17 
4 Immune response activating cell 
surface receptor signalling pathway 
1.89 3-27 
5 Cell development- differentiation 1.26 8-46 
6 Response to virus/biotic stimulus 1.04 4-8 
 
Table 3.4.3: The top six annotation clusters associated with T0.  
The table shows the top 6 out of 25 annotation clusters created by DAVID software that were related 
with the list of 117 genes found higher at T0. The enrichment score is a modified Fisher exact p value 
calculated by the software and the higher it is the more enriched the cluster is. Each annotation 
cluster contains similar  biological subcategories 
(http://david.abcc.ncifcrf.gov/content.jsp?file=functional_annotation.html). Each biological 
subcategory contains a specific number of genes; therefore, it is possible for a group of differentially 
expressed genes to be related to a particular annotation cluster via one or more of these biological 
sub categories. The range of gene counts (right column) incorporates the different gene counts 
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Gene symbol Gene name  Cluster 
HEATR1 HEAT repeat containing  40 
GLRX3 Glutaredoxin 3 40 
LYAR Cell growth-regulating nucleolar protein 40 
KIAA0020 Minor histocompatibility antigen HA-8 40 
PDCL3 Phosducin-like 3  40 
TMEM165 Transmembrane protein 165  40 
TOMM70A Translocase of outer mitochondrial membrane 70 A 40 
NOL10 Nucleolar protein 10  40 
NOM1 Nucleolar protein with MIF4G domain 1 40 
RARS Arginyl-tRNA synthetase  40 
TACC3 Transforming, acidic coiled-coil containing protein 3  40 
URB1 Ribosome biogenesis 1  40 
CCDC122 Coiled-coil domain containing 122 42 
ESM1 Endothelial cell-specific molecule 1 42 
OR5B2 Olfactory receptor, family 5, subfamily B, member 2 42 
DOT1L DOT1-like, histone H3 methyltransferase 90 
EXTL3 Exostoses (multiple)-like 3  90 
MNAT1 CDK-activating kinase assembly factor MAT1 90 
HIVEP3 Human immunodeficiency virus type I enhancer binding 
protein 3 
90 
PCGF6 polycomb group ring finger 6  90 
RBM17 RNA binding motif protein 17  90 
 
Table 3.4.4: Genes with higher expression at timepoint T1.  
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Figure 3.4.8: Expression pattern of clusters 9 (A) and 25 (B).  
Horses BU2 (A) and Horse BU6 (B) had higher expression of all the genes in this cluster than any 
other horse at either T0 or T1. Horse BU6 was the only horse with upregulated genes in this cluster at 
T1. Other clusters were also found where individual horses had a unique expression pattern not 
shared by any other horse. The x-axis shows each horse and the y-axis shows the normalised relative 
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Chapter 4: Discussion 
The principle focus of this thesis was to improve our understanding of equine AMs. 
Since these are the main cells responsible for bacterial and particulate clearance 
within the lung, it was hypothesised that they may represent an appropriate 
therapeutic target cell for IAD, which has been recently defined as a nonspecific 
inflammatory condition of the equine lower airways. In light of limited published 
data on equine macrophage biology at the commencement of the study, efforts were 
directed towards improving knowledge of basic equine AM biology, a necessary 
prerequisite to addressing the initial hypothesis.  The work was greatly facilitated by 
the abundant yield of macrophages (Section 3.1.1) which could be isolated from the 
airways,peritoneal cavity and the peripheral blood of horses, with cell retrieval 
numbers several orders of magnitude greater than those achievable from rodent 
models and differential cytological profiles comparable to those reported from live 
horses (Richard et al., 2010b, Hawkins et al., 1998). Given the successful 
cryopreservation process (Section 3.1.2), a single horse could feasibly provide 
sufficient cellular material for numerous comparative functional studies.  
By comparison to other species such as humans (Ratjen et al., 1994), Rhesus 
macaques (Cai et al., 2014), rodents (Sunil et al., 2007, Okamoto et al., 2003), dogs 
(Mercier et al., 2011), and cows (Jian et al., 1995), equine BALF contained a higher 
percentage of lymphocytes and an almost negligible percentage of granulocytes 
(Section 3.1.3). In contrast, equine PLF contained a significant proportion of 
neutrophils, as previously reported for healthy cattle (Wittek et al., 2010, Oehme, 
1969), but not for humans or mice (Kubicka et al., 1989, Ramalingam et al., 2003). 
Therefore, this equine (and bovine) PLF neutrophilia, which is markedly higher than 
of the lung compartment, likely reflects species-specific microenvironmental 
differences within the peritoneal cavity.  The mechanism underlying neutrophil 
recruitment to this site in these species remains undetermined; however, it is most 
likely related to the presence of low-grade inflammation in the equine peritoneal 
cavity. Although Barton and Collatos (1999) detected TNF, IL6 and endotoxin only 
in the PLF of horses with gastrointestinal disease and not in healthy horses, it is 
possible that the limited sensitivity of the analytical techniques used could result in 
Characterisation of the equine macrophage/monocyte 
 190 
failure to detect low concentrations of biologically active analytes, such as endotoxin 
in healthy horses (Barton and Collatos, 1999). 
The studies in Section 3.1.5 aimed to optimize conditions for the study of equine 
macrophage responses in vitro. LPS-induced TNF production was greater when 
cells cultured in medium containing heat inactivated HS compared to FCS.  Others 
have reported conflicting results, showing a direct stimulatory effect of FCS on 
equine macrophages, suggesting that a serum derived factor augmented the response 
to LPS (Figueiredo et al., 2008). Although LBP seems the most likely candidate, the 
serum content of this protein should be markedly reduced by heat treatment 
(Figueiredo et al., 2008) and the identification of other potentially responsible serum 
components may be warranted, particularly as HS is extensively used in cell culture 
experiments involving macrophages/monocytes derived from a variety of species, 
including horse (Werners et al., 2004, Ainsworth et al., 2003a, Bryant et al., 2007, 
Hondalus et al., 1992), human (Kurihara et al., 1990, Collman et al., 1989) and 
mouse (Orikasa et al., 1993). HS may contain higher levels of albumin, total proteins 
and endotoxin compared to FCS (Sugimoto et al., 1990). It may also contain CSF1.  
Active CSF1 protein is absent from FCS, in as much as most bioassays for CSF1 are 
carried out in FCS-containing medium, but CSF1 is detectable in adult serum in 
other species and promotes monocyte maturation (Hume and MacDonald, 2012). 
Nevertheless, consistent with previous findings (Frellstedt et al., 2014), equine 
macrophages or monocytes were not apparently activated by the cell culture media 
supplemented with HS or FCS in the absence of LPS.  
Endotoxin tolerance, a protective mechanism induced by continuous exposure to low 
levels of LPS in both human and murine monocytes and macrophages (del Fresno et 
al., 2009, Dobrovolskaia et al., 2003, Medvedev et al., 2000, Biswas and Lopez-
Collazo, 2009), was demonstrated for the first time in both equine AMs and blood 
monocytes (Section 3.1.8). Indeed this phenomenon may explain the greater 
sensitivity of equine monocytes, compared with AMs, to LPS stimulation (Grunig et 
al., 1991), potentially reflecting a level of desensitization of AMs by chronic low 
level in vivo stimulation. Moreover, the levels of TNFα and IL10 released by the 
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monocytes in this study are consistent with those reported previously in relation to 
equine PBMCs (Vendrig et al., 2013) (Figures 3.1.16 and 3.1.17). Interestingly, 
Barton et al (1996) reported reduced LPS responsiveness in equine PMs derived 
from horses with acute gastrointestinal disease, many of which were endotoxaemic 
(Barton et al., 1996), as previously reported for murine-derived PMs (Medvedev et 
al., 2000).  
 
4.1 Equine monocytes can differentiate to 
macrophages in vitro 
Equine blood monocytes were successfully differentiated to macrophages by rhCSF1 
(Section 3.1.9). This finding was not unexpected, since rhCSF1 was previously 
reported to cause differentiation of human and mouse monocytes (Hume et al., 1987, 
Warren and Vogel, 1985, Hume and Gordon, 1983) and pig bone marrow cells, 
(Kapetanovic et al., 2012).  There had been limited prior evidence that rhCSF1 was 
active on equine cells, including the successful differentiation and function of human 
osteoclasts on equine spongy bone (Perrotti et al., 2009) and osteoclast like cells 
from equine bone marrow cells (Gray et al., 2002). Similarly, the equine monocyte 
differentiation achieved by culture in high concentrations of HS was also a novel 
finding. HS activity on proliferation and differentiation of several primate cell types 
including human blood monocytes has been repeatedly reported (Patel et al., 1989, 
Mergenthaler et al., 1988, Potter et al., 1981, Zuckerman et al., 1979). Similarly, 
incubation with 10% HS resulted in successful differentiation of murine blood 
monocytes to macrophages (Wirth et al., 1982). Moreover, the presence of HS but 
not FCS generated granulocyte/macrophage colony formation from murine bone 
marrow cells (Sugimoto et al., 1990) and represented a prerequisite for murine stem 
cell differentiation and maintenance of long term proliferation in vitro (Dexter et al., 
1977). As noted above, CSF1 is at least one candidate protein responsible for this 
response, but CSF2 produced by the lung (Trapnell et al., 2009) could also 
contribute.   
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4.2 Microenvironment significantly influences 
function and phenotype of AMs and PMs 
Consistent with the results derived from studies on other species, equine AMs 
showed all the characteristics of typical macrophages, including CD14, CD163 and 
TLR4 expression (Figure 3.2.5), significant LPS-induced TNFα production (Figure 
3.1.7) and demonstrable phagocytic activity (Figure 2.3.8). Compared to other 
macrophage populations, AMs have a distinctive profile, likely reflective of their 
unique microenvironment (Gonzalez-Juarrero and Orme, 2001, Guth et al., 2009). 
AMs were clearly very different from PMs in the current study, in that the latter cells 
failed to produce TNFα in response to stimulation with LPS, Poly IC and heat killed 
S. typhimurium (Figures 3.1.7 and 3.2.1). Another study reported LPS-induced 
TNFα production by equine PMs, but there was marked horse-to-horse variation 
(Barton et al., 1996). Furthermore, Barton et al (1996) relied on measuring TNFα 
bioactivity. Other studies which have employed the same TNFα bioassay in the 
assessment of LPS responsiveness in equine PMs found the response to be neither 
dose nor time dependent (Morris et al., 1990, Hawkins et al., 1998, Morris et al., 
1991). Finally, the previous studies on the LPS-responsiveness of equine PMs 
utilized cells harvested from live horses. Collection of peritoneal fluid from live 
horses is conducted on standing subjects, whereby a cannula is inserted through the 
ventral abdominal midline at the most dependent site and the fluid collected 
represents that which has accumulated at this site by gravity (Morris et al., 1990, 
Hawkins et al., 1998, Morris et al., 1991). In contrast, the collection procedure used 
in the current study, which involved high volume lavage of the entire abdominal 
cavity, may have resulted in the isolation of more representative population of cells 
including those loosely adherent to the peritoneum. 
The failure of PMs to release TNFα protein, as measured by ELISA, was further 
supported by the lack of TNFα mRNA detection by RT qPCR (Figure 3.2.4). These 
combined data are consistent with the results of several studies which have shown 
relatively low levels of LPS-induced TNFα production by mice PMs (Bradbury and 
Moreno, 1993, Zheng and Specter, 1996, Sherry et al., 2007, Skuladottir et al., 2007). 
The biological reason for this apparent deficiency in responsiveness of equine PMs is 
Characterisation of the equine macrophage/monocyte 
 193 
unclear but may reflect a degree of LPS tolerance. Although the PM harvesting 
procedure was not conducted in a completely aseptic manner, it is unlikely that PM 
stimulation occurred during this process due to the magnitude of dilution with the 
lavage fluid (6L) and the immediate post sampling separation, isolation and exposure 
of the cells to antibiotic containing medium. None of the horses sampled had any 
evidence of gastrointestinal disease, which may have permitted significant endotoxin 
translocation across the intestinal wall prior to euthanasia. Therefore, low level 
endotoxin translocation may routinely occur in this species and could also explain 
the relatively high ratio of neutrophils within the peritoneal cavity of even healthy 
horses. 
There are reports that argue against an “ante-mortem” endotoxin tolerance 
hypothesis. Firstly, endotoxin was reported to be undetectable in the peritoneal 
fluidof healthy horses, rather it was detectable only in horses with colic (Barton and 
Collatos, 1999). Secondly, endotoxin tolerance in murine PMs has been associated 
with downregulation of TLR4 expression (Nomura et al., 2000). The equine PMs 
showed low surface expression of CD14, rather than TLR4, a finding also reported in 
rabbit AMs exposed to LPS or E.coli in vivo or in vitro (Lin et al., 2004). 
Considering the involvement of CD14 in the recognition and phagocytosis of gram 
negative bacteria (Grunwald et al., 1996), this lack of CD14 expression on the equine 
PMs also explains their poor phagocytic capacity compared to AMs (Figure 3.2.8) a 
phenomenon also reported in rodents (Changqi et al., 2013, Gjomarkaj et al., 1999). 
Another possible mechanism of endotoxin insensitivity is the production of IL10, an 
anti-inflammatory cytokine that is well documented to inhibit the LPS-induced 
production of pro-inflammatory cytokines, such as IL1, TNFα, IL6 and PGE2, by 
macrophage cell lines and peritoneal macrophages, with a particular effect on TNFα 
(Fiorentino et al., 1991). Furthermore, the presence of human IL10 significantly 
reduced the level of inflammatory mediators, such as IL6, TNF and PGE2, by equine 
PMs, with a particular effect on TNFα, following LPS treatment (Hawkins et al., 
1998). In the current study, LPS-stimulated AMs and PMs produced very low levels 
of IL10, even at a 24h time-point (Figures 3.1.8, 3.1.10 and 3.1.11). This lack of 
LPS induced IL10 production by AMs has also been reported in human- (Thomassen 
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et al., 1996), murine- (Salez et al., 2000) and pig-derived cells (Liu et al., 2012) and 
although the underlying mechanisms for this remain unclear, it has been proposed 
that regulation of its secretion may be influenced by certain undetermined 
environmental factors, such as surfactants (Salez et al., 2000, Wright, 1997). TLR 
activation of murine AMs and PMs was shown to inhibit IL10 signal transduction 
and IL10 induced immunosuppression at the level of TNFα (Fernandez et al., 2004). 
The secretion of IL10 by AMs is enhanced in response to excessive inflammation. 
Laan et al (2006) reported greater LPS-induced IL10 production from AMs harvested 
from horses with pre-existing airway inflammation, compared to healthy horses 
(Laan et al., 2006).   
Differences between AMs and PMs were further supported by gene expression arrays 
(Section 3.2.6), as seen in other species (Freeman et al., 2012, Hume et al., 2010, 
Changqi et al., 2013) (www.biogps.gnf.org) .  Both PCA (Figure 3.2.9) and network 
analysis (Figure 3.2.12) revealed a clear distinction between the two cell 
populations. AMs showed greater expression of genes related to macrophage 
differentiation and development, such as CD14, CD68, CD71, CD163 and CSF1 and 
its receptor (Figure 3.2.13) (Hume et al., 2010, Akagawa et al., 2006, Reynier et al., 
2012), data which complemented the flow cytometry results. The CS2RB gene 
detected in this group of genes has previously been shown in humans to regulate 
surfactant homeostasis, with recessive mutation leading to pulmonary alveolar 
proteinosis (Suzuki et al., 2011). Moreover, AMs showed relatively greater 
expression of FOXP1, which is known to play a key role in lung development, 
mainly in lung epithelium (Shu et al., 2007). Consistent with their high capacity for 
phagocytosis compared with PMs, AMs showed relatively greater expression of 
several members of the scavenger receptors family, c type lectins and others, shown 
to be also essential for functions such as endocytosis, phagocytosis, adhesion and 
antigen recognition (CD14, CD40, CD48, CD68, CD163, CD276, CLEC2B, MRS1) 
(Figures 3.2.13 , 3.2.14 and Appendix II, S3) (PrabhuDas et al., 2014).  
Equine AMs also showed relatively greater expression of certain important pattern 
recognition receptors, including TLR3, which recognises viral double stranded RNA, 
TLR6, which recognises bacterial lipopeptides and mycoplasma and both TLR7 and 
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TLR8, which recognise RNA from RNA viruses (Kumar et al., 2011).  Even though 
flow cytometric analysis revealed a slightly greater cell surface expression of TLR4 
on AMs compared to PMs (Figure 3.2.6), its gene expression was not detected by 
analysis of the microarray data as being statistically significantly greater in this cell 
population. However, this apparent inconsistency can likely be attributed to the 
thresholds applied in the analysis (e.g. Pearsons correlation, fold change and p-value) 
(Section 2.10), since focused analysis revealed the gene expression intensity of this 
receptor to be slightly greater in AMs compared to PMs (data not shown). Other 
studies have also confirmed TLR4 mRNA expression on horse AMs (Waldschmidt et 
al., 2013, Frellstedt et al., 2014). 
AMs have been considered to exhibit an M2 or alternatively activated phenotype, to 
suppress spontaneous inflammation in the lung (Jones et al., 2013). Several genes 
related to this state of polarisation were more highly expressed in AMs (Figure 
3.2.13 and 3.2.14). These included TGFB1, which plays a key role in alveolar 
homeostasis (Lambrecht, 2006), CSF1, which promotes this alternative state of 
activation (Jones et al., 2013) and the C type lectin MRC1, also shown to be highly 
expressed in porcine AMs along with several other C type lectins (Freeman et al., 
2012, Kapetanovic et al., 2013). The increased expression of MAP3K2 in equine 
AMs, as detected in the clusters, was also found in porcine AMs compared to bone 
marrow or monocyte derived macrophages (Figure 3.2.14) (Kapetanovic et al., 
2013).  
By contrast, PMs exhibited a gene expression profile that supported the view that 
their unresponsiveness to LPS was due to previous exposure to an activating 
stimulus. In particular, numerous pro-inflammatory as well as anti-inflammatory 
cytokines were detected in the gene clusters more highly expressed in PMs (Figure 
3.2.15, Appendix II, S4). No defined polarisation could be attributed to the PMs, as 
highly expressed transcripts were identified which could be related to both classical 
[M1] (CXCL1, CXCL3, IL1A, IL1B, IL8, IL23A, NFKB2) and alternative [M2] 
(CCL22, IL4R, IL10) macrophage activation. This finding is consistent with both 
mouse and human dataset analyses, which have also failed to support the existence of 
a transcriptional specific outline linked to the M1 or M2 activation status (Wells et 
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al., 2003, Mabbott et al., 2010). A novel hybrid polarisation has recently been 
reported in murine macrophages following the induction of LPS tolerance (O'Carroll 
et al., 2014). Interestingly, certain transcripts of this profile were also detected in 
equine PMs (IFNA2, IL6, THBS1). In addition, the equine PM expression profile 
showed characteristics previously attributed to both wound healing (CCL22, IL4R, 
MMP1, MMP14) and regulatory macrophages (high IL10, low IL12 expression). 
The relatively greater expression of several neutrophil chemoattractants, including 
CXCL1, CXCL3, CXCL6, IL8 and CSF3 and its receptor (Figures 3.2.15 and 3.2.16) 
could contribute to the presence of neutrophils within the PLF. Furthermore, the 
hypothesised role for low grade endotoxin translocation in this neutrophil 
recruitment may be supported both by the expression of TLR4 on the equine PMs 
and the reported TLR4-dependent increase in CXCL1/2 expression in murine PMs 
and peritoneal mast cells) following LPS stimulation, with resultant neutrophil 
recruitment to the peritoneum (De Filippo et al., 2013).  
In contrast to AMs, PMs reside within a hypoxic milieu and consistent with this 
microenvironment, some hypoxic induced genes were found to be more highly 
expressed in PMs, including VEGFA and its receptor FLT1, CXCR7 and HIF3A 
(Figures 3.2.16, Appendix II, S4). Previous studies have shown that such a hypoxic 
environment can result in the induction of genes involved in the regulation of various 
cell functions such as angiogenesis, metabolism, cell survival and apoptosis (Ando et 
al., 2013, Roda et al., 2011, J. Martin, 2013). Similarly, transcript FGF2 related to 
wound healing and development of epithelial and endothelial layers was also highly 
expressed in PMs.  
Compared with PMs, AMs are continuously challenged on a breath-by- breath basis 
with inhaled air containing a variety of pro-inflammatory agents and significant 
reliance is placed on this cell population to cope with this challenge in the most 
appropriate manner. The greater LPS responsiveness and phagocytic capacity of 
AMs compared to PMs probably reflect their adaptation to this key role, while 
minimizing the likelihood of collateral tissue damage, which may result in tissue 
remodeling and impaired gas exchange. Despite the constant pro-inflammatory 
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challenge of the airways, the negligible neutrophil presence within this compartment 
is reflective of the efficiency with which the AM fulfills this role.  
 
4.3 The response of equine AMs to LPS 
The equine AM response to LPS stimulation has been studied by others (Grunig et 
al., 1991, Waldschmidt et al., 2013, Schneberger et al., 2009, Laan et al., 2005), but 
the current study was the first to investigate the resultant alteration in genome wide 
transcriptional profile. A core set of inflammation related genes were upregulated 6h 
after LPS stimulation (Figures 3.3.5 and 3.3.8. A-L). Many of these genes have 
previously been reported to be upregulated in LPS treated AMs from a variety of 
species, including the horse (Waldschmidt et al., 2013, Liu et al., 2012) and represent 
part of a stereotypical immune response to endotoxin (Boldrick et al., 2002, Wells et 
al., 2003). In particular, known targets of both MyD88 (TNF, IL1, IL6, IL10) and 
TRIF (IFNB, CCL5 commonly known as RANTES) pathways were activated by LPS. 
This finding contrasts with another horse study, where equine monocytes seem to 
activate mainly the MyD88 pathway following LPS treatment (Figueiredo et al., 
2009). This discrepancy potentially indicates another cell specific difference. Further 
whole transcriptomic studies comparing these two cell types would help clarify this 
issue.   
Additionally, LPS stimulation also induced the expression of mRNA for various 
mediators of inflammation suppression, including the following: IL1RN, which 
inhibits IL1A and IL1B production; SOCS3, a feedback regulator of classical 
macrophage activation (M1) (Spence et al., 2013) (Figures 3.3.5 and 3.3.8. M-N, 
Appendix III, S2). LPS-induced SOCS3 expression has previously been 
demonstrated in AMs, where it was shown to subsequently suppress LPS-induced 
pro-inflammatory gene expression, a property considered to minimize excessive 
inflammation which may lead to preventing collateral tissue damage in the lung. 
Consistent with this role, SOCS3 depletion in murine AMs resulted in excessive 
secretion of inflammatory cytokines and chemokines by AMs (Spence et al., 2013).  
Characterisation of the equine macrophage/monocyte 
 198 
In agreement with the results of previous studies on murine, human and porcine-
derived cells (Wells et al., 2005, Joshi et al., 2003, Kapetanovic et al., 2013, Reynier 
et al., 2012), LPS stimulation also resulted in the upregulated expression of genes 
related to programmed cell death and apoptosis (CASP4, CASP7, CASP8 and 
APAF1), a process with an ongoing interactive association with inflammation and a 
key regulator of tissue homeostasis (Joshi et al., 2003). Considering the continuous 
exposure of AMs to pro-inflammatory agents, recruitment of processes such as 
inflammation suppression and apoptosis likely play a key role in preventing 
excessive inflammation and limiting collateral tissue damage in vivo. The response to 
LPS is a cascade of induction of transcription factors, which in turn induces further 
downstream targets.  In this study, those factors include STAT4, ETV6, ETV7, 
GATA6 and BATF3. Additionally, LPS-induced expression of several growth factors 
and some of their receptors was also detected. A main biological role attributed to 
CSF3 is neutrophil chemoattraction (Roberts, 2005). Moreover, CSF2 is responsible 
not only for the maturation and proliferation of granulocytes and 
monocytes/macrophages but also for the cytoprotection of AECs (Standiford et al., 
2012), potentially representing a further mechanism by which excessive tissue 
damage is limited. CSF2 signaling via its receptor delays apoptosis of AECs and 
plays an essential role both in surfactant homeostasis (Suzuki et al., 2011) and pro-
inflammatory cytokine secretion in response to LPS via PU.1, which regulates the 
TLR4 signaling pathway (Berclaz et al., 2007, Standiford et al., 2012). Furthermore, 
LPS stimulation also induced increased expression of several guanine nucleotide 
exchange factors and guanine nucleotide binding proteins (G proteins) which are 
known to interact with CD14 to promote LPS signaling via p38MAPK 
phosphorylation (Solomon et al., 1998). Interestingly, the phenomenon of significant 
inter-individual differences in response to LPS, observed here in both horse and 
human subjects (Figure 3.3.2 and 3.3.11, respectively), has been reported before in 
equine (Werners et al., 2006), human (Michel et al., 2003) and murine 
studies(Coutinho et al., 1977) suggesting a diverse responsiveness/susceptibility to 
bacterial infections in different individuals .  
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A comparative microarray study of LPS stimulated human and murine macrophages 
found that 24% of the orthologue genes between the two species were differently 
regulated (Schroder et al., 2012). These included CCL20, CXCL13, IL7R, P2RX7, 
IDO and STAT4, all of which were induced only in human, and not murine LPS 
treated macrophages. Although these data may partly reflect cell specific differences, 
as they were mainly derived from murine bone marrow and human blood monocyte-
derived macrophages, subsequent work has also shown the differential expression of 
these human-induced genes in both porcine bone marrow and blood monocyte-
derived macrophages (Schroder et al., 2012, Kapetanovic et al., 2012), data which 
are also supportive of species-specific differences. Comparison of the equine AM 
LPS-induced gene expression with the data reported by Schroder et al (2012) 
revealed the expression of some of the human specific genes by equine AMs. These 
included the following: IL7R, which is essential for T and B lymphocyte 
development and has variants associated with inflammatory diseases (Gregory et al., 
2007, Kondo et al., 1997); STAT4, which is essential for the induction of IL12 
signaling, involved in the Th1 response and an integral part of the host immune 
response to gram negative bacteria in the lungs (Deng et al., 2004); XAF1, a negative 
regulator of the inhibition of apoptosis (Liston et al., 2001) and others (BATF3, 
GPR183, RBMS2, RAPGEF2, PARP9, KYNU and IDO) (Figures 3.3.13 and 3.3.14). 
Other LPS-induced human specific genes, such as CLL20 or CXCL13, were not 
included in the Affymetrix arrays used in this study. Among the total differentially 
expressed LPS-induced genes in the present study, 66 orthologues were detected 
between the human and horse (Figure 3.3.13). Sixty three of these followed a similar 
expression profile in the two species, including both human specific genes and genes 
involved with the stereotypical immune response to bacteria. A few, such as IL6 and 
ISG20, showed a marked difference in their fold change, but the studies are not 
directly comparable, since Reynier et al (2012) harvested the cells following LPS 
stimulation in vivo. EREG, involved in the cell cycle and RGS2, a regulator of G 
protein signaling, were induced only in human AMs; whereas RDH10 was expressed 
only in equine AMs (Bauer et al., 2009). TLR3, a receptor generally associated with 
viral infection, was induced in equine, but not human-derived macrophages, and has 
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previously been reported in murine-derived macrophages (Heinz et al., 2003). 
Whether these differences are functionally important remains to be determined.   
 
4.3.1 Arginine and tryptophan metabolism differs across 
species  
The production of NO from metabolism of arginine is a key component of the 
response of rodents to pathogen challenge that is not conserved in human 
macrophages.  The differences are associated with complete lack of sequence 
conservation in the promoters and enhancers of the iNOS locus between rodents and 
humans (Thoma-Uszynski et al., 2001, Geller et al., 2006, Mellott et al., 2001, Yu et 
al., 2005, Schroder et al., 2012). The current study suggested that horse macrophages 
resemble those of humans.  The absence of NO metabolism in response to LPS 
stimulation in AMs (Section 3.17) contrasts an earlier report on AMs (Hammond et 
al., 1999a) and another one on equine bone marrow-derived macrophage cell line (e-
CAS) (Werners et al., 2004, Bryant et al., 2007), but is consistent with two other 
equine studies on AMs (Johnson et al., 1997) and PMs (Hawkins et al., 1998). Pig 
macrophages also fail to induce iNOS in response to LPS (Kapetanovic et al., 2012).  
As in the pig, LPS did not induce any of the genes involved in the NO pathway in 
equine AMs (Appendix III, S1 and S2). The similarity in response of the equine and 
human-derived cells is supported by the high level of conservation between the 
human and horse promoters and the poor alignment of the promoter sequences 
between mouse/horse and mouse/human (Figure 3.1.14).  
Although NO has been detected in BALF collected from horses, its production has 
been attributed to bronchial epithelial cells (Costa et al., 2001), in which the 
expression of iNOS was reported to increase in horses with summer pasture-
associated obstructive pulmonary disease, a lower airway inflammatory disorder that 
resembles asthma (Costa et al., 2001). Similarly, in light of the accepted lack of NO 
production by human macrophages in culture (Schneemann et al., 1993), the 
detection of NO in human BALF and exhaled gas has been attributed mainly to 
alveolar epithelial cells (Hamid and Springall, 1993). Indeed, increased production 
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has been reported in the epithelial cells of asthmatic patients (Hamid and Springall, 
1993). An alternative pathway for NO production has been reported, whereby nitrite 
and nitrate can reform NO independently of iNOS, mainly under hypoxic conditions 
(Lundberg et al., 2008). If this pathway exists in the horse, it may contribute to the 
reported NO detection in BALF.  
Whilst equine macrophages do not apparently metabolise arginine, they share with 
humans the inducible metabolism of tryptophan.  All of the components of this 
pathway are induced by LPS in both human (Schroder et al., 2012) and pig 
(Kapetanovic et al., 2012) macrophages. Indeed, IDO activation is involved in many 
human diseases including endotoxaemia and sepsis (Lögters et al., 2009, Campbell et 
al., 2014). The detection (RT qPCR and microarray) of LPS-induced upregulation of 
IDO in equine AMs complements  the findings of previous studies which reported 
IDO upregulation in horse AMs during intracellular bacterial infection (Heller et al., 
2010). Induction of KYNU, which encodes an enzyme involved in the IDO pathway, 
has been proposed as a potential early marker for sepsis in patients with severe 
trauma (Lögters et al., 2009). Despite the importance of this pathway in human 
inflammation and the recognized absence of IDO gene upregulation in murine 
macrophages, the mouse continues to be commonly used as a model for human 
inflammatory research. Such fundamental differences in cellular biology continue to 
support the development and use of other more appropriate animals, such as pigs, as 
models for human inflammatory diseases (Fairbairn et al., 2011, Kapetanovic et al., 
2012). Although the results of the current study largely supported inter-species 
conservation of the LPS responsiveness of the AM at the level of gene expression, 
they also highlighted important specific similarities between equine and human 
macrophage biology, thus potentially supporting the use of the horse as an 
appropriate model for human inflammatory research.   
 
4.4 The effect of training on equine AMs 
As previously reported (Raidal et al., 2000, Ainsworth et al., 2003a), the studies in 
Section 3.4 did not produce much evidence of training-associated changes in total 
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number of recovered BALF cells and their DCC. In agreement with the results of 
previous studies, training also did not appear to affect the morphological appearance 
of AMs (Huston et al., 1986, Adamson and Slocombe, 1995) or their LPS 
responsiveness, as assessed by TNFα release (Figure 3.1.7 and 3.4.1) (Frellstedt et 
al., 2014). Although the PCA revealed a distinct separation in gene expression 
between the two time points (Figure 3.4.5), it was clear that the magnitude of this 
training-associated alteration varied significantly between individual horses, an 
observation which was also clearly demonstrated at the source of variation plots 
(Figure 3.4.4). Although no clinical abnormalities were detected in these horses 
prior to their recruitment to the study, the results of subsequent BALF cytological 
examinations indicated the presence of small airway inflammation in all the horses, 
potentially supportive of subclinical IAD and/or EIPH (Richard et al., 2010a). 
Accordingly, a much larger dataset would be required to demonstrate the 
significance of any impact of training against a substantial background of inter-
individual variation.   
 
Although the initial analysis did not reveal any genes with large fold changes related 
to training, subsequent data analysis by Biolayout Express
3D
 software revealed that 
some immune related genes such as chemokines, the transcription factor STAT4, 
NFKB and several IFNs were more highly expressed in samples obtained at rest 
compared to those obtained during training (Figure 3.4.7). These data complement 
the findings of Frellstedt et al (2014), who reported a significant training-associated 
decrease in the basal expression of IFNB in equine AMs. Similar results have also 
been reported in relation to human PBMCs, where prolonged intense training 
resulted in reduction of the NFKB signaling pathway, indicating an 
immunosuppressive effect of training on blood cell compartments (Sousa e Silva et 
al., 2010). Despite the limited sample size, the analysis supports some direct effect of 
training on gene expression, particularly of immune-related genes, that may play a 
role in increasing susceptibility to opportunistic infection and suggest that larger 
population studies would be more informative. 
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4.5 Limitations of the study 
Despite efforts to optimize the experimental designs and maximize the validity of the 
data generated, there were inevitable and unavoidable limitations throughout the 
study which could theoretically have influenced the results. Despite extensive 
research on equine inflammatory diseases, specific information on the equine 
mononuclear phagocyte system (MPS) is lacking, a deficiency which can largely be 
attributed to the limited availability of appropriate molecular reagents. Consequently, 
many studies have relied on the successful use of cross reactive human/murine 
reagents, some of which were also used in this study (e.g CD163 and TLR4 
antibodies). Availability of a wider range of commercially available horse specific 
reagents throughout the period of study would likely have provided additional and 
novel information on equine AM biology. Similarly, the comparatively poor 
annotation of the equine genome may have resulted in the failure of the microarray 
experiments to reveal additional and important information. Finally, there are 
inherent limitations when working with the horse, either as a species of interest or a 
comparative animal disease model. These include financial constraints in relation to 
general maintenance of horses and limitations in relation to the adherence to optimal 
study designs when reliance is placed on the acquisition of samples from client-
owned animals, particularly those which are actively competing. The inability to 
ensure that BALF samples were derived from the racehorses at exactly the same 
stage of training is an example of such a limitation in relation to this study. 
 
4.6 Conclusions and future perspectives 
The data generated throughout this study have provided a platform on which the 
design of future studies aimed at prophylactically and/or therapeutically targeting the 
AM, can be based. To date, a limited number of studies aimed at suppressing or 
activating the equine AM have been conducted, using anti-inflammatory molecules 
or immunomodulators. An attempt to investigate the immunosuppressive effect of 
the filaria-derived immunomudulator, ES-62 on equine AMs was performed during 
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this study; however no promising results were obtained (data not shown).  Currently, 
another immunomudulator, iPPOV, presently marketed under the tradename 
Zylexis
®
 by Zoetis, is under investigation. 
The comparative data derived from this study refute the concept that “a macrophage 
is a macrophage” and highlights the importance of studying cells derived from the 
tissue of interest. Recent global analyses from mouse, human and pig have 
highlighted the fact that tissue macrophages from other locations also differ radically 
in the their gene expression profiles (Hume et al., 2010, Mabbott et al., 2010, 
Freeman et al., 2012) and there are a few transcriptomic studies highlighting tissue 
differences in the horse. Graham and coworkers commenced the investigation of the 
horse transcriptome using human microarrays on the brain, liver and articular 
chondrocytes (Graham et al., 2010). Other studies using microarrays (Huang et al., 
2008b) and RNA-seq (Coleman et al., 2010) investigated the equine transcriptome of 
different tissues and detected tissue specific expression profiles correlated with 
specialised tissue functions. These studies were not focussed at the level of tissue 
macrophage differentiation, although such information can be extracted from the data 
(Freeman et al., 2012). It will therefore be of significant interest in the future to use 
enzymic disaggregation to obtain equine macrophage populations from organs such 
as bone marrow, brain (microglia), spleen, liver (Kupffer cells), and gastrointestinal 
tract.  Moreover, further flow cytometric and gene expression experiments on equine 
monocyte subpopulations would allow the comparison with human and mouse 
monocyte subtypes. In each case, the cells could be harvested in large numbers and 
frozen for future analysis and the results would provide insight into both equine 
innate immunity and serve as models for humans.  
Horses, like other daylight-active animals including humans and pigs, have evolved 
differently to nocturnal animals, such as the mouse. The comparative analysis of 
LPS-induced gene expression of equine AMs with that of other species revealed 
significant similarities with human-derived cells and significant differences with 
murine-derived cells, supporting the potential suitability of the horse as a model of 
human lung inflammation and endotoxaemia. However, further investigation of this 
possibility using Cap analysis gene expression (CAGE) or RNA-seq could be 
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performed to examine in depth key similarities and differences in the response of 
equine and human macrophages/monocytes to LPS stimulation. Such findings could 
provide further insights into the shared phenomenon of high sensitivity of humans 
and horses to LPS and potentially provide therapeutic targets of endotoxaemia and 
sepsis in man, an area that has yielded little success through the use of rodent 
models. 
As with many domesticated animals, breeding of horses has produced an array of 
breeds selected for specific traits. More than 175 horse breeds are defined, and given 
the nature of line-breeding, each breed is likely to harbour breed-associated naturally 
occurring mutations which may be associated with enhanced susceptibility or 
resistance to several diseases. Since many equine diseases share characteristic 
features with a great range of human diseases, the use of technologies such as next 
generation sequencing and genome-wide association studies, could facilitate the 
detection of potential quantitative trait loci or even genes involved in specific 
diseases. Furthermore, the potential benefits of using genetic studies in horses for 
comparative purposes includes the extensive equine families available for inclusion. 
The genetic predisposition of equine respiratory tract diseases have recently been 
reviewed (Gerber et al., 2014). RAO, a common equine respiratory disorder and a 
recognised model for human asthma, dominates the field of interest in relation to the 
role of genetics on lower respiratory tract disease susceptibility. A few chromosomal 
regions in the horse genome have already been linked to RAO and several candidate 
genes of interleukins have been detected in these regions (Jost et al., 2007, 
Swinburne et al., 2009).  IL4RA a polymorphic gene involved in Th2 response in 
asthma was recognised as a major candidate gene for both asthma and RAO 
susceptibility (Howard et al., 2002). Nonetheless, a few contradictory results have 
already been published regarding the role of this gene, suggesting loci heterogeneity 
for such conditions and highlighting the dual effect of genetic background and 
environmental factors on their development (Jost et al., 2007, Howard et al., 2002, 
Mújica-López et al., 2002). These findings reflect the complex pathogenesis of both 
RAO and asthma, which is characterised by a polarised or mixed Th1/Th2 immune 
response (Ainsworth et al., 2003b, Lavoie et al., 2001, Abdulamir et al., 2008). 
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Given the clinical and suggested aetiopathogenic similarities between IAD and RAO, 
it is possible that a common pathologic mechanism exists between these two 
conditions. Indeed, it has been proposed that IAD may be a precursor of RAO 
(Ainsworth et al., 2003b, Giguère et al., 2002, Lavoie et al., 2011). Nevertheless, the 
genetic basis of IAD has been poorly studied, largely because of the inherent 
difficulties in accurately defining the disease phenotype.  Despite some attempts to 
detect more reliable non-invasive diagnostic markers for IAD, diagnosis is based 
mainly on the BALF DCC analysis (Couetil et al., 2007, Robinson, 2003). A more 
robust phenotypic characterisation of the IAD is essential for future genetic studies 
aimed at identifying genetic predispositions and further elucidating aetiopathogenic 
pathways with a view to  informing novel treatment and management strategies. 
Moreover, identification of specific genetic susceptibilities to IAD and/or training 
asoociated immune derangements may permit more selective breeding in the future 
focussed on reducing disease prevalence  
The horse is a natural athlete and findings derived from equine exercise studies could 
be extrapolated to elite human athletes and vice versa. Limited studies in horses have 
used microarrays to assess the effects of long-term intense exercise on peripheral 
blood monocyte global gene expression (Barrey et al., 2006, Capomaccio et al., 
2010). The application of any translational studies to investigate the effect of intense 
exercise/training on the function of AMs derived from racehorses seems most 
appropriate within the field of exercise immunology. Several mechanisms and 
biofunctions were revealed in this thesis which could be regarded as consistent with a 
training-associated immunosuppression and increased susceptibility to opportunistic 
infection. Consequently, the data generated did provide further justification for future 
longitudinal studies incorporating a larger sample size derived from appropriately 
phenotyped horses, a more defined and repeatable training regime and additional 
“post-training” sample time points. 
The major limitation throughout the study was the restricted commercial availability 
of horse-specific reagents. Although horse-specific arrays were used, they remain 
relatively poorly annotated. Over time, this limitation will become progressively less 
problematic as the annotation of the horse genome improves. An alternative means of 
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overcoming this limitation will be the extended use of techniques such as CAGE or 
RNA-seq. The recent publication of global analyses of human and mouse 
transcriptomes by the FANTOM5 consortium (www.fantom.gsc.riken.jp/5) and 
ongoing activities in Roslin to extend sheep, pig and chicken expression atlases 
based upon CAGE and RNA-seq will provide resources for comparative studies in 
the horse.   
Together, the work described in this thesis has significantly increased our knowledge 
of equine macrophage biology, particularly that of AMs. Tissue-dependent 
heterogeneity of macrophage function and phenotype was detected and has formed 
an appropriate platform of knowledge on which future studies can be based. 
Moreover, novel and valuable information on the effect of race training on AM gene 
expression could contribute to the overall knowledge base on the potential 
mechanisms, which may be involved in promoting susceptibility to exercise-
associated pulmonary inflammation, such as equine IAD. The inter-species 
comparative data have provided support for the potential role of the horse as a 
suitable model for studies on human macrophage biology. The completion of the 
equine genome annotation would provide a major tool for future transcriptomic horse 
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Chapter 5: Appendices 
All Excel files contained in CD on inside back cover. 
5.1 Appendix I 
 
Primer Name Standard curve equation Pearsons 
Correlation 
Efficiency (%) 
TNFα  Y= -3.623 * LOG(X) + 19.99 0.945 99.8 
IDO  Y= -3.374 * LOG(X) + 22.55 0.972 97.9 
STAT 4  Y= -3.404 * LOG(X) + 21.43 0.960 97.7 
IL7R  Y= -3.582 * LOG(X) + 26.81 0.998 90.2 
CYP27B1   Y= -3.208 * LOG(X) + 25.61 0.922 105.0 
TNIP3 Y= -3.590 * LOG(X) + 24.12 0.928 108.3 
18S  Y= -3.607 * LOG(X) + 9.12 0.977 90.3 
 
5.2 Appendix II 
S1- Genelist of 451 transcripts differentilly expressed between AMs and PMs 
S2 - Putative annoation of equine uncharacterised proteins across the human genome 
in Enesembl 
S3 - Top clusters of genes more highly expressed in AMs 
S4 - Top clusters of genes more highly expressed in PMs 
 
5.3 Appendix III 
S1- Genelist of LPS treated AMs 
S2 - Top five clusters of genes upregulated in AMs after LPS treatment 
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S3 - Top five clusters of genes downregulated in LPS treated AMs 
S4 - Genelist of LPS treated human AMs 
 
5.4 Appendix IV 
S1 - Top five clusters of genes more highly expressed at T0 
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